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Abstract 
Loss or dysfunction of GABAergic inhibitory neurons is involved in many neurological disorders, 
including epilepsy. Transplantation of GABAergic neuron progenitors in rodent models of 
epilepsy significantly reduces seizure occurrence and duration. Therefore, transplantation of 
GABAergic neuron progenitor of human origin is being considered as a potential therapy for 
drug resistant epilepsy. 
The microenvironment plays an important role in regulating survival, proliferation and 
differentiation of neuronal stem cells. Evidence shows an inflamed microenvironment with 
significant upregulation and secretion of inflammatory cytokines after seizures. Whilst the major 
emphasis to date has been on generating the optimal cell types for cell therapy in epilepsy, there 
has been little attention paid to the effects of the neuroinflammatory environment into which 
cells will be delivered.  
In this study, it is found that in a 3D model of human adult neural tissue excised at epilepsy 
surgery, the inflamed microenvironment reduced the survival, impaired neurite growth, and 
differentiation of in-vitro transplanted hESC-derived MGE progenitors. IL-1β was recognized as 
an important pro-inflammatory cytokine which affected the survival and differentiation of hESC-
derived MGE progenitors in this model. Restored differentiation and promotion of neurite growth 
was observed in MGE progenitors by blocking the IL-1R. 
Further experiments in monolayer cultures on electrophysiology found MGE-like neurons were 
less excitable after acute exposure to IL-1β. The mechanism was due to reduction in sodium 
current rather than alternation in channel activation or inactivation kinetics. And this effect was 
not persistent when level of IL-1β returned to normal concentration. But when repetitively treated 
by IL-1β for a week, MGE-like neurons became unhealthy and their excitability reduced even 
more.  
In conclusion, the inflamed microenvironment, especially IL-1β is detrimental for survival, 
differentiation and electrophysiological activities of transplanted MGE-like neurons in this in-
vitro primary human tissue model. The results suggest anti-inflammatory treatment could be 
beneficial to improve efficiency of neuron transplantation therapy. The results also potentially 
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imply that neuroinflammation may cause a reduced excitability of interneurons as a potential 
mechanism for epilepsy. 
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1. Introduction 
1.1 Neuropathology in epilepsy 
1.1.1The etiology of epilepsy 
Epilepsy affect millions of people in the world and half of patients with chronic epilepsy suffer 
from cognitive or psychiatric disorders such as learning and memory deficits, anxiety and 
depression. Epilepsy can be classified into two categories by etiology. One is acquired epilepsy 
which caused by stroke, brain trauma, infection, medication etc. The other is idiopathic epilepsies 
caused by genetic mutations or undiscovered genetic deficits. Thanks to fast development of 
gene sequencing, so far, the researchers have identified 977 genes related with epilepsy (Wang, 
Lin et al. 2017). The most common epilepsy genes are mutations in ion channels, synaptic 
receptors and enzyme/enzyme-modulators. Several decades of exploration have established the 
idea that the mutation which cause an imbalance between inhibitory and excitatory conductance 
lead to seizures. Functional shifts in the balance between inhibition and excitation arising from 
abnormal synaptic plasticity could transform high but normal levels of network activity into 
epileptic events (Staley 2015). The long-term histological and cellular change of circuity can 
gradually lead to the imbalanced shifts. Therefore, the pathological changes in neurons, circuits 
and microenvironment together lead to epileptogenesis and the subsequent development of the 
epileptic state.     
1.1.2 Pathology of Temporal Lobe Epilepsy (TLE) in hippocampus 
Temporal lobe epilepsy (TLE) is one of the most common forms of epilepsy. All patients with TLE 
suffer from chronic seizures. TLE usually arises from the hippocampus or hippocampal formation, 
where chronic abnormalities are detected in histology, and at cellular and molecular levels 
(Vezzani, Aronica et al. 2013). 
1.2.2.1 Hippocampus sclerosis  
Hippocampus sclerosis (HS) is the pathological in size and volume of hippocampus resulted from 
seizure induced severe neuron loss, abnormal neurite growth and distribution and gliosis. It has 
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been observed in about 90% of operated cases in patients with chronic TLE (de Lanerolle, Kim et 
al. 1989, Thom, Sisodiya et al. 2002).  
The hippocampus is composed of 4 subfields: CA1, CA2, CA3, and CA4, including the dentate 
gyrus (DG). DG consists of three layers: the molecular layer, the granular layer, and the 
polymorphic layer (hilus) and is the only region, except for sub ventricular zone (SVZ), which 
supports adult neurogenesis (Goncalves, Schafer et al. 2016). Researchers have found three main 
pathological changes of DG in HS: loss of neurons; impaired neurogenesis (Bengzon, Kokaia et 
al. 1997, Gray and Sundstrom 1998, Barkas, Redhead et al. 2012) and formation of new recurrent 
excitatory circuits (Dudek and Sutula 2007, Goldberg and Coulter 2013). What’s more, the 
histological are not restricted to DG, the neuron loss and gliosis also exist in the subfields of CA1 
to CA3, and even extend to extrahippocampal tissues, such as the amygdala and para-
hippocampal gyrus (Thom 2014). Two third of the patients with TLE recovered become seizure 
free after surgical removal of HS (Salanova, Markand et al. 2002), suggesting the critical role of 
hippocampal sclerosis in generating epileptic seizures.  
Granule cell dispersion (GCD) 
GCD in the dentate gyrus is a frequent feature and occurs in 45.5% of hippocampal specimens 
from 66 patients with TLE (da Costa Neves, Jardim et al. 2013). 
In normal hippocampus, the cell bodies of granule cells located in the granule layer form a 
uniform pattern. In HS, the bodies of granule cells form a thicker layer with disrupted order in 
clusters or bi-laminar structures in the granule layer and appear in ectopic regions such as the 
molecular layers and hilus (Parent, Yu et al. 1997). A study based on resected hippocampus from 
patients with TLE showed that GCD in sclerotic hippocampus is caused by an abnormal migration 
of mature granule cells along a radial glial scaffold (Fahrner, Kann et al. 2007). Similarly, in the 
kainic acid (KA) induced epilepsy model, the time lapse uncovered the surviving cell changed the 
dendrite organization and translocated the cell body into an apical dendrite, expending its 
innervation territory as the compensation for neuron loss (Chai, Munzner et al. 2014). 
Except for aberrant migration, the differentiation of granule cells is also affected during GCD. 
Calbindin is expressed by mature granule cells, it is essential for long-term potentiation and 
synaptic plasticity which are the cellular basis of learning and memory (Abraham, Veszpremi et 
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al. 2009). Loss of calbindin expression in granule cells has been found in samples of most TLE 
patients (Magloczky, Halasz et al. 1997), and clinical evidence support its association with memory 
dysfunction in TLE patients (Karadi, Janszky et al. 2012).  
Granule cells participate in spatial memory formation by receiving synaptic input from the 
entorhinal cortex via the perforant path and play an important role in long-term potentiation 
and long-term depression by delivering synaptic output to CA3 and CA1.  Clinical research shows 
that the presence of GCD in right sided hippocampal sclerosis is correlated with worse 
visuospatial memory performance (Neves, de Souza Silva Tudesco et al. 2012).  
Mossy fiber sprouting (MFS) 
In normal hippocampus, the dendrites of granule cells are in the molecular layer, and the cell 
bodies form the granule cell layer. The axons of granule cells go through the hilus, forming 
synaptic connection with mossy cells, CA3 pyramidal neurons and interneurons. The axon fiber 
gives rise to large presynaptic swellings at its terminal, which look like giant mossy boutons as 
seen by electron microscopy, thus called mossy fibers.  
In sclerotic hippocampus, the mossy fibers extend into the molecular layer and granule layer, 
forming exclusively asymmetric, putatively excitatory synapses with dendritic spines and the soma 
of granule cells, which create a recurrent excitatory input with a potential to stimulate 
synchronized hyperactivity of neuronal networks (Frotscher, Jonas et al. 2006).  
The MFS is triggered by seizure activity and neuron loss. The mature granules cells contribute to 
MFS at early stage, 4-9 days after induced seizures in mice (Mello, Cavalheiro et al. 1993), but 
the new born neurons from SGZ also give rise to similar mossy fibers when they are functionally 
excitable (Restivo, Niibori et al. 2015). The development of MFS could be suppressed by constant 
application of rapamycin before and after induced seizures (Buckmaster, Ingram et al. 2009, Zeng, 
Rensing et al. 2009). Application of rapamycin after induced seizures, reduced seizure frequency 
(Zeng, Rensing et al. 2009). In contrast, preventing MFS by cycloheximide did not work on 
spontaneous recurrent seizures (Longo and Mello 1999). Mice model showed that MSF reached 
a plateau 100 days after induced seizures (Mello, Cavalheiro et al. 1993). As for human, MFS 
become a permanent change even after seizure were well controlled (Thom, Martinian et al. 
4 
 
2009). So, it is still hard to decide whether MFS promotes epileptic seizure in all TLE cases 
(Buckmaster 2012). 
Seizure-generated cells 
The new born neuron generated after seizure adopt abnormal identity, morphology and 
electrophysiological functions. Neuronal hyperactivity induced by seizures activate the radial glia 
cells the majority of which differentiate towards reactive astrocyte instead of neurons (Sierra, 
Martin-Suarez et al. 2015, Shtaya, Sadek et al. 2018). And even the seizure-born neurons have 
distinct excitability performance due to the heterogenous morphology. The majority new-born 
neurons have reduced spine number, suggesting reduction in excitability. A significant subset 
shows enlarged cell bodies, long basal dendrites and received more mossy fiber input, implying 
those cells robustly integrated into the pathological circuit (Murphy, Pun et al. 2011).  
Given that abnormal neurogenesis produces either defects in newly born granule cell neurons or 
glial cells, suppressing abnormal neurogenesis turns out to be a therapeutic target for epilepsy. 
Conditional ablation of neuron stem cells in the hippocampus before pilocarpine-induced acute 
seizures reduced the frequency of seizure and restored cognition deficiencies in mice (Cho, 
Lybrand et al. 2015). In chronic epilepsy, neurogenesis is reduced in contrast to rapid increase in 
neurogenesis in the acute phase (Shtaya, Sadek et al. 2018). Overproduction of seizure-born cells 
in the acute phase depletes the stem cell niche in the SGZ, eventually leading to memory loss 
and cognitive deficit (Sierra, Martin-Suarez et al. 2015).  
1.2.2.2 Selective Interneuron loss and dysfunction 
Early research has shown significant reduction of interneurons and principal neurons in sclerotic 
hippocampus of TLE patients (Dam 1980, de Lanerolle, Kim et al. 1989), especially in the dentate 
hilus. The sub granular population of Somatostatin (STT) expressing interneurons is nearly 
completely lost in TLE patients (de Lanerolle, Kim et al. 1989). 
Neuron loss is caused by seizure induced neuron necrosis and apoptosis. The necrosis is 
mediated by excitotoxicity due to high glutamate levels, excessive Na+ and Ca2+ and cellular free-
radical production and inflammatory mediators in the microenvironment (Aktas, Ullrich et al. 
2007, Vezzani, Aronica et al. 2013, Vezzani and Viviani 2015). The apoptosis is caused by intrinsic 
mitochondrial dysfunction induced activation of Bcl-2 and Caspase families and the extrinsic 
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activation of cell surface receptors which deliver the programmed cell death signaling (Henshall 
2007).  
Hippocampal interneurons originate from the same region as cortical interneurons, the MGE and 
CGE area of ventral telencephalon. The inducible fate mapping of MGE and CGE derived 
interneuron revealed interneuron progenitors migrate to hippocampus from E14.5–E18. CGE-
derived interneurons (CR-, CCK- and VIP-expressing) primarily distribute in superficial layers of 
the hippocampus especially in stratum lacunosum moleculare and deep stratum radiatum, while 
MGE-derived interneurons (PV-, STT-and NPY-expressing) are distributed through all layers 
(Thom, Martinian et al. 2009).  
Interneuron migration significantly decreases after birth (Thom, Martinian et al. 2009). Therefore, 
unlike granule cells loss being potentially replaced by newly born neurons, the loss of 
interneuronS is likely permanent. The GABAergic interneurons have diverse functions correlated 
with distinct subtypes in hippocampal networks, including regulating network excitability, 
controling network synchronization, modulating neurogenesis (proliferation, migration and 
maturation) and supporting memory consolidation. The functional alterations in relation to 
cellular, network changes and epileptogenesis, can be closely correlated with histological 
changes in interneuron subgroups (Thom 2014). 
STT-expressing interneurons 
In DG, STT positive interneurons take up 50% of total interneuron population in hilus, innervating 
the most prominent territory in the molecular layer of DG, where the fibers of the perforant path 
terminate (Katona, Acsady et al. 1999). Serving as modulators between perforant path and 
granule cells, STT positive neurons also have a feedback circuit with granule cells (Katona, Acsady 
et al. 1999). Selective loss of STT positive interneurons has been observed in both animal models 
of TLE and HS in patients with TLE, implying the STT positive interneurons are vulnerable in 
response to pathological microenvironment of sclerotic hippocampus (Sloviter 1987, de Lanerolle, 
Kim et al. 1989, Buckmaster and Dudek 1997). Meanwhile, the surviving STT positive interneurons 
have enlarged cell bodies with extended innervation territory formed by overgrowth of dendrites 
and axons and more synaptic connections with granule cells, as a possible compensation for 
neuron loss (Zhang, Yamawaki et al. 2009).  
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PV-expressing interneuron 
The PV-expressing interneurons are usually in the granule cells, forming synaptic input with 
somata, proximal dendrites, and axon initial segments of granule cells. Although the PV-
expressing neurons are lower in number compared with STT-expressing neurons in hippocampus 
and have no significant reduction in number after seizures, when STT-expressing neurons were 
lost in rat model with kainate induced epilepsy, PV-expressing neurons provide robust inhibitory 
synaptic output which compensate the loss of STT-expressing neurons (Buckmaster and Dudek 
1997). Therefore, the PV-expressing neurons are the major type of interneuron suppressing the 
hyperexcited neuron circuit. Besides, peri somatically targeted PV-expressing neurons are 
essential for generating gamma oscillations which is critical for cognition functions including 
memory formation and sensory processing (Bartos, Vida et al. 2007), implying the dysfunction of 
PV expressing neurons may lead to cognitive and psychiatric disorders found in TLE. Except for 
the inhibitory effect, the PV-expressing neurons have a special function of regulating adult 
neurogenesis in hippocampus. Activation of PV-expressing interneurons promotes survival and 
proliferation of newborn neurons at critical stage of adult hippocampal neurogenesis in sub 
granule zone (SGZ) (Song, Sun et al. 2013, Zaben et al 2009). Although the PV-expressing 
neurons form direct synaptic contacts with new born neurons, the effect could come through 
circuity modulation (via neuropeptide VIP mediated neurotransmission (Zaben et al 2009) or 
releasing growth factors other than GABA (Song, Sun et al. 2013).  
Calretinin and reelin-expressing interneuron 
Calretinin and reelin-expressing interneurons are all derived from CGE origin and distribute 
mainly in the superficial layer. The calretinin expressing interneurons target not only the principal 
neurons but also the interneuron population. The disinhibition function of calretinin expressing 
interneurons is essential for synchronization within interneuron population. The number of 
calretinin-expressing interneurons significantly decreased in relation with the principal cell loss 
in excised HS tissue from patients with TLE (Toth, Eross et al. 2010). Besides, surviving calretinin 
expressing interneurons in HS formed dramatical had less connections with other calretinin 
expressing interneurons (Toth, Eross et al. 2010). The dysfunction of interneuron synchronization 
due to calretinin expressing interneuron loss and reorganization could lead to pro-epileptic 
activities.   
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Reelin protein in extracellular matrix maintains the layered structure of hippocampus and controls 
neuronal migration partially by acting on the radial glial scaffold required for neuronal grafting 
(Frotscher, Haas et al. 2003). KA application caused decreased expression of reelin, particularly in 
hilar interneurons (Chai, Munzner et al. 2014). Reelin distribution affects the migration of both 
newly born neurons and the mature granule cells. In the absence of neurogenesis, dysfunction 
in reelin cause displacement of mature neurons which is relevant to the development of Granule 
Cell Dispersion. While exogenous application of reelin prevented abnormal migration in GCD 
(Haas and Frotscher 2010).  
In summary, all types of hippocampal interneurons contribute to the delivery of inhibitory 
synaptic output and to maintaining the balance between excitation and inhibition. Meanwhile, 
dysfunction and/or loss of certain subtypes is correlated with distinct pathology encompassing 
abnormal neurogenesis, ectopic migration and network synchronization, in the sclerotic 
hippocampus.   
1.1.3 Neuroinflammation in TLE 
1.1.3.1 Inflammation in CNS 
With increasing understanding of the immune response towards injury, infection and 
neurological diseases in CNS, the inflammatory microenvironment has been found to affect cell 
survival, neurogenesis, neuronal integration and migration, which are relevant to the 
development of brain diseases in CNS (Toulmond, Parnet et al. 1996, Belarbi and Rosi 2013).  
Microglia are the resident cells contributing most to the inflamed microenvironment. In response 
to pathogen-associated or damage-associated molecules, microglia are activated and 
transformed to different phenotypes, secreting inflammatory mediators including pro-and anti-
inflammatory cytokines, complement and reactive oxygen species (Allan, Tyrrell et al. 2005, 
Belarbi and Rosi 2013). They also recruit inflammatory cells like monocytes and macrophages 
from the circulation to injured brain area. Apart from microglia, nearly all endogenous brain cells 
in CNS can release inflammatory mediators, especially in chronic phases even the neurons and 
astrocytes participate in maintaining the inflammatory microenvironment (Allan, Tyrrell et al. 
2005).  
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It is hard to determine if the function of inflammatory cytokines are beneficial or detrimental in 
CNS. At the acute phase after brain injury cell of the innate and adaptive immune systems are 
activated and release inflammatory mediators to remove lethal pathogens and damaged tissue. 
At later stages, activated microglia can acquire distinct phenotypes, which either support or 
interfere with processes of neuron stem cell renewal needed for neurogenesis. In the persistent 
and chronic stage, the inflamed microenvironment usually undermines recovery of brain damage 
(Vezzani, Aronica et al. 2013, Xanthos and Sandkuhler 2014). Neuroinflammation also involves 
cooperation between local and peripheral immune cells and complex stimulating or inhibiting 
downstream signals received from various cytokines. A lot of effort has been made to elucidate 
the mechanism of neuroinflammation in different rodent models and cell culture models, the 
results are various due to applying timing, dosage and duration of inflammatory stimulators 
(Strijbos and Rothwell 1995, Vezzani, Conti et al. 1999, Diem, Hobom et al. 2003, Fogal, Hewett 
et al. 2005, Hewett, Jackman et al. 2012, Dey, Kang et al. 2016). The inflammatory cytokines such 
as TNF-α, IL-1β, IL-16 etc which are significantly upregulated in pathological conditions have 
been heavily studied as the potential anti-inflammatory targets for CNS diseases.  Although the 
research has demonstrated positive outcomes in rodent models of CNS diseases, due to the 
complex mechanism of neuroinflammation the clinical translation of anti-inflammatory therapy 
for CNS diseases is still under investigation.  
1.1.3.2 Neuroinflammation and abnormal neurogenesis in TLE. 
Hippocampal neurogenesis is consistent throughout life (Shors, Miesegaes et al. 2001). In adult 
humans, 700 new neurons are added per day and the vast majority of dentate gyrus neurons in 
hippocampus are subject to exchange postnatally (Spalding, Bergmann et al. 2013). The neuron 
stem cells exist in the SGZ of the DG. These stem cells can divide asymmetrically to produce one 
daughter progenitor cell and one stem cell. The progenitor cell can then divide asymmetrically 
and give birth to daughter cells that differentiate into either astrocytes or neurons (Kohman and 
Rhodes 2013). Hippocampal neurogenesis is regulated by the microenvironment in the 
neurogenic niche. The immune system is the most important factor in the microenvironment 
which regulates neurogenesis in neurogenic niche by releasing different inflammatory cytokines. 
Evidence suggests that in healthy hippocampus the inflammatory cytokines secreted by immune 
cells participate in maintaining normal neurogenesis (Kokaia, Martino et al. 2012). However, in 
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the pathologically inflamed brain microenvironment, neurogenesis is suppressed and is related 
with memory loss, cognition deficiency and behavior abnormalities. For example, reduced 
proliferation of neural progenitor cells and accumulated non-migratory neuroblasts have been 
observed in the neurogenic niche of SVZ in persistent brain inflammation (Pluchino, Muzio et al. 
2008).  
Abnormal hippocampal neurogenesis has been observed in epilepsy (Cho, Lybrand et al. 2015, 
Shtaya, Sadek et al. 2018). Accumulated evidence suggests cytokines which are upregulated in 
TLE, such as IL-1β, TNF-α, INF-γ (Butovsky, Ziv et al. 2006), could increase proliferation of neuron 
progenitor cells. But increased proliferation in acute phase of neuroinflammation does not 
necessarily compensate neuron loss in epilepsy. Because in the inflamed hippocampus, the 
proportion of new-born radial-glia-like NPCs instead of neuroblasts significantly increases in the 
SGZ of the dentate gyrus (Giannakopoulou, Grigoriadis et al. 2013), therefore the differentiation 
of neuronal cells decreases despite an increase in cell proliferation. And not all new-born neurons 
are able to develop into mature neurons and cooperate in the local network, around 70% new-
born neurons will be eliminated (Chesnokova, Pechnick et al. 2016). So early increase in 
proliferation will deplete storage of neuron stem cells in SGZ and suppress hippocampal 
neurogenesis in chronic epilepsy. Evidence suggested that administration of LPS into rat 
hippocampus activated microglia and strongly impaired basal hippocampal neurogenesis (Ekdahl, 
Claasen et al. 2003). While inflammatory blockade prevented reduction of neurogenesis in adult 
hippocampus (Monje, Toda et al. 2003).  Therefore, understanding the relationships between the 
inflamed microenvironment and abnormal neurogenesis will be critical to develop therapeutic 
strategies.   
1.1.4 IL-1 family and signaling pathway 
Interleukin-1 (IL-1) is a large family of cytokines which mediate innate immune responses during 
acute brain injury as well as chronic neurological and neurodegenerative diseases. The IL-1 family 
has 11 family members (IL-1F1 to IL-1F11), and they are encoded by 11 distinct human genes 
(Figure 1-1 A). Among all IL-1 family members, IL-1α (IL-F1) and IL-1β (IL-1F2) has been heavily 
investigated due to their importance in inflammatory diseases. They have similar biological effects 
by activating the IL-1 receptor-mediated signalling pathway. But IL-1α is only released after cell 
death, while IL-1β is secreted into the bloodstream by living cells (Dinarello 2009). IL-1RA (IL-
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1F3) is an antagonist for IL-1α and IL-1β, but in most inflammatory syndrome, IL-1RA is usually 
produced at the later stage and has an anti-inflammation effect by antagonizing IL-1α or IL-1β. 
Other members such as IL-18 (IL-1F4), IL-33 (IL-1F11), IL-36 (IL-1F6) have a similar 
proinflammatory function as IL-1α and IL-1β. The different members of the IL-1 family play an 
essential role in many autoinflammatory diseases. 
Correspondingly, the IL-1R family has also expanded to 9 distinct genes and includes coreceptors 
(IL-1RAcP), decoy receptors (IL-1R2), and inhibitory receptors (IL-1RAcPb) (Figure 1-1 A). 
Receptor IL-1R1 is the primary receptor which delivers a downstream signal when binds with its 
ligands. IL-1RAcP is the coreceptor which is recruited after IL-1β or IL-1α binding with IL-1R1. 
IL-1R2 is lack of intercellular domain, therefore, is incapable of activating the downstream signal. 
In the brain and spinal cord, the variant IL-1RAcPb can form the heterodimeric complex with IL-
1or IL-1 and IL-1RI, but this complex fails to recruit MyD88, and there is inhibition of the IL-1 
signal (Figure 1-1 A).  
The most important pathway follows activation of IL-1 receptors is similar as activation of Toll-
like receptor (TLR) which recognise a diverse number of bacterial products, nucleic acids, and 
possibly some endogenous lipoproteins (Figure 1-1 B). Because the intercellular segment of IL-
1 receptor shares similar structure as the TLR receptor, which is also called Toll-IL-1 receptor 
(TIR), both receptor recruit MyD88 as the first step after activation (Dinarello 2011). At its 
downstream, tumour necrosis factor-associated factor 6 (TRAF6) is activated. Then TRAF6 and 
phosphorylated IRAK1 and IRAK2 dissociate and migrate to the membrane to associate with TGF-
β-activated kinase 1 (TAK1) and TAK1-binding proteins TAB1 and TAB2. And This is the critical 
point where the inflammatory signalling pathway coming from TNF-α and TGF-β are merged 
with the IL-1 pathway.  Phosphorylated TAK1 activated the inhibitor of nuclear factor kappa-B 
kinase subunit beta (IKKβ) and activated IKKβ phosphorylates the nucleus factor kappa-B inhibitor 
(IκB) which gets degraded, so that nucleus factor kappa-B kinase (NF-κB) is released and migrates 
to the nucleus. TAK1 can also activate mitogen-activated kinases (MAPK) p38, c-Jun N-terminal 
kinases (JNK) and extracellular signal-regulated kinases (ERK) by activating MAP kinase (MKK) 
proteins (Acuner Ozbabacan, Gursoy et al. 2014) (Figure 1-1 B). Except for this popular pathway, 
there is also evidence suggesting TIR receptor actives PI3K-Akt pathway (Figure 1-1 B) which is 
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also at the downstream of IL-6, another important cytokine massive releases in inflammatory 
syndrome (Diem, Hobom et al. 2003).  
The activation of transcription in the nucleus will produce many bioactive proteins which have 
multiple effects on survival, differentiation, growth, secretion and functional state of the cells. 
Meanwhile, the production of IL-1β can further increase as one of the consequences (Figure 1-
1 C). The IL-1β precursor is first released from nucleus to cytoplasm in a non-functional state. 
Then IL-1β precursor is cleaved by caspase-1 which is one of the inflammasomes also produced 
from nucleus transcription in secretory lysosome (Weber, Wasiliew et al. 2010, Grishman, White 
et al. 2012). In this way, the active IL-1β finally be transported outside the cells.  Immune cells 
such as monocytes and macrophages contribute to the early production of IL-1β. All endogenous 
brain cells including microglia, astrocytes and neurons could secrete IL-1β at a later stage after 
brain insults (Allan, Tyrrell et al. 2005). Therefore, elevated levels of IL-1β can accumulate in 
chronic epilepsy. Also, the function of IL-1β is not merely restricted by itself. For example, HMGB1 
which is secreted at the later stage after brain injury could enhance the effect of IL-1β through 
the formation of complexes with IL-1β (Wähämaa, Schierbeck et al. 2011). In this scenario, the 
strength of IL-1 receptor activation can increase about 100-fold.   
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1.2 Cortical interneurons 
Cortical interneurons comprise 20 - 30% of the total neuron population in the central neuron 
system (CNS). Unlike the principal neurons which propagate the excitatory signals, most 
interneurons connect with the surrounding neurons, releasing inhibitory neurotransmitters such 
Figure 1-1 IL-1 family and signaling pathway 
A) IL-1 family has 11 family members, including pro- inflammatory cytokines (IL-1α, IL-1β) and anti-inflammatory cytokine 
(IL-1RA). Correspondingly, the IL-1R family has also expanded to 9 distinct genes and includes coreceptors (IL-1RAcP), decoy 
receptors (IL-1R2), and inhibitory receptors (IL-1RAcPb). B) The most important pathway follows activation of IL-1 receptors 
is similar as activation of Toll-like receptor (TLR), because the intercellular segment of IL-1 receptor shares similar structure 
as the TLR receptor, which is also called Toll-IL-1 receptor (TIR). Once activated, the downstream of IL-1 pathway converges 
with signal coming from other pro-inflammatory cytokines, such as TNF-α TGF-β and IL-6. C) The production of IL-1β can 
further increase as one of the consequences when the transcription is activated in nucleus. The IL-1β precursor is first released 
from nucleus to cytoplasm in a non-functional state. Then IL-1β precursor is cleaved by caspase-1 which is one of the 
inflammasomes also produced from nucleus transcription in secretory lysosome. 
13 
 
as GABA, modulating the transmission of excitatory signals and regulating the balance of the 
neuronal circuit activities. Cortical interneurons also serve a vital role in neurogenesis which 
modulate neuronal proliferation and differentiation during pre-and post-natal CNS development 
(Le Magueresse and Monyer 2013).  
1.2.1 The heterogeneity of cortical interneurons  
Most cortical interneurons are born in the subpallial ganglionic eminence (GE) during prenatal 
CNS development (Anderson, Eisenstat et al. 1997, Hansen, Lui et al. 2013). Distinct subtypes of 
cortical interneurons originate from discrete areas of the subpallial GE (Gelman, Martini et al. 
2009, Miyoshi, Hjerling-Leffler et al. 2010, Kepecs and Fishell 2014). The heterogeneity of 
interneurons is achieved by the acquisition of different properties such as morphology, molecular 
targeting, synaptic transmission and physiological characters. (De Marco Garcia, Karayannis et al. 
2011). Dysfunction or loss of specific types of interneuron is closely related to different CNS 
disorders, including epilepsy, autism and schizophrenia (Nakazawa, Zsiros et al. 2012, Le 
Magueresse and Monyer 2013, Hunt and Baraban 2015).  
During last decades, a lot of effort has been made to elucidate the relationship between 
heterogeneity of cortical interneurons and their correlated morphology, molecular and 
electrophysiological properities (Petilla Interneuron Nomenclature, Ascoli et al. 2008, Kepecs and 
Fishell 2014).  
1.2.2 The genetic development of cortical interneurons  
The subtypes of cortical interneurons are initially being determined by intrinsic expression of 
regional gene markers at temporal developmental stages when the cells are born in ventral 
telencephalon; which consists of three distinct progenitor zones, the lateral, medial, and caudal 
ganglionic eminences (LGE, MGE, and CGE). MGE has been recognized as the specific region 
where around 70% to 80% GABAergic interneurons are produced. Genetic fate mapping studies 
revealed that the CGE also contributes to 30% of cortical interneurons in the adult mouse (Miyoshi, 
Hjerling-Leffler et al. 2010). LGE has been considered as the factory for striatal interneurons and 
only gives rise to a small number of cortical interneurons (Wonders and Anderson 2006).  
Nkx 2.1 is most representative regional transcriptional markers for MGE and ventral CGE. It is the 
initial specification gene which promote the differentiation of parvalbumin (PV), somatostatin 
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(STT) and neuropeptide Y (NPY) expressing interneurons (Butt, Sousa et al. 2008). Nkx 2.1 also 
inhibits the possibility of becoming dorsal CGE-like interneurons which are dominated by 
expression of Coup TFⅡat the progenitor stage and eventually become Calretinin, Vasoactive 
Intestinal Polypeptide (VIP) and Reelin expressing interneurons (Fogarty, Grist et al. 2007). Other 
genetic makers such as homeobox gene DLX1/2, Gsh2, Olig2, Mash1 are pan-GE makers and 
participate in encoding the GABAergic lineage together with the specific regional makers. When 
interneuron progenitors are fully developed within MGE and CGE, the cells exit the cell cycle and 
start to migrate under control of DLX1/2, towards their destined layers in neocortex and 
hippocampus. The genetic subgroups of interneurons have been determined by the location and 
birth date at progenitor stage before the cells migrate to achieve morphological and 
physiological maturation. Even the interneuron progenitors which do not express specific genetic 
makers when they become post mitotic neurons, taking several weeks for maturation during 
migration, their fate does not change by the factors encountered in migration (Wonders and 
Anderson 2006). Therefore, it become critical to understand the regulation genes and 
biochemicals which contribute most to specify the subtypes of cortical interneuron during 
embryonic development  
Conditional knockdown and fate mapping of specific genes uncovered the genetical 
development of cortical interneurons in sequence (Anastasiades and Butt 2011). The proneuronal 
gene Mash 1 in ventral telencephalon induces the expression of DLX1/2 which marks the origin 
of GABAergic lineage (Anderson, Eisenstat et al. 1997, Castro, Martynoga et al. 2011). Expression 
of Nkx 2.1 restricts the future regional identity of cells within MGE origin (Butt, Sousa et al. 2008). 
The post-mitotic marker Lhx6 is expressed under control of Nkx2.1 and finally gives rise to PV 
and STT positive interneurons (Flandin, Zhao et al. 2011). In  Lhx6 absent regions, or with 
conditional knock down of Lhx6, calretinin expressing interneurons become the major subtype. 
Sox6, the downstream transcriptional factor of Lhx6 is also involved in subtype specification when 
the interneuron progenitors exit the cell cycle (Batista-Brito, Rossignol et al. 2009). Loss of Sox6 
does not affect the total number of GABAergic neurons but results in a significant reduction of 
MGE-derived early born interneurons (PV and STT expressing) and correspondingly causes a 
significant increase of NPY expressing neurons, which are born later during embryonic 
development (Azim, Jabaudon et al. 2009). 
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As for CGE-derived lineage, the ventral CGE shares similar regional specification genes with MGE. 
But dorsal CGE has distinct regional gene markers. Coup TFII is preferentially expressed in dCGE, 
regulating together with Sp8 which is expressed in one fifth of cortical interneurons, promote the 
growth of Reelin, VIP, NPY, and Calretinin expressing interneurons (Miyoshi, Hjerling-Leffler et al. 
2010, Ma, Zhang et al. 2012, Reinchisi, Ijichi et al. 2012, Hansen, Lui et al. 2013). 
The genetic subtypes of cortical interneuron are closely related with their laminar positions in 
cortex. The MGE-derived PV/STT positive neurons are usually found in  layer IV to VI, while the 
dCGE-derived calretinin, NPY and reelin positive neuron prefer to stay in the superficial layer I to 
III (Flandin, Zhao et al. 2011, Ma, Zhang et al. 2012). Likewise, the synaptic function, morphological 
and electrophysiological properties of different cortical interneuron subgroups are also partly 
determined by the genetic features. PV-expressing interneurons which are also called basket or 
chandelier cells based on their morphology, target the soma of projection neurons and are 
usually fast spiking neurons (Cauli, Audinat et al. 1997); STT-expressing interneurons also called 
Martinotti cells, target the dendrite of projection neurons and are usually late or regular spiking 
neurons (Kawaguchi and Kubota 1996, Tamas, Lorincz et al. 2003); VIP and Calretinin expressing 
interneurons which demonstrate bipolar shape and burst spiking electrophysiological activity 
have a specially disinhibition function by suppressing activity of other interneurons (Kawaguchi 
and Kubota 1996); nNOS expressing interneurons also called neurogliaform cells are late spiking 
neurons and are responsible for the slow GABAergic inhibition of projection neurons and 
interneurons (Tamas, Lorincz et al. 2003, Karagiannis, Gallopin et al. 2009, Kepecs and Fishell 
2014). While NPY expressing interneurons have been classified into three major subgroups, 
neurogliaform-like neurons, Martinotti-like cells and a fast-spiking subgroup which co-express 
PV (Karagiannis, Gallopin et al. 2009). But due to the diversity of interneurons, there is no 
classification system which can exclusively anticipate the function of a certain interneuron 
phenotype. For example, there are at least 3 type of PV expressing interneurons, and at least two 
different subgroups of STT expressing interneurons (Kepecs and Fishell 2014). Recent research 
has found another specialized GABAergic neuron subtype called “rosehip” cells (GAD1+CCK+) 
(Boldog, Bakken et al. 2018). Those rosehip cells are in layer 1 and target apical dendritic shafts 
of layer 3 cortical projection neurons (Boldog, Bakken et al. 2018). With the development of an 
understanding of interneurons subtypes, the function of interneurons in different genetic 
subtypes will be clearer in the future. 
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1.2.3 The function of cortical interneurons in CNS 
The major function of inhibitory interneurons is regulating neuronal network activity by releasing 
inhibitory neurotransmitter GABA. GABA is synthesized by glutamic acid decarboxylase (GAD) 
which is present only in GABAergic interneurons not excitatory neurons. Pre-synaptic release of 
GABA activates ionotropic post synaptic GABA type A (GABAA) receptors to increase permeability 
of chloride and bicarbonate ions in the mature neurons. 
Apart from regulating neuronal network excitability, the cortical interneurons also play an 
important role in pre-and post-natal neurogenesis, neuron migration and maturation. GABA 
release controls the proliferation and differentiation of neuron precursors (Represa and Ben-Ari 
2005). During cortical neurogenesis, GABA can activate GABAA receptors to prevent the 
proliferation of cortical progenitors (LoTurco, Owens et al. 1995, Antonopoulos, Pappas et al. 
1997), leading to an increased number of differentiated neurons (Antonopoulos, Pappas et al. 
1997). GABA also promotes the migration of glutamatergic neurons and GABAergic interneurons 
during embryonic development and directs the cells to stop migration at their destined laminar 
positions in cortex by hyperpolarization (Bortone and Polleux 2009, Inamura, Kimura et al. 2012).  
In the mature CNS, cortical interneurons are also critical for memory consolidation. The negative 
regulation of GABA signaling which inhibits the proliferation of newborn synapsis while 
promoting maturation of remaining nascent synapse, is a vital process for memory formation 
(Wu, Fu et al. 2012). Repression of the activity of PV positive interneurons in the hippocampus 
impaired augmented sleep-associated oscillations and stabilization of functional connectivity 
patterns in CA1 neurons and causes deficits in memory consolidation (Ognjanovski, Schaeffer et 
al. 2017).  
Since the inhibitory interneurons consistently and dynamically affect neuronal network activity, 
the CNS development and memory formation, dysfunction or loss of GABAergic neurons will lead 
to a range of neurological and neurodegenerative disorders.      
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1.3 Interneuron transplantation for epilepsy 
Despite rapid development of anti-epilepsy drugs, 20-30% patients are poorly responsive to drug 
treatment (Loscher, Klitgaard et al. 2013). Moreover, the gradual development of drug resistance 
in some patients further undermines the efficiency of seizure control. Surgical removal of sclerotic 
hippocampus has proved to be more effective than long-term medication treatment, more than 
two thirds of patients with TLE were seizure free or have significant less seizure events after 
surgery, but the adverse effects due to surgery can't be ignored in around 10% of patients, 
including verbal memory deficiency and infection (Wiebe, Blume et al. 2001). Therefore, novel 
therapeutic methods are required for improve outcome of patients with drug-resistance epilepsy.  
1.3.1 Cell replacement therapy for brain diseases 
The possibility of cell replacement therapy for neuron loss or dysfunction in CNS has been 
investigated for more than two decades. A lot of progress based on in vitro and in vivo neuron 
transplantation studies has been made since the concept was proposed. Evidence showed the 
transplanted neurons could integrate into local neuronal circuitry and improve the outcome in 
animal models of Parkinson’s disease (PD), Huntington’s disease (HD), epilepsy and stroke (Freed, 
Greene et al. 2001, Bliss, Guzman et al. 2007, Maucksch, Vazey et al. 2013, Southwell, Nicholas et 
al. 2014, Hunt and Baraban 2015). And the clinical trials of neuron replacement therapy have 
been approved for PD and HD which have the precise brain regions to target and cell type to 
replace, and strong evidence from relevant rodent and primate models suggests high efficiency 
of improvement (Olanow, Kordower et al. 1996, Bachoud-Levi, Bourdet et al. 2000, Freed, Greene 
et al. 2001, Olanow, Goetz et al. 2003). As for epilepsy, the consequence of pathology varies from 
different models and patients, the mechanism of how neuron transplantation works is still unclear, 
more evidence is required to optimize the strategy and support future clinical trials.  
Neuron progenitors with committed lineage identity are best-suited for cell replacement therapy. 
Undifferentiated neuron stem cells proliferate quickly and hold the potential to become any type 
of cells, which increases the incidence of teratoma formation after transplantation (Conti and 
Cattaneo 2010). Furthermore, neuron stem cells without a committed lineage identity are not 
designed to supplement dysfunction or neuron loss in certain CNS disorders (Conti and Cattaneo 
2010, Steinbeck and Studer 2015). Alternatively, specified post mitotic neurons have a very limited 
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ability for migration and fail to establish reciprocal connectivity with existing neuron network, and 
are therefore, unable to provide functional improvement.  
Transplanted neuron progenitors also have other physiological functions rather than just 
reestablishment of the impaired neuron circuit. They could secrete neurogenic or neurotrophic 
factors which affect entire microenvironment, modulating neuron proliferation, differentiation 
and maturation. So, it is essential to understand how transplanted neurons work in pathological 
conditions before clinical use.      
1.3.2 GABAergic neuron transplantation in epilepsy 
Epilepsy is not a singular disease as in PD or HD in which predominant loss of dopaminergic 
neurons or medium spiny neurons is the direct cause of the diseases. In epilepsy, neuron loss, 
dysfunction is accompanied with aberrant neurogenesis, and the neuropathological in principal 
cells, mossy cells, interneurons and glia cells all contribute to shifted balance between excitation 
and inhibition. It is unlikely any single factors could be identified to explain and reverse all 
pathological changes. 
Various types of neuronal cells have been selected to test the cell replacement therapy including 
fetal brain tissue from hippocampus, neocortex, and subcortical structures, mouse and human 
neural stem cells, and genetically engineered neurons or glia designed to express putative 
anticonvulsant substances (Goldberg and Coulter 2014). Although all those cell replacement 
therapies have positive outcomes and special benefits, the GABAergic neuron progenitors are 
the best candidate so far compared to the other types of cell. Despite the complexity and variety 
of the neurophysiology, GABAergic interneuron is the major type of neuron which delivers 
inhibitory signals and contribute most to suppress the over activated neuronal circuit in epilepsy. 
The first GABAergic neuron progenitor transplantation was conducted in Kv1.1 mutation induced 
mouse seizure model. The bilateral transplantation of MGE graft derived from donor embryo into 
postnatal cortex efficiently reduced the duration and frequency of spontaneous seizures (Baraban, 
Southwell et al. 2009). Following that breakthrough, primary cultured mouse MGE cells have been 
transplanted into mice after pilocarpine induced epileptic status. Similar to the previous study, 
the MGE progenitors can migrate widely following transplantation into the adult hippocampus, 
differentiate into mature GABAergic neurons and form synaptic integration with local projection 
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neurons (Hunt, Girskis et al. 2013). After transplantation, the mice receiving exogenous MGE 
progenitors had 92% reduction in spontaneous seizures as well as a reduction in aggressive 
behavior and improvement in short-time spatial memory (Hunt, Girskis et al. 2013). In agreement 
with this finding, another research group confirmed significant reduction of seizure frequency 
and seizure duration after receiving bilateral transplantation of primary culture of mouse MGE 
cells in similar pilocarpine induced mouse model of epilepsy. This research has also showed that 
transplanted cells formed mature inhibitory synaptic complexes at their terminal and apposed 
onto the somas, apical dendrites, and axon initial segments of dentate granule cells, suggesting 
enhanced synaptic inhibition from transplanted MGE cells (Henderson, Gupta et al. 2014). Those 
studies provide promising evidence for using MGE progenitors as a treatment for human epilepsy.  
For the potential future clinical application in TLE patients, the GABAergic neuron progenitors 
from fetal tissue maybe the ideal cell type, at least theoretically, for cell transplantation, as 
transplanted human fetal tissues derived neuron progenitors have been proved to be safe in PD 
and HD patients and one is replacing cells with their immediate progenitors. However, the 
limitation in tissue availability and ethical concerns become the major obstacles in addition to 
scientific utility. To provide reproducible, reliable and constant neuron progenitors for cell 
transplantation, many researchers have investigated the potential of using hESC, human 
pluripotent stem cells (hPSC) or induced hPSC to generate linage specific neuron progenitors. By 
precisely controlling the temporal and regional patterning signals to simulate human 
telencephalon development, the GABAergic neuron progenitors with committed linage identity 
could be generated from hPSCs and ihPSCs (Hunt, Girskis et al. 2013, Liu, Weick et al. 2013, 
Cunningham, Cho et al. 2014, Kim, Yao et al. 2014). Meanwhile, the possibility of using MGE-like 
interneurons generated from hESCs and hPSCs has also been under investigation for treatment 
of epilepsy. In one study, mice given hESC-derived MGE cells showed improvements in learning 
and memory deficits after receiving induced learning and memory loss by P75-SAP (Liu, Weick 
et al. 2013). However, unlike primary MGE cells, the hESC-derived MGE cells show limited grafts 
in hippocampus and only 45% cells become GABAergic neurons 6 months after transplantation 
(Liu, Weick et al. 2013). Similar results have been reported by another study in which 50% GAD 
expressing neurons was identified 3 months after transplantation into TLE model of mouse 
(Maisano, Litvina et al. 2012).  In another recent study, transplanting hPSC-derived MGE-like 
progenitors showed similarly anti-epileptic effects as primary culture of mouse MGE cells in 
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pilocarpine induced mouse model of epilepsy (Cunningham, Cho et al. 2014). But the 
electrophysiological data showed the transplanted hPSC-derived MGE-like neurons did not 
reach the same maturation state as mature adult neurons (Cunningham, Cho et al. 2014). This 
suggests that grafted neurons were capable of suppressing seizures even before acquiring full 
electrophysiological maturation.           
But some scientific concerns still need to be investigated especially in terms of long-term efficacy. 
A recent study found that the effectiveness of transplanted GABAergic progenitors did not extend 
to long-term epileptic seizure control (Henderson, Gupta et al. 2014). So, the former short –term 
EEG recordings and behavioral improvement may overestimate the efficiency of MGE grafts. 
Therefore, it is important to determine the exact mechanism of how GABAergic progenitors 
suppress seizures. The research also demonstrated the GABAergic neuron progenitor did not 
improve pathological alterations in sclerotic hippocampus like MFS (Maisano, Litvina et al. 2012, 
Hunt, Girskis et al. 2013). Moreover, not all transplanted MGE cells of human original 
differentiated into neurons, there were small populations of astrocytes and oligodendrocytes (Liu, 
Weick et al. 2013, Cunningham, Cho et al. 2014). And although GABAergic neurons modulate 
neurogenesis and during brain development and in normal adult neurogenesis, so far, no direct 
evidence showed they could modulate aberrant neurogenesis in the sclerotic epileptic 
hippocampus. It might be due to distinct function of interneuron subtypes correlated with 
heterogeneity in genetic development, as only certain type of interneurons (PV- and NPY- 
expressing) have been suggested to regulate neurogenesis in brain development (Howell, Doyle 
et al. 2005, Howell, Silva et al. 2007, Song, Sun et al. 2013). Indeed, in transplanted MGE-like cells, 
the population of PV or NPY expressing interneurons is less than 10% (Cunningham, Cho et al. 
2014). In addition, a large population of injected hESC or hPSC derived MGE-like cells stay within 
the injection site and the differentiation of mature human interneurons takes a long time 
(Maisano, Litvina et al. 2012, Liu, Weick et al. 2013, Cunningham, Cho et al. 2014). So, it is hard 
to predict how long it will take for the transplanted cells to show their effects in patients with TLE. 
Microenvironment is completely different in sclerotic hippocampus. Inflammatory cytokines such 
as TNF-α, IL-1β, IL-16 etc are enriched in sclerotic hippocampus, (Jimenez-Pacheco, Diaz-
Hernandez et al. 2016). They are involved in neuron death, abnormal neurogenesis and 
electrophysiological dysfunctions of neurons (Schafers and Sorkin 2008, Vezzani, Balosso et al. 
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2008, Belarbi and Rosi 2013, Vezzani and Viviani 2015). Many research studies suggest that 
pathological levels of inflammatory cytokines are detrimental for neuronal survival and 
neurogenesis (Toulmond, Parnet et al. 1996, Aktas, Ullrich et al. 2007, Vezzani, French et al. 2011, 
Kokaia, Martino et al. 2012). Recently Genome-wide association studies (GWAS) and exome 
sequencing has been used to recognize the major detrimental inflammatory mediators in 
different relevant animal models and patients with brain diseases (Johnson, Behmoaras et al. 
2015). IL 1R–TLR (Toll like receptor) signaling is thought to be pivotal for initiating the 
inflammatory brain response following seizures or epileptogenic brain insults. And the release of 
IL-1β caused neuron injury, hyperexcitability which further aggravate occurrence of seizures.  
Interleukin-1 (IL-1) is one of most powerful pro-inflammatory cytokines which contributes to a 
variety of neurological and neurodegenerative diseases in CNS (Toulmond, Parnet et al. 1996, 
Allan, Tyrrell et al. 2005). Researches have shown that IL-1β produced by activated microglia 
affects the generation, differentiation and survival of neural stem cells (Green, Treacy et al. 2012, 
Belarbi and Rosi 2013). Immune cells such as monocytes and macrophages contribute to early 
production of IL-1β, all endogenous brain cells including microglia, astrocytes and neurons could 
secrete IL-1β at later stage after brain insults (Allan, Tyrrell et al. 2005). Therefore, IL-1β can 
accumulate in chronic epilepsy. It is critical to understand how persistent inflamed 
microenvironment of epilepsy affect neurogenesis in human. 
So far, the researchers are focused on the effect of inflammatory microenvironment on local brain 
cells. It remains to be known about the cross- talk between exogenous neurons and local 
microenvironment in brain diseases. Especially transplanted human neurons will take several 
months for neuronal differentiation before incorporating with the local neuronal circuit. Therefore, 
during that long period how transplanted exougenous neuron progenitors adapt to the 
pathological microenvironment is still unclear. There is also a lack of evidence on whether chronic 
pathologic microenvironment of epilepsy will affect the survival, differentiation and 
electrophysiological activity of transplanted GABAergic interneuron progenitors.   
1.4 Aim 
This project will investigate how transplanted cells behave in the chronic pathological 
environment and how the inflamed microenvironment affects the survival, proliferation, 
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functional maturation and electrophysiological activities of transplanted MGE progenitors. In 
addition, hESC derived 3D neuronal culture which can recreate a modifiable microenvironment 
will be established to observe the effect of inflammatory cytokines on neuronal cells 
Objective 1, Generation and characterization of cortical neuron progenitors, cortical GABAergic 
neuron progenitors and astrocytes from hESC 
Objective 2, Integration of GABAergic neurons into human epileptic hippocampal Hi-Spot 
Cultures and an examination of their effects compared to cultures derived from “normal” or non-
epileptic cortex. 
Objective 3, Investigate the effect of IL-1β on cell survival and differentiation of transplanted 
MGE-like neuron progenitors. 
Objective 4 Generation and characterization of hESC-derived three-dimensional neuronal 
cultures. 
Objective 5 Investigate the effect of IL-1β on the functional electrophysiological properties of 
MGE-like neuron progenitors    
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2. Methods and Materials 
2.1 Cell culture 
The cell incubator (Galaxy 170 R, New Brunswick) was used to maintain the cell culture at 37°C 
and 5% CO2. The laminar flow hood (Maxisafe 2020, Thermo Scientific) was used for the cell 
culture work under sterile conditions. The cell culture-treated plastic multi-well plates (Thermo 
Scientific) or glass coverslips (VWR) with specific coating were used for cell growing. 
2.1.1 Human ESC culture and maintain 
H7 hESC line (Passage number 10 to 35) or their tau-GFP-transfected counterparts (TG-H7, from 
Zoe Noakes) (Passage number 4 to 25) were used for the all stem cell experiments. Multi-well 
plates were coated with Matrigel (Corning) diluted 1 in 100 with DMEM/F-12 (Gibco) medium 
for at least 1 hour at 37°C. H7 or TG-H7 cells were seeded at the density approximately 50000 
to 150000 cells/cm2 and maintained in TeSR-E8 medium (Stem Cell Technlogies) in 6-well plates. 
The medium was changed every day or every other day depending on the confluence of the cells. 
The cells were split as follows when they reached 80-90% confluence. The cells were washed once 
with D-PBS (Gibco) before adding EDTA (Sigma) or gentle cell dissociate reagent (Stem Cell 
Technlogies) for 3 to 5 mins at 37°C. EDTA or gentle cells dissociate reagent was aspirated and 
substituted with E8 medium. A serological pipette was used to mechanically scratch and manually 
dissociate the cells by titrating into small clusters. Cell suspension was centrifuged at 1150 rpm 
for 3 minutes (5810 R, Eppendorf) to create a cell deposit. Discarded the supernatant and 
replaced with fresh E8 medium. The cells were then re-suspended and seeded at gradient ratios 
(1: 2, 1:3, 1:6).   
2.1.2 Human ESC freezing and thawing 
H7 and TG-H7 cells split at low passage number were stored in liquid nitrogen for future use. 
The stem cells for storage were kept in large clusters when dissociated as described above. Cells 
were harvested when the cells reached 80% to 90% confluence in muti-well plates. The cell 
suspension was then transferred in to cryogenic vials with E8 medium containing 10% DMSO. The 
cryogenic vials were then placed inside a cell freezing container which helped achieve gradient 
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temperature decrease in -80°C freezer. The cells were kept in -80°C for at least 24 hours before 
eventually transferred into the liquid nitrogen tank. 
The cryogenic vials with cells for thawing were transferred in dry ice from liquid nitrogen. The 
cryogenic vials were put into 37°C water bath as quickly as possible. Shake the cryogenic vial 
while thawing the cells. Removed the vials from the water bath when only a small ice pellet left 
in the vial. Transferred the cell suspension at the ratio of 1 in 10 into the pre-warmed E8 medium 
and centrifuged at 1150 rpm for 3 min. Discard the supernatant, re-suspended the cells with E8 
medium and seeded the cells into a single well of a 6-well plate. 
2.1.3 Human hHA culture and maintain 
The human hippocampal astrocytes (hHA) were purchased from ScienCell Research lab (#1830). 
(Lot number 1670) Muti-well plates or glass coverslip were coated with poly-D-lysine (10ug/ml 
diluted in D-PBS) for at least one hour in room temperature, rinsed by D-PBS and left to dry. The 
hHAs were seeded at 5000 cells/cm2 and maintained in conditioned medium (DMEM/F12 100ml, 
Neurobasal 50ml, FBS 5%). The culture medium was aspirated every two or three days. The cells 
were passaged when reached 80% to 90% confluency. The cells at low passage number were 
stored in liquid nitrogen for future use. The cells at passage 3 to passage 6 were used to support 
neuron growth for electrophysiological experiment.  
2.1.4 Human ESC differentiation 
The 12- well plate were coated with Growth Factor Reduced Matrigel (Corning) diluted 1:15 in 
DMEM/F12 Cells for 1 hour at 37°C. hESC were harvested from the 6-well plate and placed into 
the prepared 12-well plate. When the cells grew to 90% confluency, the medium was change 
from E8 to defined N2B27 medium (100 ml DMEM-F12, 50 ml Neurobasal, 1 ml N2 supplement, 
1 ml B27 without retinoic acid, 2 mM L-glutamine, penicillin-streptomycin, 0.1 mM β-
mercaptoethanol, all from Gibco). And that day was defined as day 0.  
To obtain MGE progenitors, LDN-193189 (LDN;100nM, Tocris), SB431542 (SB;10uM, Tocris) and 
XVA939 (XVA;2uM, Tocris) were given from day 0 to day 9. The 1st passage was taken at day 9-
10. The cells were pre-incubated with ROCK inhibitor for at least 1 hour at 37°C and dissociated 
with EDTA as described above. Gently titrated the cell suspension and kept the cells in large 
cluster for good survival. The cells were then split at a 2: 3 ratios and seeded into the 12-well 
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plate coated with fibronectin (15 μg/ml, 2 hours at 37°C; Millipore). Sonic hedgehog 
(SHH;200ng/ml, R&D) and Purmorphamine (Pur,1uM; Millipore) were given from day 10 to day 
18. The 2nd passage was taken after day 20. The 12-well plate were pre-coated with poly-D-
lysine (PDL, Sigma;10 μg/ml in D-PBS, was added for 1 hour at room temperature, rinsed once 
with D-PBS) and laminin (Sigma;10 μg/ml in D-PBS, incubated overnight at 37°C after PDL 
coating.) The cells were dissociated with EDTA as described above, vigorous titrated into small 
clusters and spilt at a ratio of 1:3 to 1:4. When the cells started to grow processors at around day 
25, the supplement B27 with Retinol acid (RA) were given to replace the previous supplement 
B27 without RA. The medium was also supplemented with BDNF and GDNF (10 ng/ml; Peprotech) 
which promoted neuron differentiation and maturation. 
To obtain cortical progenitor, LDN-193189 (LDN;100nM, Tocris), SB431542 (SB;10uM, Tocris) 
were given from day 0 to day 12. The 1st passage was taken at day 9-10. The cells were pre-
incubated with ROCK inhibitor for at least 1 hour at 37°C and dissociated with EDTA as described 
above. Gently titrated the cell suspension and kept the cells in large cluster for good survival. The 
cells were then split at a 2: 3 ratios and seeded into the 12-well plate coated with fibronectin (15 
μg/ml, 2 hours at 37°C; Millipore). When the cells started to grow processors at around day 25, 
the supplement B27 with Retinol acid (RA) were given to replace the previous supplement B27 
without RA. Half medium were replaced every other day.  
The neuron progenitors generated from h-ESC were used for astrogila differentiation. The MGE 
or cortical progenitors were cultured in N2B27 medium until differentiation day 20 with the 
method described above. The cells were then dissociated and passaged at the density of 
10000~20000/cm2 onto poly-d-lysine (10ug/ml) and Laminin (10ug/ml) coated plate. Switch to 
medium composed of DMEM/F12, Neurobasal, 10%FBS, FGF2(20ng/ml), 1%L-glutamine, 
Mycozap (Lonza), β-mercaptoethanol thereafter. The cells were passaged weekly when they 
reached 80% to 90% confluency. The medium was changed every two to three days. 
2.2 Hi-spot culture 
2.2.1 Brain tissue preparation  
The cortical and hippocampal tissue was obtained from the patients undergoing epilepsy or brain 
tumor surgery. The brain tissue was collected with sterile falcon tubes filled with 10-20ml of Gey's 
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balanced salt solution (Sigma) supplemented with MK-801(Tocris), then transferred into a 10-cm 
petri-dish and washed 3 times with D-PBS. The tissue was then placed onto a plastic flask inside 
the tissue chopper (Mcllwain) and mechanically chopped into 1mm3 size. The tissue was 
dissociated in papain (Sigma) for 30min at 37℃. Once dissociated, the cells were vigorously 
titrated and flittered twice by 100um mesh cell strainers (Millipore). The viable cell number was 
estimated using the trypan blue (Sigma) exclusion assay. 
2.2.2 human Hi-spot generation and maintain 
The hi-spot culture dishes were prepared under sterile condition in advance as follows. 1ml hi-
spot medium composed of 62% DMEM/F12, 20% FBS, 10% Ham's F-12 Nutrient Mix, 5% horse 
serum 1% pen-strep-glutamine, 1% hepes, 1% GlutaMAX supplement (all form life tech) was added 
into each well of 6-well plates. The Millipore membrane inserts (Millicell® PCF ,30mm, 0.4 µm, 
polycarbonate) were then placed into each well. 3 to 4 Teflon membrane discs (pore size 0.4 μm 
with a thickness of ~30 μm; purchased from Biocell Interface, SA) were taken by forceps and 
carefully placed onto the Millipore membrane inserts. The prepared 6-well plates were left at 
37°C overnight.  
The GFP-MGE progenitor (differentiation from TG-H7 cell line) around differentiation day 20 or 
differentiation day 45 were dissociated by accutase (Sigma) for 10 min at 37 °C and vigorous 
titrated into single cell suspension. The viable cell number was estimated by trypan blue.  
 
 
 
Hippocampus 
Cortex 
Mixing with 10% GFP-labelled 
MGE progenitors 
Enzymatic dissociation,  
spinning, counting 
Sclerotic 
Hippocampus 
Figure 2-1 Diagram for generating hi-spot from human brain tissue 
27 
 
10% GFP-MGE progenitors were well mixed with 90% previous prepared viable human brain cells 
(2.2.1) in suspension. The mixed cell suspension was centrifuged at 1200 rpm for 5 mins. Discard 
the supernatant and replaced with certain amount of hi-spot medium (1ul per 50,000 cells). Re-
suspended the cell pellet and pipetted 5ul high-density cell suspension in a single drop and 
placed on the top of each Teflon membrane disc. (Figure 2-1)(Bailey, O'Connor et al. 2011). The 
medium was replaced twice a week  
2.2.3 ES hi-spot generation and maintain  
The human ES-derived cortical progenitors, astrocytes and MGE progenitors were dissociated by 
accutase for 10min at 37℃.The viable cell number was estimated using the trypan blue exclusion 
assay. The astrocytes, cortical progenitors and the MGE progenitors were mixed at the ratio of 
90:9:1. The cell suspension was centrifuged at 1150rmp for 5 min and the cell rich pellet was re-
suspended in hi-spot medium (described in 2.2.2). Pipetted 5ul high-density cell suspension in a 
single drop and placed on the top of each Teflon membrane disc. The medium was replaced 
twice a week.  
2.2.4 Experimental Groups and time points 
For each experiment, the sclerotic hippocampal tissue was used to simulate epileptic 
microenvironment while neocortical tissue from the same patient was considered to simulate 
non-inflamed microenvironment. To block the effect of IL-1β, IL-1RA (100ng/ml; PeproTech EC 
Ltd), the antagonist of IL-1R1 was added to the medium of sclerotic hippocampal and cortical 
hi-spots from day 1 to day 28. Same concentration of IL-1RA was given to the cultures when 
change the medium every three days. To observe the effect of IL-1β in non-pathological 
environment, IL-1β (10ng/ml) was add to the culture medium of non-epileptic hippocampal and 
cortical hi-spot culture from day 1 to day 28. Same concentration of IL-1β was given to the 
cultures when change the medium every three days the hi-spots were fixed at day 14 and day 
28 for immunochemistry.  
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2.3 Cell and hi-spot analysis 
2.3.1 Immunochemistry  
The cells in culture plate or on coverslip were washed once with D-PBS and fixed in 3.7% PFA for 
15 minutes at room temperature. For nuclear and cytoplasmic makers, the cells were washed 
three times with PBS-T (PBS+0.3% Triton-X-100), 10 mins each, for permeabilization. 
For cell surface maker (IL-1R1 receptor), the cells were washed three times with PBS only. 
For hi-spots, PBS-T with 0.5% to 1% Triton-X-100 was given for thorough permeabilization. 
The cells or hi-spots were incubated with 2% BSA (Sigma) and 3% donkey serum (Merck-Millipore) 
for 20-30 minutes at room temperature for blocking. Primary antibodies listed in the Table 1 
were diluted in PBS-T with 3% donkey serum at given concentration and left overnight at 4°C. 
The cells and hi-spots were rinsed three times, 10 mins each, with PBS-T the next day and 
incubated in secondary antibodies diluted with PBS-T (1:1000 for cells and 1:500 for hi-spots, 
AlexaFluor anti-donkey 488, 555, 594, 647; Life Technologies) for 1 hour at room temperature in 
dark. After that, DAPI (1:3000 in PBS; Molecular Probes) was added for 3 mins at room 
temperature. Stained cells or hi-spots were rinsed 3 times with PBS and mounted in Mowiol 4-
88 (Sigma) and fixed on to glass slides (VWR).   
Image analysis was performed using Leica DM6000B upright (for slides) or Leica DMI6000B 
inverted (for plates) fluorescent microscopes at 10X, 20X or 40X magnification. 
2.3.2 Annexin V/Propidium Iodide (PI) Apoptosis Assay 
The cells in culture plate or on coverslip were washed once with fresh medium. The cells were 
then incubated with PI (BD Pharminge,1:500) and Annexin V (BD Pharminge ,1:1000) at 37Cº for 
30mins. The cells were rinsed one time with PBS. DAPI was given to the cells for another 10mins 
at 37Cº. The coverslips were rinsed one times with PBS and mounted in Mowiol 4-88 and fixed 
on to glass slides. Image was taken using Leica DM6000B upright fluorescent microscopy. 
2.3.3 Cell quantification  
Cell counting was performed with images taken from at least four random fields of a coverslip or 
a hi-spot. The number of marked cells were manually counted by using Fiji (Image J). The density 
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and the area of fluorescent were automatically measure by image J. The average density was 
calculated by density/area.  
2.3.4 Sholl analysis 
 Sholl analysis is widely used to evaluate morphological complexity of neurons (Sholl 1953). Sholl 
profile is described by plotting the number of neurite intersections against the gradient radial 
distance from the soma (Figure2-2). The area under the Sholl curve can be used as a single 
measure of dendritic complexity.  
The labelled neurons for Sholl analysis were placed around the centre of the view when taking 
photos. The pictures were then imported into Fiji for Sholl analysis. The scale of image was 
adjusted by the scale bar. The cells were firstly processed by the plugin - Simple Neurite Tracer. 
The estimated geometric centre of the cell body was marked as the starting point for the 
processors. The processors were semi-automatically traced one by one from the starting point 
to the visible end. The secondary and above branches were traced from the connection point at 
certain primary or above branches. The detailed information about branch length and branch 
number was automatically obtained after tracing the neurons. The short cut ‘Ctrl+Shift+A’ were 
applied to calculate the number of intersections with digitally tracing rings at different distances 
form the soma centre. The area under the intersection-distance relation curve was measured by 
Graphpad Prism for individual neurons. 
2.4 Electrophysiological analysis 
The whole cell patch clamp recording was performed at room temperature (20 to 22°C) , using 
Multiclamp 700B amplifier and Digidata 1550B analogue to digital converter with pClamp 10 
software (all Molecular Devices, USA). Glass pipettes (4-6 MΩ) were pulled from borosilicate 
Figure 2-2  Diagram for Sholl analysis 
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capillary glass (Sutter Instruments, USA) and filled with fresh internal solution before patching. 
The GFP-labelled neurons were visualized and selected at 40X magnification under the 
fluorescent microscope. The external solution in the recording chamber was cycled by the pump 
at the flow rate of 2-2.5ml/mins. Data was sampled at 20kHz with a 6 kHz Bessel filter. Recording 
traces were extracted by Clampfit 10.7 software (Molecular Devices) exported to Excel and plotted 
using Graphpad Prism. 
2.4.1 Cell preparation  
The 24-well plate with 13 mm glass coverslips were coated with PDL as described above. hHA (P 
3 to P6) were passaged onto the glass coverslip. The hHA were kept in conditioned medium 
(2.1.3) until 90% to 100% confluent. The culture medium was then gradually replaced by SCM 
medium (25 ml DMEM-F12, 25 ml Neurobasal A, 1 ml B27 with RA, 2 mM L-glutamine, 100 μl 
Mycozap, 0.1 mM β-mercaptoethanol, 2 μM PD0332991, 3 μM CHIR 99021, 0.3 mM CaCl2, 200 
μM ascorbic acid, 10 ng/mL BDNF, 1 μM LM22A4)(Telezhkin, Schnell et al. 2016). The GFP-MGE 
progenitors (generated from TG-H7 cell line) around differentiation day 20 were dissociated by 
accutase (Sigma) for 10 min at 37 °C. The cells were then vigorous titrated into single cells and 
seeded on the top of hHA at the density of 10,000 to 25,000 cells/cm2. The astrocyte-supported 
neuronal differentiation was kept in SCM medium for up to 6 weeks. The medium was changed 
every three days. 
In IL-1β acute exposure experiment, (IL-1β 10ng/ml was given to the cells for 24 hours before 
recording. In IL-1β chronic exposure experiment, IL-1β (10ng/ml) was give twice in 7 days. In IL-
1β chronic repetitive exposure experiment, IL-1β (10ng/ml) was given to the cells every day to 
replace the old medium for 7 days. 
2.4.2 Whole cell current clamp 
The current clamp was used to record resting membrane potential (RMP) and action potentials 
(AP). Data were sampled at 20kHz with a 6 kHz Bessel filter. A coverslip of astrocytes supported 
neuronal culture (described above) was transferred into the recording chamber perfused with 
external solution. The external solution was composed of 135mM NaCl, 5mM KCl, 1.2mM MgCl2, 
1.25mM CaCl2, 10mM D-glucose, 5mM N-2-265 hydroxyethylpiperazine-N'-2-ethanesulfonic 
acid (HEPES) (all from Sigma), and pH was titrated to 7.4 by NaOH. The internal solution filled in 
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the glass pipettes was composed of 117mM KCl, 10mM NaCl, 11mM HEPES, 2mM Na2-ATP, 
2mM Na-GTP, 1.2mM Na2-phosphocreatine, 2mM MgCl2, 1mM CaCl2 and 11mM ethylene-
glycol-tetra-acetic acid (EGTA) (all from Sigma), and pH was titrated to 7.2 by NaOH. The 
resistance of a patch pipette filled with intracellular solution was about 3–9 MΩ. The series 
resistance component was fully compensated using the bridge balance function of amplifier. The 
RMP of cells was recorded immediately after breaking into the cells in gap free mode. A 
systematic current injection protocol (duration, 1 s; increment, 20 pA; from -100pA to 200pA) 
was applied to the neuron held at -70mv to evoke APs. Further analysis for action potentials were 
carried out by clampfit 10.7.  
2.4.3 Whole cell voltage clamp 
The whole cell voltage clamp was used for voltage-dependent sodium current recordings. Data 
were sampled at 20 kHz with a 6 kHz Bessel filter. To isolate pure ionic currents, P/6 leak 
subtraction was applied in recording protocol. The external solution was composed of 60mM 
NaCl, 80mM TEA-Cl, 5mM KCl,1.8mM CaCl2, 0.8mM MgCl2, 10mM D-glucose,10mM HEPES, 1mM 
NiCl2, 1mM CdCl2, 1uM TTA-P2, 50um Nifedipine, and pH was titrated to 7.4 by KOH. The internal 
solution filled in the glass pipettes was composed of 20mM NaCl ,20mM TEA-Cl,100mM 
CsCl,1mM CaCl2,2mM Mg-ATP,0.3mM Na2-GTP,10mM EGTA, 10mM HEPES, and pH was titrated 
to 7.4 by CsOH. The predicted liquid junction potential is -5 mV. The resistance of a patch pipette 
filled with intracellular solution was about 3–9 MΩ. The cells were holding at -40mv when break 
into. The series resistance was compensated by 70%. To record well controlled Na+ currents in 
neurons with complex processes, a pre-pulse (duration 10ms, 50mV) was used to eliminate the 
uncontrolled currents from axon(Milescu, Bean et al. 2010).（Figure 2-3） 
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Figure 2-3 Pre-pulse eliminates uncontrolled currents from axons 
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2.4.2.1 Steady state INa activation 
The cells were held at -60mv, hyperpolarized to -80mV and stimulated by a range of systematic 
depolarizing voltages (duration 50ms, 10mV incriminate, -60mV to 80mV) were given to evoke 
Na+ current. For voltage-dependent activation curve, conductance (g) through Na+ channels 
were calculated using the equation:  
g =INa/ (V - Er) 
where INa is the peak Na+ current, V is the test membrane potential, and Er is the observed 
reversal potential when the no net flow of INa. 
For activation curve, the data for I-V relationship was fitted with a Boltzmann equation: 
g/gmax=1/ (1 – exp [(V50 – V)/k]) 
Where gmax is the peak conductance, V is the membrane potential under which the Na+ current 
develops, and V50 is the half-maximal activation potential, k is the slope factor.  
2.4.2.2 Steady state INa inactivation 
The neurons were held for a range of hyperpolarizing voltage (duration 1s, 10mV incriminate, 
from -130mV to 0mV) and depolarized to 10mV. 
For voltage-dependent inactivation curve, the data were fitted with a Boltzmann equation: 
I/Imax=1/ (1 – exp [(V50 – V)/k]) 
Where Imax is the peak current, V is the membrane potential under which the Na+ current develops, 
and V50 is the half-maximal inactivation potential, k is the slope factor.  
2.4.4 Non- stationary fluctuation analysis (NSFA) 
NSFA is used to analyze microscopic currents from single ion channel (i) and the number of total 
channels on cell membrane (N)(Heinemann and Conti 1992, Alvarez, Gonzalez et al. 2002). The 
data were recorded in whole cell voltage clamp mode. The internal solution and external solution 
were the same as described in 2.3.3. Date were sampled at 40 kHz with a 10 kHz Bessel filter. To 
isolate pure ionic currents, P/4 leak subtraction was applied in recording protocol. The series 
resistance was compensated by 70%. The cells were held at -60mv at the beginning of the 
recording. The cells were then hyperpolarized to -80mv for 200ms followed by depolarizing 
stimulation from -80mv to -10mv for 50ms. The recording protocol was repeated for at least 60 
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times for each cell. The first ten sweeps of each set of data were neglected to minimize the 
contamination of variance coming from gradual activation of sodium channels. The rising phase 
of sodium current were used for variance-mean plot. To correct the variance coming from time-
dependent channel rundown, variance is calculated from the ensemble average of the squared 
differences of successive records, i.e.  
𝑦௜ =
1
2
(𝑥௜ − 𝑥௜ାଵ) 
Where yi is differences of successive points, xi and xi+1 indicate the point of the same time along 
successive sweep(Heinemann and Conti 1992).   
The variance could be calculated by equation as follow,  
𝜎ଶ =
1
𝑛 − 1
෍(𝑦௜ −  yത)ଶ
௡
ଵ
 
Where σ2 is squared differences from pairs of successive points (yi), n is the number of sweeps. I 
represents the averaged current from recording 
Values for the total number of channels (N) and the single-channel current (i) were estimated by 
fitting the functional relationship between the variance - mean current. 
𝜎ଶ = iI −
1
𝑁
𝐼ଶ 
The channel open possibility P(o) was calculated by  
                             𝑃ை = 𝑖𝑁 𝐼⁄ ௠௔௫ 
 2.5 Statistical analysis 
All data shown are expressed in terms of Mean ± SEM. Statistical analyses were performed using 
GraphPad Prism software (version 7.03) or SPSS (Version 22). In instances where single 
measurements are taken from two groups, a two-tailed t-test was used to compare means. In 
instances where the data are compared at multiple level, a one-way or two-way analysis of 
variance (ANOVA) was applied to test for significant differences between groups, with Tukey's 
post-hoc or Sidak’s multiple comparisons test for multiple pairwise comparisons. In instances 
where the data represent a mixture of between-group and repeated-measures variables, mixed 
design of repeated measures ANOVA was applied to test significant differences between 
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matched data in different groups.  In instances where difference of the sample frequency was 
compared between groups, chi-squared test or Fisher's exact test (n<5) was used comparing the 
distribution of samples. The null hypothesis was rejected at 0.05 for t-test, ANOVAs and post hoc 
tests.  
The statistical results for analysis which showed significant difference between groups were listed 
in appendix  
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Table 1 List of antibodies used for immunostaining 
Nkx 2.1 rabbit Abcam 1:1000 
Mash1 mouse Abcam 1:1000 
Pax 6 mouse DSHB 1:1000 
Nestin mouse BD 1:1000 
Tuj1 rabbit Biolegend 1:500 
GABA rabbit Sigma 1:500 
GAD 67 mouse Millipore 1:500 
GFAP rat Invitrogen 1:1000 
Calbindin rabbit Swant 1:500 
Calretinin rabbit Swant 1:500 
STT rat Millipore 1:100 
GFP rabbit Invitrogen 1:500 
GFP mouse Invitrogen 1:500 
Trb2 rabbit Abcam 1:500 
IL-1R1 rabbit Abcam 1:100 
GLAST rabbit Abcam 1:500 
S100β mouse Sigma 1:1000 
Nav-pan rabbit Alomone lab 1:200 
Nav1.1 rabbit Alomone lab 1:200 
Nav1.2 rabbit Alomone lab 1:200 
Nav 1.6 rabbit Alomone lab 1:200 
Navβ2 rabbit Alomone lab 1:200 
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3. The Epilepsy microenvironment compromises survival and 
differentiation of transplanted human ES-derived MGE 
progenitors in vitro  
3.1 Introduction 
During last two decades, cell replacement therapy attracted more and more attention for treating 
neurological and neurodegenerative disorders such as Parkinson disease (PD), Huntington’s 
disease (HD) and epilepsy (Bjorklund and Lindvall 2000, Roper and Steindler 2013). Since adult 
neurogenesis occurs only in restricted brain areas with limited capacity for brain repair (Danzer 
2012), transplantation of exogenous neuron progenitors of human origin could potentially 
restore brain function caused by neuron loss and dysfunction. 
Inhibitory interneurons are critical for the stability of neural network function. Genetic deficits or 
dysfunction of inhibitory GABAergic neurons are involved in development of many types of 
seizures, including focal and absence seizures (Powell, Campbell et al. 2003, Yu, Mantegazza et 
al. 2006, Yalçın 2012, Powell 2013). The imbalance between neural excitation and inhibition due 
to interneuron loss and dysfunction will accelerate progress of seizures (Liu, Yu et al. 2014). The 
literature suggests that signaling imbalance can be restored by replacing lost GABAergic 
interneurons, and transplanted interneurons have been shown to modify inhibitory signaling and 
disease phenotypes in epilepsy (Hunt, Girskis et al. 2013, Cunningham, Cho et al. 2014, 
Henderson, Gupta et al. 2014). Therefore, the GABAergic interneuron-based cell transplantation 
has great therapeutic potential for the treatment of epilepsy (Goldberg and Coulter 2014). The 
seizure suppressing effect of transplanted interneurons is thought to rely on their ability to 
restored synaptic inhibition (Henderson, Gupta et al. 2014). The intrinsic potentially excitatory 
abnormalities such as mossy fiber sprouting didn't alter after receiving transplantation of MGE 
progenitors in mouse model of TLE (Hunt, Girskis et al. 2013). However, the seizure suppressing 
effect of transplanted interneurons takes several weeks to be confirmed and their therapeutic 
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effects over extended periods is still doubtful (Henderson, Gupta et al. 2014). One possibility is 
that the survival of transplanted cells is reduced longer term (Hunt, Girskis et al. 2013). So, an 
optimized strategy is needed to improve survival and promote maturation of transplanted 
interneurons. 
Inflammatory cytokines such as TNF-α, IL-1β, IL-16 etc are enriched in sclerotic hippocampus 
(Jimenez-Pacheco, Diaz-Hernandez et al. 2016). They are involved in neuron death, abnormal 
neurogenesis and electrophysiological dysfunctions of neurons (Schafers and Sorkin 2008, 
Vezzani, Balosso et al. 2008, Belarbi and Rosi 2013, Vezzani and Viviani 2015). Many studies 
suggest that pathological levels of inflammatory cytokines are detrimental for neuronal survival 
and neurogenesis (Toulmond, Parnet et al. 1996, Aktas, Ullrich et al. 2007, Vezzani, French et al. 
2011, Kokaia, Martino et al. 2012). So far, there is a lack of evidence on whether the chronic 
pathologic microenvironment of epilepsy will affect the survival or differentiation of transplanted 
GABAergic interneuron progenitors.  
To address these issues, in this chapter I generated MGE progenitors from hESC and transplanted 
the cells into 3D hi-spot cultures generated from brain tissue of patients undergoing epilepsy 
surgery to observe how “transplanted” cells behave in a relevant pathological microenvironment. 
The results showed the inflamed microenvironment caused reduced survival, impairment in 
morphological maturation and functional differentiation of transplanted hESC-derived MGE 
progenitors.  
3.2 Results 
3.2.1. Generation and characterization of Nkx 2.1+ progenitor cells from hESC 
Nkx2.1 is one of most specific markers of ventral forebrain. Nkx2.1+ cells derived from medial 
ganglionic eminence (MGE) contribute to about 70% of total cortical interneuron population (Butt, 
Sousa et al. 2008, Miyoshi, Hjerling-Leffler et al. 2010). To generate MGE progenitors from 
hESC ,dual SMAD inhibitors (SB-451542 and LDN-193189) were applied from day 0 to day 10 to 
improve neural induction(Chambers, Fasano et al. 2009). Meanwhile, Wnt inhibitor XVA939 were 
supplemented to help the cells achieve anterior telencephalic identity (Nicoleau, Varela et al. 
2013). Subsequent addition of sonic hedgehog (Shh) and Purmorphumine (Pur) from day 10 to 
day 18 promoted ventralization of early neuroectoderm and directed the cells towards MGE 
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lineage (Maroof, Keros et al. 2013) (Figure 3-1A). The average expression of Nkx2.1 on day 25 
post-differentiation was estimated over 90% (Figure 3-1B). Other ventral telencephalic progenitor 
markers Olig2 and Ascl1 (Mash1) also expressed at the same period (Figure 3-1B). In contrast, 
Pax6, a marker for dorsal telencephalic neural progenitors, was not detected (Figure 3-1B). 
Therefore, the hESC-derived NKX2.1+ cells represented a ventral telencephalic MGE-like 
neuronal lineage.  
The maturation of hESC-derived neuron progenitors occurs over a long-term in vivo. The cells 
were treated with retinoid acid (RA) from day 20 and BDNF for further maturation after day 25. 
The expression of GABAergic neuron markers was inspected by Immunostaining on 
differentiation day 60. GAD 67 synthesizes GABA which is the major inhibitory neuron transmitter 
produced by cortical interneurons (Chattopadhyaya, Di Cristo et al. 2007). About 60% cells 
expressing GAD 67 on differentiation day 60 suggesting that most cells were becoming 
GABAergic neurons (Figure 3-1C). The interneuron subtype marker calbindin, calretinin and 
somatostatin (Monyer and Markram 2004) were also detected as the same time. About 60% cells 
express calretinin ,50% express calbindin, only 5% express STT and no PV positive cells were 
detected (Figure 3-1C).    
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A) Schematic timeline of MGE progenitor differentiation from H7 cell line. SB451542, inhibitor of the TGFb1 activin 
receptor-like kinases; LDN193189, inhibitor of bone morphogenetic protein (BMP) type I receptors; XVA939, wnt 
signaling inhibitor; Shh, Sonic hedgehog; Pur, Purmorphamine; BDNF, brain-derived neurotrophic factor. B) On 
differentiation day 20 the cells robustly expressed NKX2.1, nestin, Olig 2 and nestin and were negative for PAX6. Scale 
bar 100um.C) On differentiation day 60, the cells expressed post mitotic marker tuj1+; GABAergic marker GAD 67 and 
interneuron subtype marker Calbindin, Calretinin, Somatostatin. (Scale bar 50um) 
Figure 3-1 Generating MGE cells from hESC 
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3.2.2. Characterizing MGE progenitors for transplantation 
H7 hESCs were labelled with GFP by transfecting a plasmid containing expression of tau-GFP 
fusion protein (TG4). TG4-H7 cell line was used for generating MGE progenitor using the protocol 
described above. Time dependent maturation of MGE progenitors was examined by comparing 
expression of the post-mitotic neuron marker Tuj1 between post differentiation day 20 and day 
45. The result revealed on differentiation day 20, the cells grew in rosette and only 7% ±1.4% cells 
expressed Tuj1. By differentiation day 45, the cells migrated away from the rosette and the ratio 
of tuj1+ cells significantly increased to 37.6%±3.5% (n=4 from the same differentiation ), two-tail 
unpaired t-test, t=8.041, df=6, P=0.0002) (Figure 3-2A, C.) Subsequently result showed 41.6% cells 
express GABA and 32.3% express GAD 67 on post-differentiation day 45(Figure 3-2 B, D).  
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Figure 3-2 Characterizing MGE progenitors during differentiation 
A) TG4-H7 cell line was used for MGE differentiation with the protocol described above. The negative control which 
applied only secondary antibodies showed no staining. The immunostaining showed expression of Nkx2.1 and Tuj1 
on differentiation day 20 and day 45. Scale bar 50um B) The ratio of cells expressed Tuj1 was significantly increased 
on differentiation day 45 compared to differentiation day 20. (Data show mean± SEM, n=4, t-test, ***P<0.001) (C-D) 
The ratio of Nkx 2.1, GAD 67 and GABA positive cells respectively on differentiation day 45 (Data show mean± SEM, 
n=4)   
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3.2.3. hESC-derived MGE progenitors survive and differentiate in hi-spot culture 
Hi-Spot culture is a new cell culture method developed for culturing postnatal brain tissue (Bailey, 
O'Connor et al. 2011). With this method, the brain tissue is dissociated and reorganized as a self-
organised, dense, organotypic-like culture in air-liquid surface. The hi-spot culture allows cells 
to grow in 3D which simulate the construction and the microenvironment of postnatal brain 
rather than conventional 2D monolayer culture. Previous data from our lab show the inflamed 
microenvironment and major cellular components in human brain tissue are preserved in hi-spot 
culture (Figure 3-3, Zaben & Gray). Nearly all relevant cells in brain tissue can be detected in hi-
spots derived from human hippocampus, including immature hippocampal neurons, mature 
neuron, microglia, astrocytes, neuron stem cells and endothelial cells (Figure 3-3 A-D). In 
addition, the level of IL-1β in the medium of sclerotic hippocampus is self-maintained in higher 
level compared to non-sclerotic cortical hi-spots (Figure 3-3E). It suggests the pathological 
inflamed microenvironment of sclerotic hippocampus can be maintained in hi-spot culture. 
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A-D) The immunostaining showed relevant cells survived in hi-spots generated from sclerotic hippocampal tissue 
resected from patient undergoing epilepsy surgery. E) The line graph showed the level of IL-1β in the medium of 
sclerotic hippocampal hi-spot significantly increased from day 10 compared to non-sclerotic cortical Hi-spots 
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Figure 3-3 Human hi-spots contain all relevant brain cells and mimic pathological 
microenvironment. (Zaben & Gray) 
 
45 
 
To set up and test the culture model for observing the effect of microenvironment on 
transplanted MGE progenitors in vitro, 10% GFP expressing MGE progenitors were mixed with 90% 
dissociated human brain tissue removed from patients undergoing epilepsy surgery to generate 
“transplanted ”hi-spot cultures (Figure 3-4 A-B).  
First, the survival and morphological change of MGE progenitors in hi-spot culture were 
inspected by observing live imaging of surviving GFP expressing MGE progenitors at different 
time points. The live imaging showed the MGE progenitors displayed round cell body and evenly 
distributed inside the hi-spots on day 1. The majority of MGE progenitors were lost by day 7. The 
remaining MGE progenitors started to grow primary processors and form small colonies on day 
14. Cells displayed secondary processors and migrated away from the cluster on day 28(Figure3-
4 C). The gradual changes in number and morphology of MGE progenitors suggest part of the 
initial cell population survive and differentiate inside the hi-spot cultures.  
Next, the hi-spots were fixed at post culture day 14 and 28 to investigate the phenotype of 
surviving MGE progenitors. The immunostaining showed Nkx 2.1 was co-stained with GFP. 
Similar to the phenotypes of MGE progenitor before transplantation (Figure 3-2A), the 
populations of Nestin+ and Tuj1+ cells could be both observed among Nkx2.1+ GFP+ cells on day 
14. On day 28, the population of GFP+Tuj1+cells co-expressed GABA+ or GAD 67+ could be 
observed in hi-spots, suggesting the transplanted MGE progenitors differentiated into functional 
GABAergic neurons (Figure 3-4D). Together, these results demonstrated that although there was 
distinct maturation kinetics among MGE progenitors due to the heterogeneity of the cells during 
differentiation, part of MGE progenitor population can survive and differentiate into 
morphologically identifiable GABAergic neurons in hi-spot culture.  
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Figure 3-4 Transplanted MGE progenitors into 3D hi-spot culture derived from human 
brain tissue show evidence of survival and GABAergic differentiation  
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A) The diagram of 3D hi-spot culture. The human brain tissue resected from patients during epilepsy surgery were 
dissociated with papain and mixed with 10% TG4-H7 derived MGE progenitors to generate hi-spots B) The cells were 
centrifuged into high density and placed as 3D hi-spot culture in air-liquid surface. C) The live image of MGE 
progenitors in hi-spot culture at different time points showed time-dependent morphological maturation. Scale bar 
50um D) Neuronal subsets co-expressed Nkx 2.1 and Nestin or Nkx2.1 and Tuj1 in GFP+ hESC-derived MGE 
progenitors on day 14, and Neuronal subsets co-expressed GABA and Tuj1 or GAD 67+and Tuj1c in GFP+ hESC-derived 
MGE progenitors on day 28. 
3.2.4. The epileptic microenvironment caused reduction in survival of MGE progenitors 
The epileptic microenvironment affects survival, proliferation and differentiation of new-born 
neurons in epilepsy (Barkas, Redhead et al. 2012, Danzer 2012, Cho, Lybrand et al. 2015). There 
is lack of evidence to elucidate whether transplanted neuron progenitors will be affected by the 
epileptic microenvironment. Previous research in our lab demonstrates pathological level of 
inflammatory cytokine IL-1β is maintained in the medium of sclerotic hippocampal hi-spots not 
in cortical hi-spots (Figure 3-3E). Therefore, in this research, hi-spot culture generated from 
sclerotic hippocampal tissue was used to simulate the epileptic microenvironment of chronic 
epilepsy. Meanwhile the hi-spots generated from cortical tissue removed from the same patient 
were used to simulate non-epileptic microenvironment.  
To decide on the most suitable MGE progenitors for hi-spot culture, the MGE progenitors of 
different differentiation days (differentiation day 20 and differentiation day 45) were transplanted 
in hi-spot culture(Figure3-5A).  
First, the number of surviving young MGE progenitors (Diff 20) and old MGE progenitors (diff 45) 
in hippocampal and cortical hi-spot were compared at different time points by live imaging 
(n=12 hi-spots coming from two patients in each condition). On Day 1 the number of surviving 
diff 20 and diff 45 MGE progenitors were similar in both cortical and hippocampal hi-spots (two-
way ANOVA, P>0.05) (Figure 3-5B), suggesting initial number of transplanted MGE progenitors 
was similar in hi-spots.   However, on day 7, the number of surviving diff 20 MGE progenitors 
was significantly reduced in both cortical and hippocampal hi-spots compared to the number of 
surviving diff 45 MGE progenitors in cortical and hippocampal hi-spots respectively (two-way 
ANOVA, F (1, 70) = 11.78 P=0.001) (Figure 3-5C). On day D14, diff 20 MGE progenitors were 
invisible in live imaging, only 3 cells were identified later in cortical hi-spot by immunostaining 
(not shown), while all were lost in hippocampal hi-spots. Mmeanwhile, diff 45 MGE progenitors 
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were still detectable with live imaging in both cortical and hippocampal hi-spots. These results 
suggest diff 20 MGE progenitors cannot survive as long in hi-spots compared to diff 45 MGE 
cells, irrespective of the microenvironment.  
Therefore, the hi-spot transplanted with Diff 45 MGE progenitors were used to investigate the 
effect of the inflamed microenvironment on cell survival at indicated time points (Figure 3-5D) 
The bar graph revealed that the number of surviving diff 45 MGE cells showed similar pattern of 
significant time dependent reduction in cortical and hippocampal hi-spots (n=12 hi-spots 
coming from three patients in each condition), two-way ANOVA. F (1,66) =42.35, P<0.0001). 
Overall, the number of surviving MGE cells was significantly higher in cortical hi-spot compared 
to the number in hippocampal hi-spot. (two-way ANOVA. F (2,66) =832.5, P<0.0001). Sidak’s 
multiple post-hoc comparison revealed the number of surviving MGE progenitors was 
significantly lower in hippocampal hi-spot compared to cortical hi-spots on post culture day 7 
and day 14. (276.98±9.68 vs 397.6±12.41, P<0.0001;181.72±11.76 vs 86.59±7.53, P<0.0001). 
(Figure 3-5B). The results suggest that the epileptic microenvironment of sclerotic hippocampus 
is detrimental to survival of MGE progenitors. 
Last, the phenotypes of surviving MGE progenitors were compared between cortical and 
hippocampal hi-spots (Figure3-5G). Nkx 2.1 is significantly downregulated at post-natal stage 
compared to pre-natal in populations of interneurons (Butt, Sousa et al. 2008). Previous data 
(Figure 3-4D) suggests Nkx 2.1 is rigidly expressed in transplanted MGE progenitor. In this 
experiment, the result revealed the proportion of Nestin+ Nkx2.1+ cells was significantly decreased 
in hippocampal hi-spots compare to cortical hi-spots (Figure 3-5E) (n=6 hi-spots coming from 
one patient in each condition, 17%±3% vs 36%±3%, unpaired t-test, P<0.01). In contrast, the 
proportion of Tuj1+ Nkx2.1+ cells among population of Nkx2.1+ cells was similar between cortical 
and hippocampal hi-spots (39%±5% vs 29%±10% two-way t-test, P>0.05) (Figure 3-5F). These 
results indicate Nestin+ young MGE progenitors are more vulnerable than Tuj1+ immature MGE-
like neurons in epileptic microenvironment. It implies that the epileptic microenvironment is 
having different effects on MGE progenitors with different phenotypes. 
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Figure 3-5 The survival of MGE progenitors in Hi-spot culture. 
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A) The illustration of experiment groups. The sclerotic hippocampal tissue simulated epileptic microenvironment while 
the cortical tissue simulated non-epileptic microenvironment. The survival of MGE progenitors of differentiation day 
20 or day 45 were quantified in cortical and hippocampal hi-spots. B) The bar graph showed the initial number of 
differ 20 and differ 45 MGE progenitors in hi-spot cultures on day 1. C) The bar graph showed the surviving number 
of differ 45 MGE progenitors was significantly higher in both cortical and hippocampal hi-spots compared to the 
number of diff 20 MGE progenitors on day 7(Data show mean± SEM, n=12,two-way ANOVA with, Sidak’s multiple 
comparisons test * denote significant differences between the conditions ***P<0.001; ****P<0.0001).D) Significant time 
dependent reduction of GFP-MGE progenitors in both cortical and hippocampal hi-spots. The surviving number of 
GFP-MGE progenitors was lower on D7 and D14 in hippocampal hi-spots compared with the number in cortical hi-
spots. (Data show mean± SEM, n=8, two-way ANOVA with Tukey’s post-hoc multiple comparisons test, * and # denote 
significant differences between the conditions and the time points, respectively. ##, **P<0.01; ####,****P<0.0001) E-
F) The bar graph showed the ratio of Nestin + Nkx2.1+and Tuj1+ Nkx2.1+ among population of Nkx2.1+ cells in cortical 
and hippocampal hi-spots (Data show mean± SEM, n=4, t-test, ns P>0.05, ***P<0.001) G) The immunoassaying 
compared population of Nkx2.1+Nestin+ and Nkx2.1+ Tuj1+ in hippocampal and cortical hi-spot cultures fixed on day 
14. (Scale bar 50um)  
3.2.5. The epileptic environment impaired maturation of MGE progenitors 
Next, the effect of epileptic microenvironment on morphological growth of MGE progenitors was 
investigated by comparing the cells in hippocampal hi-spots to cortical hi-spots. GFP density 
represents the number and morphological growth of the transplanted MGE progenitors. In 
cortical hi-spots, the overall MGE-like cells were more complex in morphology and covered 
larger area than the cells in hippocampal hi-spot. (n=10 cells coming from two patients in each 
condition) (Figure3-6 A, C). To further compare the morphological complexity and branch growth 
of MGE-like cells in cortical and hippocampal hi-spots, Sholl analysis was performed to single 
MGE progenitor in hippocampal and cortical hi-spots (Figure3-6 D). The repeated measures 
revealed that there was no significant variance among the MGE cells in hi-spots coming from 
two different patients. The area under curve which represents neurite complexity revealed 
impaired neurite complexity of MGE progenitors in hippocampal hi-spots compared to cortical 
hi-spots (Repeated measures ANOVA, F (1,8) =8.15, P=0.021) (Figure3-6 E). The branch of the 
cells in cortical hi-spots covered much longer distance (200um to 300 um) compared to the cells 
in hippocampal hi-spots. Correspondingly, total branch length (400±36 um vs 216±25 um, n=10, 
Repeated measures ANOVA, F (1,8) =28.493, P=0.001) and maximum branch length (210±22 um 
vs 120±10 um, n=10, Repeated measures ANOVA, F (1,8) =15.174, P=0.005) of MGE progenitor 
were significantly shorter in hippocampal hi-spots compare to cortical hi-spots (Figure3-6G-H). 
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On the other hand, cells in hippocampal hi-spots had similar number of branches compared to 
cells in cortical hi-spot. (two-way unpaired t-test, t=1.464, df=18, P=0.16) (Figure3-6F). These 
results suggest inflamed microenvironment interfered with branch elongation of MGE-like cells. 
Last, the differentiation of MGE progenitors in hippocampal and cortical hi-spot was compared 
by the ratio of Tuj1 and GAD 67 expressing MGE cells among the population of surviving MGE 
progenitors. The result showed that the proportion of Tuj1+ MGE cells was significantly increased 
on day 28 compared to day 14 in both types of hi-spots (n=12 hi-spots coming from three 
patients in each condition, two-way ANOVA, F (1,44) =17.74, P=0.0001). And the Sidak’s post-
hoc multiple comparison showed the ratio of Tuj1+ MGE-like cells in hippocampal hi-spots was 
significantly lower compared to the ratio in cortical hi-spots on day 28 (0.76±0.03 vs 0.57±0.05 
P=0.0014) but not on day 14 (0.32±0.06 vs 0.45±0.02 P=0.051) (Figure3-6I) Similarly, the 
population of GAD67+ MGE cells among the population of surviving MGE cells in hippocampal 
hi-spot was also significantly lower than that in cortical hi-spot on day 28 (Figure 3-6J). Together 
these results suggest that the epileptic microenvironment impaired neuronal differentiation of 
MGE progenitors in over 28 days in culture. 
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 A) The cortical and hippocampal hi-spots was fixed on day 14. The images of MGE progenitors processed by image J 
was shown in “Threshold”. Scale bar 50um B) The immunostaining showed the population of MGE cells co-expressed 
Tuj1 in cortical and hippocampal hi-spots on day 14. Scale bar 100um C) The bar graph showed average GFP density 
in cortical and hippocampal hi-spots. (Data show mean± SEM, n=4, t-test, *P<0.05) D) Cells were selected for Sholl 
analysis in image J. The number of crossings was counted at different distances. Data show mean± SEM, n=10 for each 
condition. E-H) The area under curve, the number of branches, the total length of branch and the maximum length of 
branch were compared between cells in cortical and hippocampal hi-spots. (Data show mean± SEM, n=10 for each 
condition, t-test, ***P<0.001). I) The bar graph showed the ratio of Tuj1+ MGE cells within total MEG cells at indicated 
time points and conditions. Data show mean± SEM, n=8, two-way ANOVA with Tukey’s post-hoc multiple 
comparisons * and # denote significant differences between the time points and the conditions, respectively. 
##,**P<0.01;****P<0.0001) J) The bar graph showed the ratio of GAD 67+ MGE cells within total MGE cells on Day 28 
(Data show mean± SEM, n=8, t-test, ***P<0.0001).  
  
Figure 3-6 The morphology and differentiation of MGE progenitors in hi-spot culture. 
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3.3 Discussion 
In this chapter, MGE progenitors, which can particularly give rise to inhibitory interneurons, were 
generated from hESCs according to the protocol published previously (Maroof, Keros et al. 2013). 
Next, a novel 3D hi-spot culture model which is composed of human brain tissue coming from 
patients undergoing epilepsy surgery to recreate the pathological microenvironment of chronic 
epilepsy has been established. With this model, it is possible to investigate the effects of epileptic 
microenvironment on human transplanted MGE-progenitors. The following results revealed that 
the epileptic microenvironment of TLE is detrimental for survival, neurite growth and 
differentiation of transplanted hESC-derived MGE progenitors in vitro. 
Transplanting MGE progenitors has been investigated as a cell replacement therapy for TLE in 
the last two decades. By simulating the microenvironment of telencephalon development in the 
embryonic stage, MGE progenitors can differentiate from hESCs (Liu, Liu et al. 2013). The former 
study suggests Wnt signaling and the SHH signaling pathway are the critical factors which direct 
the cells to achieve ventral–anterior telencephalic identity during brain development (Li, Zhang 
et al. 2009, Maroof, Keros et al. 2013). Early inhibition of the Wnt signaling pathway promotes 
hESC- derived neural progenitors to achieve anterior forebrain identity. SHH is one of the best-
known ventral pattern factors working throughout the neuron tube. In the absence of SHH 
signaling, the hESC-derived neural progenitors acquire a default dorsal identity (Nicoleau, Varela 
et al. 2013). The timing and degree of SHH activation modulates the ventralization of 
telencephalic cells (Maroof, Keros et al. 2013) (Liu, Liu et al. 2013, Nicoleau, Varela et al. 2013). 
The data showed homogeneous and effective production of MGE-like Nkx2.1+ neuron 
progenitors with time-controlled activation of SHH signaling. However, PV-expressing cells were 
absent at the later stage of differentiation, possibly because the cells in differentiation exhibit the 
identity of dorsal MGE not ventral MGE, which is where most PV cells arise from (Reinchisi, Ijichi 
et al. 2012, Tyson, Goldberg et al. 2015). The other reason could be that PV is expressed at a later 
stage which requires extended time for differentiation in vitro. 
To observe the survival and differentiation of hESC-derived MGE-like progenitors in the epileptic 
microenvironment after neuron transplantation, 3D hi-spot cultures were used to simulate the 
pathological microenvironment in chronic TLE. Only a small proportion of MGE-like progenitors 
were found to survive in human hi-spots. About 60% to 80% of MGE progenitors died in hi-spots 
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culture during the first week in both cortical and hippocampal hi-spots. The exact reason for early 
death of MGE progenitors in still unknown. One possibility is the hi-spots generated from adult 
brain tissue are lacking neurogenic factors which are essential to support survival of neuronal 
stem cells (Bjornsson, Apostolopoulou et al. 2016). So far only two regions of the hippocampus, 
SVZ and DG, have been proven to support neurogenesis in an adult rodent model(Jin, Minami et 
al. 2001). So, transplantation of MGE progenitors (around differentiation day 20) usually targets 
the DG in adult rodent models (Henderson, Gupta et al. 2014, Kepecs and Fishell 2014, Kim, Yao 
et al. 2014, Wang, Hong et al. 2016). The cortical tissue and the hippocampal tissue removed 
from patients may lack the neurogenic niche to support the survival of MGE progenitors. 
Secondly, the young progenitors require survival signals from each other by direct contact 
(Southwell, Paredes et al. 2012). The immature nestin+ cells which survive in hi-spot usually form 
small clusters. The mature tuj1+ cells were more independent and tended to migrate away from 
the cluster. Similar phenomena were seen in animal MGE transplantation experiments, where 
more than half of the transplanted MGE cells which stay in the injection site were immature cells, 
but only a small proportion of MGE cells became mature neurons and migrated (Hunt, Girskis et 
al. 2013, Cunningham, Cho et al. 2014). This suggests mechanical isolation of MGE progenitors 
when generating hi-spots might cause cell death due to lack of survival signals from each other 
in hi-spots where they are distributed uniformly at least initially. Thirdly, the brain 
microenvironment strictly selects the new born neurons and only a small proportion of new born 
neurons are finally qualified to develop into functional neurons (Southwell, Paredes et al. 2012). 
Therefore, transplanted MGE progenitors could be eliminated by intrinsic factors during early 
stages of development.  
Unlike old MGE progenitors (diff 45), young MGE progenitors (Diff 20) are less likely to survive in 
hi-spot culture. Possibly because survival of young neuron progenitors relies on neurotrophic 
factors, such as BDNF, NGF. Evidence suggests neurotrophic factors are critical to promote 
proliferation and survival of neuron stem cells (Chao 2003, Jiao, Palmgren et al. 2014). It is 
necessary to further characterize the hi-spot culture to figure out the levels of major detrimental 
cytokines and beneficial growth factors in hi-spots. It will be also interesting to investigate 
whether survival of MGE progenitors can be improved by treatment with neurotrophic factors.    
A GWAS and exome sequencing based on human sclerotic hippocampus reported upregulation 
of TLR-signaling and various cytokine genes which cause neuron death and abnormal 
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neurogenesis (Johnson, Behmoaras et al. 2015). The levels of IL-1β, TNF-α and IL-6 increased 
within 24 h after epilepsy in patients and experimental models (Uludag, Duksal et al. 2015, de 
Vries, van den Munckhof et al. 2016, Alapirtti, Lehtimaki et al. 2018). The cytokines secreted after 
acute injury could lead to excitotoxicity, oxidative stress, and neuron apoptosis (Lorigados Pedre, 
Morales Chacon et al. 2018). Several studies suggested attenuated acute inflammatory response 
prevented neuron injury and reduced seizures in experimental models of epilepsy (Vezzani and 
Granata 2005). In chronic epilepsy, neuroinflammation could last for years. Cytokines produced 
by immune cells and the local brain cells regulate neurogenesis (Kokaia, Martino et al. 2012). The 
chronic inflamed microenvironment aggravates abnormal neurogenesis in the 
hippocampus(Belarbi and Rosi 2013). Previous experiments in our lab found that the pro-
inflammatory cytokines were enriched and maintained at a high concentration for weeks in hi-
spots generated from human sclerotic hippocampus (Zaben &Gray). So, the hi-spot culture 
makes it possible to observe the survival and differentiation of hESC-derived MGE cells in a 
human brain-based organ-like structure with a preserved pathological microenvironment. 
Consistent with previous research which found that pathological levels of pre-inflammatory 
cytokines produced in neurodegenerative diseases and brain injury induce neuron death (McCoy 
and Tansey 2008, Glass, Saijo et al. 2010), the results demonstrated that the inflamed 
microenvironment of the hippocampus led to reduced surviving number of transplanted 
exogenous MGE progenitors. The possibility that an inflamed microenvironment prevents 
proliferation of MGE progenitors should be taken in to consideration as well. Evidence suggested 
systematic inflammation acutely prevented proliferation of neuron precursors in DG (Fujioka and 
Akema 2010). But in the experiment, the number of surviving MGE progenitors in hi-spot culture 
didn’t significantly increase on post culture day 28 compared to post culture day 14 in both 
cortical and hippocampal hi-spots. This suggests MGE progenitors may not proliferate in hi-spot 
culture. Therefore, the reduced number of surviving MGE progenitors is mainly caused by cell 
death rather than reduced cell proliferation. 
There are two possible reasons for the reduced number of mature neurons (Tuj1+ and GAD 67+ 
cells) in sclerotic hippocampal hi-spots, one is altered neuronal differentiation; the other is 
delayed neuronal differentiation in pathological microenvironment. Some research support the 
idea that pro-inflammatory cytokines, such as IL-1β and TNF-α, promote astroglial 
differentiation instead of neuronal differentiation(Peng, Whitney et al. 2008, Green, Treacy et al. 
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2012), while there is also evidence to support the later assumption. BDNF is an environmental 
neurotrophic factor that promotes neuronal differentiation and improves neuron survival(Jiao, 
Palmgren et al. 2014). IL-1β has been reported to suppress BDNF signal via activating P38-MAPK 
pathway(Tong, Balazs et al. 2008, Tong, Prieto et al. 2012). It is possible that IL-1β prolongs 
neuronal differentiation of MGE progenitors in inflamed microenvironment by interfering with 
the BDNF neurotrophic signal. This hypothesis needs to be investigated in the future.   
In general, the results suggest that the epileptic microenvironment can cause reduced efficiency 
of cell replacement treatment. There is still much work needed to recognize the main 
inflammatory cytokines which are detrimental for survival and differentiation of transplanted 
neuron progenitors. Hi-spots culture is a method to predict how inflammation affects the 
transplanted neuron progenitors, therefore providing an optimized strategy for future clinical 
neuron transplantation therapy. 
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4. IL-1RA restored differentiation of transplanted MGE progenitors 
in inflamed microenvironment. 
4.1 Introduction 
Cytokines, in physiological levels, play an important role in regulating cell proliferation, survival, 
and neuronal differentiation during CNS development (Mehler and Kessler 1997). The 
inflammatory milieu is entirely different after seizures and in chronic epilepsy where significant 
upregulation and secretion of inflammatory cytokines by peripheral immune cells, local microglia, 
astrocytes and neurons are observed (Vezzani, Balosso et al. 2008, Uludag, Duksal et al. 2015, 
Vezzani and Viviani 2015). To a physiological extent, cytokines are necessary for activating the 
growth and differentiation of neuronal stem cells which might replace the lost neurons and 
facilitate neuronal circuit repair (Kokaia, Martino et al. 2012, Belarbi and Rosi 2013). On the 
contrary, evidence showed prolonged and intensive stimulation of inflammatory cytokines lead 
to neuron death and abnormal neurogenesis in epilepsy and brain injury (Belarbi and Rosi 2013, 
Webster, Sun et al. 2017). The detrimental effects of inflammatory cytokines further increase 
seizure susceptibility in epilepsy (Ravizza, Gagliardi et al. 2008, Maroso, Balosso et al. 2011). 
However, it is not always clear what the significant and key mediators of neuroinflammation are 
in epilepsy or indeed the many brain diseases for which cell therapy might be applicable.  
Interleukin-1 (IL-1) is one of most powerful pro-inflammatory cytokines which contributes to a 
variety of neurological and neurodegenerative diseases in the CNS (Toulmond, Parnet et al. 1996, 
Allan, Tyrrell et al. 2005). IL-1R has two different ligands, IL-1α and IL-1β. They have similar 
biological effects caused by the activation of the IL-1 receptor mediated signaling pathway. IL-
1α is only released after cell death, while IL-1β is secreted into the blood stream by living cells 
(Dinarello 2009). Researches reveal that IL-1β produced by activated microglia affects the 
generation, differentiation and survival of neural stem cells (Green, Treacy et al. 2012, Belarbi and 
Rosi 2013). IL-1β is also one of the major pro-convulsant inflammatory factors released in both 
seizure generation and epileptogenesis. Its pro-convulsant effect is involved in regulating 
neuronal network excitability, turnover and release of various neurotransmitters, expression of 
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neuropeptides and neurotrophic factors, and altering synaptic transmission and ionic currents 
(Vezzani, Moneta et al. 2000, Friedman 2001, Allan, Tyrrell et al. 2005, Johnson, Behmoaras et al. 
2015)..  
Immune cells such as monocytes and macrophages contribute to the early production of IL-1β. 
All endogenous brain cells including microglia, astrocytes and neurons could secrete IL-1β at a 
later stage after brain insults (Allan, Tyrrell et al. 2005). Therefore, elevated levels of IL-1β can 
accumulate in chronic epilepsy. In the previous chapter, it was found that the epileptic 
microenvironment reduced cell survival and compromised branch growth and differentiation of 
hESC-derived MGE progenitors. It is interesting to know whether the detrimental effect of the 
epileptic microenvironment could be reversed by modifying the environment. In established hi-
spot cultures generated from sclerotic hippocampus, IL-1β is continuously secreted and 
maintained in high concentration (Zaben&Gray). So, it is worth to figure out, whether the 
increased level of IL-1β affects survival, branch growth and differentiation of MGE progenitors in 
the pathological microenvironment of epilepsy.  
In this chapter, IL-1RA, a competitive antagonist of IL-1R1 was applied to epileptic hippocampal 
hi-spots to investigate whether there was any potential benefit in improving the efficiency of 
MGE transplantation therapy for epilepsy. The results showed an improvement in branch growth 
and a restored ratio of mature MGE-like neurons but no significant increase in cell survival in IL-
1RA treated hi-spots. To investigate whether IL-1β plays a dominant role in inflamed 
microenvironment, IL-1β was applied to non-sclerotic hippocampal hi-spots to test its effects on 
survival and differentiation of MGE progenitors. The result showed IL-1β caused reduced survival 
and branch growth but didn’t affect differentiation of MGE-like cells. The data provide evidence 
that IL-1β is one of the important targets to restore the detrimental effects of pathological 
microenvironment on MGE progenitors. 
4.2 Results 
4.2.1 IL-1RA didn’t improve the survival of MGE cells in an inflamed environment. 
Having found the detrimental effects of the epileptic microenvironment on the survival and 
differentiation of MGE-like cells, this experiment tried to modify the inflamed microenvironment 
by applying IL-1RA and testing its effects (see method 2.2.4). The surviving number of MGE-like 
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cells in IL-1RA treated hi-spots were compared to untreated hi-spots on post culture day 14 and 
day 28 (Figure 4-1A). The results revealed the number of surviving MGE-like cells did not 
significantly improve in IL-1RA treated hippocampal hi-spot compared to untreated at either 
time point (n=12 hi-spots coming from three patients for each condition, two-way ANOVA, F 
(1,44) =1.459, P=0.23) (Figure 4-1B). Likewise, in cortical hi-spots, the number of surviving MGE-
like cells wasn’t changed by the application of IL-1RA. (n=12 hi-spots coming from three patients 
for each condition, two-way ANOVA, F (1,44) =0.465, P=0.49) (Figure 4-1C). Besides, in both 
cortical hi-spots (two-way ANOVA, F (1,44) =0.823, P=0.40) and hippocampal hi-spots (two-way 
ANOVA, F (1,44) =2.819, P=0.1) the number of surviving MGE-like cells on post culture day 14 
was similar to post culture day 28. These results suggest IL-1RA did not improve the survival of 
MGE progenitors in the epileptic microenvironment. 
4.2.2 IL-1RA promoted neurite growth and restored differentiation of MGE progenitors in 
epileptic microenvironment. 
Next, Sholl analysis was used to compare the morphological complexity of MGE-like cells in IL-
1RA treated hippocampal hi-spots to the cells in untreated hi-spots (Figure 4-1F). Interestingly, 
maximum branch lengths were improved in IL-1RA treated cells than untreated (164.1±13.0um 
vs 120.9±10.3um, Repeated measures ANOVA, F (1,8) =6.707, P=0.032 (Figure 4-1J). The cells in 
IL-1RA treated hi-spots showed longer extensions over 160um compared with cells in untreated 
hi-spots. Correspondingly, the area under the curve for the sholl analysis was in IL-1RA treated 
cells compared to untreated (229.5±14.0 vs 173.5±23.2, n=10 for each condition, Repeated 
measures ANOVA, F (1,8) =7.379, P=0.026) (Figure 4-1G) However, the number of branches was 
similar between IL-1RA treated and untreated cells () (Figure 4-1H). These results suggest IL-1RA 
partially restored neurite elongation but didn’t improve neurite sprouting of MGE progenitors in 
epileptic microenvironment. 
Lastly, the differentiation of MGE progenitors was examined by comparing the expression of Tuj1 
and GAD 67 in MGE-like cells in IL-1RA treated hippocampal and cortical hi-spots to untreated. 
The results revealed the ratio of Tuj1+ MGE-like cells (n=12 hi-spots coming from three patients 
for each condition, two-way ANOVA, F (1,44) =5.081, P=0.029) and GAD 67+ MGE-like cells (n=12 
for each condition, two-way ANOVA, F (1,44) =7.655, P=0.0082) were significantly higher in IL-
1RA treated hi-spots compared to untreated (Figure 4-1D-E). Tukey’s multiple comparison 
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revealed the ratio of Tuj1+ MGE-like cells (0.71±0.03 vs 0.57±0.05, P=0.032) and GAD 67+ MGE-
like cells (0.43±0.03 vs 0.27±0.02, P=0.001) were significantly improved in hippocampal hi-spots 
but not in cortical hi-spots by the application of IL-1RA (Figure 4-1D-E). This result suggests 
increased neuronal differentiation of MGE progenitors in epileptic microenvironment of the 
epileptic hippocampus only 
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Figure 4-1 The effect of IL-1RA on MGE progenitors in the inflamed microenvironment  
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A) The illustration of experimental groups. Brain tissue removed from patients with TLE was used in the experiment. 
IL-1RA was added into culture medium from the beginning. The hi-spots from different conditions were fixed on day 
14 and day 28. B-C) The bar graph showed no significant changes on day 14 and day 28 in survival of MGE progenitors 
which received IL-1RA treatment. Data show mean± SEM, Patient =2, n=4 for each condition, two-way ANOVA with 
Tukey’s post-hoc test, ns P>0.05. D-E) The bar graph showed on day 28 the ratio of Tuj1+ and GAD 67+ cells in MGE 
progenitors were improved after IL-1RA treatment. Data show mean± SEM, Patient =2, n=4 for each condition, two-
way ANOVA with Tukey’s post-hoc test, *P<0.05, ***P<0.001. F) Cells in hippocampal hi-spots were selected for sholl 
analysis in image J. The number of crossings were counted at different distances. Data show mean± SEM, n=10 for 
each condition. G-J) The area under curve, the number of branches, the total length of branch and the maximum 
length of branch were compared between MGE-like cells with or without treatment of IL-1RA in hippocampal hi-spots.  
4.2.3 IL-1β caused acute death and altered branch growth of MGE-like cells in a non-
epileptic environment                                       
Previous results showed the detrimental effects of the epileptic microenvironment on 
transplanted MGE progenitors were partly reversed by applying IL-1RA. In the following 
experiment, the effect of IL-1β alone on the survival and differentiation of MGE progenitors was 
inspected in the non-epileptic hippocampus.  
The hi-spots were generated from a unique patient with non-sclerotic hippocampal and cortical 
tissue removed from patient undergoing lesional brain tumor surgery. First, the surviving number 
of MGE-like cells in IL-1β (10ng/ml) treated hi-spots were compared to untreated hi-spots on 
post culture day 14 and day 28 (Figure 4-2A). The results showed the number of surviving MGE-
like cells was significantly reduced in IL-1β treated hippocampal hi-spots compared to untreated 
(n=8, two-way ANOVA, F (1,28) =14.59, P=0.0007) (Figure 4-2 B). Moreover, Tukey’s post-hoc 
comparison revealed the number of surviving MGE cells was significantly lower in IL-1β treated 
hippocampal hi-spots on day 14 (66.8±7.8 vs 139.3±11.7, P=0.0012) but not on day 28 (57.9±5.7 
vs 77.7±18.8, P=0.65) (Figure 4-2B-C). In addition, the number of surviving MGE cells didn’t 
reduce from post culture day 14 to day 28 in IL-1β treated hi-spot, (Tukey’s multiple comparison, 
P=0.95). while in untreated hi-spots, the number was significantly lower on post culture day 28 
compared to day 14 (Tukey’s multiple comparison, P=0.0062) (Figure 4-2 B-C). On the contrary, 
the surviving number of MGE-like cells didn’t change in IL-1β treated cortical hi-spots compared 
to untreated at both time points. (n=8 for each condition, two-way ANOVA, F (1,28) =0.7555, 
P=0.39) (Figure 4-2 B). The results suggest IL-1β temporarily reduced the initial survival of MGE 
progenitors but didn’t affect cell survival in the longer-term perspective between days 14-28. 
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Next, Sholl analysis was used to inspect the effect of IL-1β on the morphological development 
of MGE-like cells in non-epileptic hippocampal hi-spots. As shown in the graph, MGE-like cells 
in IL-1β treated hi-spots showed fewer crossings than cells in untreated hi-spots from 0 to 
120um (Figure 4-2 E). Consistently, the area under the curve was significantly smaller in cells 
treated with IL-1β compared to untreated (224.0±17.4 vs 306.5±17.7 n=10 for both conditions, 
two-way unpaired t-test, t=3.315, df=18, P=0.0035) (Figure 4-2 F). The number of branches was 
lower but not significantly so, in cells treated with IL-1β compared to untreated (2.3±0.3 vs 
3.3±0.4, t=2.013, df=18, P=0.0593) (Figure 4-2 G). There were no significant changes in total 
branch length (P=0.11) or maximum branch length (P=0.49) (Figure 4-2 H-I).  
Lastly, the effect of IL-1β on differentiation of MGE progenitors was investigated by comparing 
the ratio of Tuj1+ MGE-like cells in IL-1β treated to untreated hi-spots. The result showed the 
ratio of Tuj1+ MGE-like cells was similar between IL-1β treated and untreated hi-spots (two-way 
ANOVA, F (1,28) =0.3821, P=0.54) (Figure 4-2D). Together, these results suggested IL-1β alone 
had limited effect on survival and branch growth in non-epileptic hippocampal hi-spots but did 
affect differentiation of MGE progenitors. 
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Figure 4-2 The effect of IL-1β on MGE progenitors in non-inflamed microenvironment
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A) The illustration of experimental groups. Non-epileptic brain tissue removed from patients was used in the 
experiment. IL-1β was added into culture medium from the beginning. The hi-spots from different conditions were 
fixed on day 14 and day 28. B-C) The bar graph showed survival of MGE progenitors on day 14 and day 28 in IL-1β 
treated and untreated cortical and hippocampal hi-spots. Data show mean± SEM, Patient =1, n=4 for each condition, 
two-way ANOVA with Tukey’s post-hoc test, ns P>0.05. D) The bar graph showed on day 28 the ratio of Tuj1+ in MGE 
progenitors were similar in IL-1β treated and untreated hi-spots, (two-way ANOVA with Tukey’s post-hoc test, *P<0.05, 
***P<0.001. E) Cells in hippocampal hi-spots were selected for sholl analysis in image J. The number of crossings were 
counted at different distances. Data show mean± SEM, n=10 for each condition. F-I) The area under curve, the number 
of branches, the total length of branch and the maximum length of branch were compared between cells with or 
without treatment of IL-1β in hippocampal hi-spots. Data show mean± SEM, n=10 for each condition, t-test, *P<0.05) 
4.3 Discussion  
The results in this chapter demonstrate that applying IL-1β alone temporarily reduced the survival 
of transplanted MGE progenitors and delayed their morphological maturation in epileptic 
hippocampal hi-spots. By blocking IL-1β activation of the ILR1 receptor, the detrimental effects 
of microenvironment on neurite growth and differentiation of MGE progenitors were partially 
reversed. These findings highlight the potential importance of an optimal microenvironment for 
achieving optimal outcomes from cell transplantation for chronic epilepsy and identify the IL-
1β/IL-1R1 pathway as an important component of the pathological microenvironment relevant 
to cell replacement therapy in human TLE.  
This research found that IL-1β reduced survival of MGE progenitors when applied to non-
epileptic hippocampal hi-spots. However, when the IL-1β/IL1-R1 pathway was blocked in 
epileptic hippocampal hi-Spot tissue, the survival of transplanted MGE progenitors didn't 
improve. Moreover, in non-epileptic cortical hi-spots, addition of IL-1β didn’t affected cell 
survival at all. There are several possibilities underlie the conflicting results. Firstly, IL-1β seems 
to exert complex effects by interacting with, and being influenced by, multiple cell types, such as 
microglia and astrocyte, in the brain (Allan, Tyrrell et al. 2005). It is important to remember that 
in epileptic hippocampal hi-spots, immune cells and microglia have been recruited and the 
inflammatory cytokines have been accumulated before generation of the hi-Spot. Therefore, 
other signalling pathways which cause cell death have been already activated before giving IL-
1RA. On the contrary, in non-epileptic hi-spots, only inactivated local immune cells exist, so 
adding IL-1β merely evokes immune response locally and is not strong enough to cause similar 
detrimental effect as the inflammatory cytokines in epileptic hi-spots do. Although microglia are 
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present in all major divisions of the brain, the distribution of microglia is much denser in 
hippocampus compared to cortex(Lawson, Perry et al. 1990) and therefore the immune 
responses is milder in cortex than hippocampus. That may explain why there is no significant 
death of MGE progenitors in cortical hi-spots treated with IL-1β. Similar to my result, an in vivo 
study shows injection of IL-1β (20ng) into normal cortex fails to cause any brain damage 
(Stroemer and Rothwell 1998). Secondly, although IL-1/TLR is the most common and classic cell 
signalling pathway activated by IL-1β, mice lacking IL-1 receptors have 
exacerbated ischemic brain damage caused by IL-1β (Touzani, Boutin et al. 2002). So, it is 
possible that IL-1β can activate other receptors which are independent of the IL-1 receptor. This 
may be another reason that cell survival didn’t improve by treatment of IL-1RA. Thirdly, evidence 
suggests IL-1β has contradictory effects on neurons in vitro corresponding to its concentration 
and duration of treatment. For example, IL-1β shows a protective effect for cortical neurons 
incubated with excitatory amino acids when applied for 24hr, but resulted in neurotoxicity when 
the application is extended to 72hr (Strijbos and Rothwell 1995). In addition, IL-1β cooperates 
with other cytokines and damage signals, because IL-1β by itself is not neurotoxic in some cell 
cultures (Fogal, Hewett et al. 2005). For example, HMGB1 which is secreted at the later stage after 
brain injury could enhance the effect of IL-1β through formation of complexes with IL-
1β(Wähämaa, Schierbeck et al. 2011).  Moreover, combined treatment with TNFα, IL-1β, and IFNγ 
in astrocytes results in distinct upregulation of several genes for cytokines and growth factors 
which can't be induced by applying IL-1β alone (Meeuwsen, Persoon-Deen et al. 2003). Therefore, 
in healthy microenvironment, where other cytokines are absent, the effect of IL-1β may be limited. 
It is also worth to notice that in health hippocampal hi-spots, MGE progenitors survive better 
than cortical hi-spots; while in sclerotic hippocampal hi-spots, the survival of MGE progenitors is 
reduced compared to cortical hi-spots. It is possibly due to that the dentate gyrus of the 
hippocampus is the region for adult neurogenesis and was chosen for MEG progenitor injection 
site in many rodent experiments (Henderson, Gupta et al. 2014, Kepecs and Fishell 2014, Kim, 
Yao et al. 2014, Wang, Hong et al. 2016). Thus, health hippocampus could be more supportive 
of the survival of MGE progenitors. But due to the limitation of human tissue, it is impossible to 
compare the survival of MGE progenitors in normal to sclerotic hippocampus from the same 
patient. And the composition of cortical tissue is not the same as hippocampal tissue even from 
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the same patient. Therefore, it will be important to validate the assumption with rodent model in 
the future. 
Although the surviving number of MGE cells is important in cell transplantation, the surviving 
number of functional inhibitory neurons is more critical for restoring the overexcited neuronal 
network of epilepsy. In this experiment, the proportion of MGE cells expressing Tuj1 or GAD 67 
were recovered by applying IL-1RA in hippocampal hi-spots. In line with the results, previous 
research shows that during neuronal differentiation, IL-1β has an anti-neurogenic but pro-
gliogenic effect on neuron progenitor cells mediated by IL-1R1 (Green, Treacy et al. 2012), and 
restored neuronal differentiation of hippocampal neuron progenitors can be achieved by IL-1RA 
(Zhang, Xu et al. 2013). While there is also evidence supports the other assumption. BDNF is an 
environmental neurotrophic factor that promotes neuronal differentiation and improves neuron 
survival(Jiao, Palmgren et al. 2014). IL-1β has been reported to suppress BDNF signal via 
activating P38-MAPK pathway(Tong, Balazs et al. 2008, Tong, Prieto et al. 2012). It is possible 
that IL-1β prolongs neuronal differentiation of MGE progenitors in inflamed microenvironment 
by interfering with the BDNF neurotrophic signal. In addition, IL-1RA also partly restored branch 
growth of MGE cells in the epileptic microenvironment. So far, there is a lack of evidence for the 
direct effect of IL-1RA on improving branch growth. However, evidence showed an IL-1RA 
activated specific phenotype of microglia which has repair and regenerative functions (Chhor, Le 
Charpentier et al. 2013). The growth factors released by those microglia may help to restore 
neurite growth of MGE-like neurons.  
Although previous researches show chronic application of IL-1β supresses hippocampal 
neurogenesis in mice and reduces proliferation of hippocampal neuron progenitors (Goshen, 
Kreisel et al. 2008, Ryan, O'Keeffe et al. 2013), there is no evidence in hi-spots that the 
proliferation of MGE cells was affect by IL-1β in hi-spot cultures, as the number of surviving MGE 
cells were similar on day 28 compared to day 14. The reason might be the brain tissue used for 
hi-spots might not form the neurogenic niche which is necessary for cell proliferation. In addition, 
alterations in neuronal differentiation via IL-1β (Peng, Whitney et al. 2008, Zhang, Xu et al. 2013) 
were not observed in MGE progenitors cultured in hi-spots. This is also in contradiction with the 
result that IL-1RA restored neuronal differentiation of MGE progenitors in the epileptic 
microenvironment. It implies IL-1β alone is not enough to cause alterations in the neuronal 
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differentiation of MGE progenitors but collaboration with other cytokines is necessary to trigger 
the regulatory signal downstream.   
Despite the area under the curve of Sholl analysis showed a significant difference between IL-
1RA treated and untreated MGE-like cells in sclerotic hippocampal hi-spots, the complexity of 
MGE-like cells was not different, as the branch number was similar, and the highest number of 
crossings showed at the initial segment were similar between treated and untreated cells. This 
result represented that the MGE-like neurons displayed simple morphology with predominantly 
primary branches in hippocampal hi-spots. As one of the limitations for hi-spot cultures, the hi-
spots can’t be kept for longer than a month, which is not long enough for complex neurite 
formation of hESC derived MGE-like cells. Even in health hippocampal hi-spots, the average 
number of branches is about only 3, which is similar to the number in untreated sclerotic 
hippocampal hi-spots. So, restricted by the culture model, it is not enough the draw a conclusion 
that IL-1RA or IL-1β can affect nascent neurite formation. But the Sholl analysis also presented 
information about neurite elongation. Neurite initiation and elongation simultaneously occur 
during neurite differentiation, but the mechanism is not exactly the same. The initiation of a 
nascent neurite starts with the formation of an actin rich filopodia from the neuronal cell body, 
followed by a broadening of the filopodia into a neurite. While neurite elongation is due to the 
extension of microtubules into actin rich filopodia (Sainath and Gallo 2015, Athamneh, He et al. 
2017). My results suggested neurite elongation not neurite formation is partially revered by apply 
IL-1RA in sclerotic hippocampal hi-spots. Similar to my observation, IL-1β reduces neurite 
growth of rat hippocampal precursor cells when being applied for 7 days (Green, Treacy et al. 
2012). And in KA model of epilepsy, the morphological complexity of PV and CCK expressing 
interneurons was significantly reduced (Khan, Shekh-Ahmad et al. 2018). However, in addition to 
IL-1β, TNF-α is also upregulated in chronic epilepsy, and can directly inhibit neurite formation 
by activating GTPase RhoA (Neumann, Schweigreiter et al. 2002). This additional signalling may 
explain why IL-1RA can't completely reverse the detrimental effect of the inflamed 
microenvironment on neurite growth. 
In general, blockage of the function of IL-1β is beneficial for MGE progenitors in an epileptic 
microenvironment. The restored differentiation of MGE progenitors could be critical in long term 
restoration of imbalance between inhibition and excitation in epilepsy. The results suggest that 
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combined anti-inflammatory therapy may improve the outcome of MGE progenitor 
transplantation in epilepsy. 
  
71 
 
5. IL-1β mediated modulation of voltage-gated sodium currents 
reduces cellular excitability in HESC-derived MGE-like neurons  
5.1 Introduction 
Previous studies suggest that neuronal activity is compromised by inflammatory cytokines 
released after brain injury, infection and seizure. Increasing evidence supports the idea that 
cytokines can interact with receptor and voltage-gated ion channels to regulate neuronal 
excitability, synaptic plasticity and neuron transmitter release (Schafers and Sorkin 2008, Vezzani 
and Viviani 2015). The disrupted neuronal activity in the inflamed environment is closely related 
to ictal discharges and the development of epileptiform activity (Librizzi, Noe et al. 2012, Webster, 
Sun et al. 2017).  
IL-1β is one of the predominant cytokines released after seizures. In the previous chapter, the 
effect of IL-1β on survival and differentiation of inhibitory neuron progenitors was discussed. This 
chapter will present the results of electrophysiological experiments performed to determine the 
effects of IL-1β on neuronal excitability. Several studies suggest that a pathological concentration 
of IL-1β in the CNS and PNS can affect excitability of principle neurons (Diem, Hobom et al. 2003, 
Liu, Yang et al. 2006, Schafers and Sorkin 2008, Zhou, Qi et al. 2011, Vezzani and Viviani 2015). 
Furthermore, IL-1β also significantly reduces GABAA-R mediated currents in the hippocampus 
and the temporal cortex of patients with TLE (Roseti, van Vliet et al. 2015). However, the effects 
of inflammatory cytokines, including IL-1β, on the function of inhibitory GABAergic neurons 
remain unknown. 
Although inhibitory neurons make up only 20% of the neuronal population in the cortex, they 
provide input to a large group of surrounding excitatory neurons to coordinate network activities, 
and their dysfunction in seizures and epilepsy is well known. Thus, this work investigated the 
acute and chronic effects of IL-1β on the electrophysiological activities of hESC-derived MGE-
like inhibitory neurons. The experiments found that acute exposure to IL-1β caused a reduction 
of voltage-gated sodium channel (VGSC) currents which lead to reduced excitability in MGE 
neurons. Chronic exposure to IL-1β causes apoptosis of astrocytes which indirectly affects the 
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viability of MGE neurons. These results suggest the function of inhibitory neurons is compromised 
in the inflamed microenvironment which may contribute to insufficient inhibitory output in 
epilepsy.  
5.2 Results 
5.2.1 MGE progenitors co-cultured with human astrocytes develop mature 
electrophysiological properties 
To investigate the electrophysical activity of hESC-derived neurons ex vivo, the neuron 
progenitors were usually cultured with mouse astrocytes or conditioned medium to accelerate 
the electrophysiological maturation of neuron progenitors (Maroof, Keros et al. 2013, Bardy, van 
den Hurk et al. 2016, Telezhkin, Schnell et al. 2016). Since astrocytes of different origins are 
diverse in phenotype and function (Song, Stevens et al. 2002, Roy, Cleren et al. 2006) and to 
simulate the microenvironment of the human hippocampus where the MGE transplantation is 
targeted, human hippocampal astrocytes from foetal tissue were used to support the functional 
maturation of MGE cells in conditioned medium (See Method 2.3.1). HESC-derived MGE 
progenitors after differentiation day 20 were collected and plated on the top of coverslips 
covered with human hippocampal astrocytes. The standard culture medium (see 2.1.4 Human 
ESC differentiation) was replaced with conditioned medium (SCM) which contained a 
combination of neurotrophic factors to promote neuronal maturation (Telezhkin, Schnell et al. 
2016) (2 weeks: N = 14, 6 weeks: N = 10 ) (Figure 5-1C-D)  
Whole cell patch clamp recordings were performed in the current clamp (Iclamp) mode to measure 
the excitability of MGE-like cells as they developed in vitro (2 weeks: N = 14, 6 weeks: N = 10 ) 
(Figure 5-1C-D)  
Spontaneously occurring and current-step evoked over-shooting (full action potentials were 
defined as spikes whose peak crossed 0mV) and action potentials (APs) were measured after 2 
and 6 weeks of astrocyte co-culture. Patch clamp recordings performed at 2 weeks post co-
culture demonstrated presence of APs (9 from 14) in MGE-like cells. Six weeks after co-culture, 
the cells showed more repetitive APs than after two weeks (2 weeks: N = 14, 6 weeks: N = 10 ) 
(Figure 5-1C-D)  
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Consistent with functional development of neurons in vitro previously described by others 
(Nicholas, Chen et al. 2013),  these recordings showed the resting membrane potential 
(RMP)(P<0.05, unpaired t-test) and input resistance (RIN) (P<0.01, unpaired t-test) of MGE-like 
neurons were significantly reduced after 6 weeks of astrocyte co-culture versus two weeks co-
culture (2 weeks: N = 14, 6 weeks: N = 10 ) (Figure 5-1C-D)  
A) Schematic representation of the astrocyte-neuron co-culture protocol.  TG4-H7 cell line derived MGE-like 
progenitors (Diff day 20) line were cultured with human hippocampal astrocyte in SCM medium. Electrophysiological 
data were collected at 2 and 6 weeks after co-culture. B) MGE-like progenitors were labelled with Tau-GFP. Neurons 
with large smooth cell bodies were selected for patch clamp recording. ‘wide-field fluorescence image on a neuron 
expressing GFP’ and on the right ‘a differential interference contrast image of the cell showing the whole-cell recording 
electrode C-D) RMP was significantly more hyperpolarized and RIN were significantly lower in MGE-like neurons co-
cultured with astrocytes for 6 weeks compared to 2 weeks. E) The graph showed traces of evoked action potentials of 
MGE-like neurons 2w and 6w after co-culture.  
  
Figure 5-1 MGE progenitor co-cultured with astrocyte developed functional electrophysiological 
activities 
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5.2.2 MGE progenitors showed reduced excitability after acute exposure to IL-1β 
Having established that MGE-progenitors can develop mature functional neuronal properties 
when co-cultured with human astrocytes in vitro, the next experiment tested the effects of an 
inflammatory environment on neuronal excitability by the addition of the pro-inflammatory 
cytokine IL-1β to the cell culture media. IL-1R1 is the major functional receptor for IL-1β. The 
expression of IL-1R1 was confirmed by immunostaining. In the co-culture system, The IL-1R1 
was found to be expressed on both ages of MGE neurons, as can be seen by its co-localization 
with GFP and astrocytes (Figure 5-2D). After six weeks astrocyte co-culture, MGE neurons were 
exposed to IL-1β (10ng/ml) for 24 hours before electrophysiological recordings were performed 
(Figure 5-2A). Current clamp recordings showed that the RMP and RIN were not significantly 
altered in MGE-like neurons acutely exposed to IL-1β compared to control cells (Control, N=27; 
IL-1β treated, N=33; unpaired t-test, P>0.05). (Figure 5-2B-C) 
A) Schematic representation of the experimental protocol. MGE progenitors after 6 weeks co-culture with human 
astrocytes were treated with IL-1β (10ng/ml) for 24 hours before patch clamp recording. G-H) The acute application 
of IL-1β didn’t change the resting membrane potential and input resistance in MGE progenitors. D) The 
immunostaining showed expression on IL-1 receptor (IL-1R1) on MGE cells and astrocytes. Scale bar 50um. 
The effects of IL-1β on neuron excitability were tested by comparing the ability of treated and 
untreated neurons to fire APs.  Current-clamped cells were held at -70 mV using d.c. injection. 
Co-culture 
Control 
IL-1β 10 ng/ml   
24hours 
6 weeks 
IL-1β+ 
GFP/IL-1R1/DAPI 
IL-1R1/ DAPI 
A 
B C 
D 
Figure 5-2 Acute exposure of IL-1β didn’t change RMP and input resistance in MGE-like cells 
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The cells were held at -70mV to measure action potentials evoked by current steps and APs 
evoked using depolarizing current steps (duration, 1 s; increment, 20 pA; from -100pA to 200pA). 
The neurons in control and IL-1β treated cells were classified into three groups based upon their 
cellular excitability. 
Group 1 cells fired single immature (‘Attempted’) APs that did not overshoot 0 mV;  
Group 2 cells fired single mature over-shooting APs;   
Group 3 cells were capable of firing trains of 2 or more overshooting APs (Figure 5-3A). As shown 
in Figure 5-3B, the number of recorded group 3 neurons, with the ability to fire AP trains, was 
reduced in IL-1β treated cells compared to control cells (27% vs 63%). Correspondingly, the 
number of group 3 neurons capable of firing only single APs was higher in IL-1β treated cells 
than control cells (67% vs 36%) indicating reduced excitability following IL-1β treatment. 6% cells 
showed attempt action potential in IL-1β treated group while all cells displayed proper action 
potentials in control group (Figure 5-3A-B). Then, the excitability of control and IL-1β treated cells 
in Group 3 were compared by plotting the number of evoked APs against the amplitude of the 
current injection step. Figure 5-3C-D shows a plot of the number of APs evoked by each current 
step revealing that IL-1β treated MGE-like neurons displayed fewer action potentials in response 
to current steps than control. The total number of APs recorded in response to all current 
injections steps (0-200 pA) was significantly lower in IL-1β treated cells compared to control cells 
(n=27 control; n=29 IL-1β treated; unpaired t-test, **P<0.01) (Figure 5-3D-E).  
Subsequently, to further examine the effects of IL-1β on MGE derived neuron excitability, the 
rheobase of cells in Group 2 and Group 3 was compared respectively in control and IL-1β treated. 
Rheobase is the minimal stimulation current of infinite duration (in practice about 300 ms or 
longer) that results in the AP threshold potential being reached and a spike fired (Figure 5-3 F-
H). Consistent with reduced excitability following IL-1β treatment, the result showed that 
rheobase current was significantly higher in IL-1β treated cells compared to control (Control 
82.96 ± 6.97 pA, n=27; IL-1β treated 119.3 ± 7.458 pA, n=30; two-way ANOVA, F (1,48) =7.196, 
P=0.01), especially among Group 2 cells (Sidak’s post-hoc comparison t=2.58 df=28 P=0.026) 
(Figure 5-3 I). Together, these results suggest that the impaired excitability of MGE-like cells after 
acute exposure to IL-1β may be caused by the alterations in ion channels. 
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Figure 5-3 MGE-like neurons were less excitable after acute exposure to IL-1β 
 A) The neurons were classified by their cellular excitability into three groups. The graph represented traces for 
neurons of different groups. B) The distribution of MGE-like neurons with different cellular excitability in control 
and IL-1β treated cells. C) The graph represented example traces for number of APs in response to depolarizing 
current steps in control and IL-1β treated cells D) The number of APs evoked by each depolarization current 
step in control and IL-1β treated cells. E) The total number of APs recorded in response to all current injection 
steps (0-200 pA) in control and IL-1β treated cells. F-I) The rheobase current was higher in IL-1β treated cells 
compared to control cells, especially among Group 3 cells. J-L) The analysis of singular AP was based on the first 
mature over shooting AP recorded from Group 2 and Group 3 cells. The bar graph showed increased threshold 
voltage and decreased amplitude in IL-1β treated cells compared to control. 
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5.2.3 Acute exposure to IL-1β reduced sodium currents in MGE-like cells 
Voltage gated sodium channels (VGSCs) play a critical role in generating and propagating action 
potentials. The previous findings show that IL-1β treatment reduces the excitability of MGE-like 
neurons, elevates AP threshold potential and decreases AP amplitude. For an AP, the initial trigger 
and the rising phase of action potential is generated by sodium influx. So, the previous results 
suggest that reduced cellular excitability in IL-1β treated MGE-like cells might be due to a 
reduction in sodium currents. Whole-cell voltage clamp and immunohistochemistry were used 
to test the effects of IL-1β exposure on sodium channel expression and sodium currents in MGE-
like cells. Immunostaining revealed expression of several TTX sensitive sodium channel isoforms 
on MGE cells (Figure 5-4A). Pan-Nav and Nav1.1 were expressed on cell body, proximal and 
medial neurites. Nav 1.2 and Nav 1.6 were expressed on cell body, medial and distal neurites. 
Navβ2 were expressed on the cell body of both neuron and astrocytes. 
Next, voltage clamp was applied to compare steady -state sodium channel activation and 
inactivation in control and IL-1β treated cells. Sodium currents recorded from MGE-like cells were 
nearly blocked by TTX, which suggests that recorded sodium currents were mainly TTX-sensitive 
sodium currents (Figure 5-4 B). The example traces also showed a reduction of sodium currents 
in response to command voltage steps in IL-1β treated cells compared with control cells. The I-
V relation graph based on steady-state sodium current recording revealed the maximum current 
density was significantly reduced by nearly 40% in IL-1β treated cells compared to control (n=17 
control, n=13 IL-1β treated, n=10 IL-1β+IL-1RA treated, one-way ANOVA ,P=0.03) (Figure 5-4 
D). To further examine the specificity of IL-1β signalling in sodium current reduction, the IL-1β 
antagonist IL-1RA was applied to the cell cultures at the same time as IL-1β. The results show 
that the reduction of sodium current was prevented by IL-1RA in IL-1β treated MGE-like cells 
(P>0.05). (Figure 5-4D) 
To further investigate the properties of VGSCs, sodium channel activation -voltage and 
inactivation -voltage relation were plotted according to recorded sodium current from command 
voltage steps (Figure 5-4 B,I). The data for I-V relationship was fitted with a Boltzmann equation. 
The results show sodium channel activation and inactivation curve didn’t shift in IL-1β treated 
cells compared to control. Likewise, the V50 calculated from Boltzmann fit for sodium channel 
activation and inactivation in IL-1β treated cells were similar to control cells (P>0.05). The results 
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also show addition of IL-1RA didn’t affect sodium channel activation and inactivation curves or 
V50 for activation and inactivation in IL-1β treated cells compared with control (P>0.05) (n=17 
control, n=13 IL-1β treated, n=10 IL-1β+IL-1RA treated, one-way ANOVA) ( Figure 5-4E-H). 
These results suggest the reduction of sodium current is not caused by alterations in the 
properties of VGSCs. 
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A) The expression of TTX-sensitive sodium channels Pan-Nav, Nav 1.1, Nav 1.2, Nav 1.6 and Navβ2 in MGE-like 
neurons. Scale bar 50mm B) The whole cell voltage clamp showed voltage-dependent and tetrodotoxin (TTX) sensitive 
sodium current in control, IL-1β treated and IL-1β+IL-1RA treated cells C-D) Significant reduction of sodium current 
density in MGE-like cell treated with IL-1β compared to control and IL-1β+IL-1RA treated cells. E-F) The voltage 
dependence for steady-state activation profile didn’t change in IL-1β treated MGE-like cells compared to control and 
IL-1β+IL-1RA treated. G-H) The voltage dependence for steady-state inactivation profile didn’t change in IL-1β 
treated MGE-like cells compared to control and IL-1β+IL-1RA treated. I) The example trace recorded from sodium 
channel steady-state inactivation. 
5.2.4 The reduction of sodium current in IL-1β treated MGE-like cells was due to 
reduction in single channel current of sodium channels 
The influx of sodium current (I) is determined by single channel current amplitude (i) multiplied 
by the number of opening sodium channels (N) (𝐼 = 𝑖 ∗ 𝑁)(Sigworth 1980, Alvarez, Gonzalez et 
al. 2002). Therefore, either a reduction in i or N causes the reduction of sodium current in IL-1β 
treated cells. To determine the direct cause of sodium current reduction, Non-stationary 
fluctuation analysis (NSFA) (See method 2.3.4) was used to calculate i and N according to the 
variance (σ2) from repeated recording against the mean current (I) and compare i and N between 
IL-1β treated and control cells (Alvarez, Gonzalez et al. 2002). The recording was performed in 
voltage clamp as described above. The cells were hyperpolarized to -80mv (200ms), then 
depolarized to -10mv (50ms) where the maximum currents were recorded in previous 
experiment. The recording was repeated at least 50 times for each cell. The rising phase of the 
sodium current was used for analysis. The data for variance against mean current was fitted with 
equation    
𝜎ଶ = 𝑖 ∗ 𝐼 − 𝐼ଶ 𝑁⁄  (Figure 5-5 A). The different colors in Figure 5-5 B&C represent a set of data 
recorded from an individual cell in IL-1β treated or control condition. The fitted data in which R2 
is less than 0.8 was discarded (4 out of 19 in control cells, 5 out of 20 in IL-1β treated cells). The 
results revealed the single channel current was reduced around 30% in IL-1β treated cells 
compared to control (control n=16, IL-1β treated, 6.94±0.69 vs 4.76±0.55, two-tailed unpaired 
t-test, t=2.44, df=29, P=0.021) (Figure 5-4 D). Meanwhile, the number of opening sodium 
channels was similar between control and IL-1β treated cells. (207.9±27.87 vs 269.2±46.91 P=0.26) 
(Figure 5-4E) Since N represents only opening ion channels, the channel open possibility (PO) was 
Figure 5-4 Acute exposure to IL-1β caused reduction of sodium currents in MGE-like cells 
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calculated by equation𝑃ை = 𝑖 ∗ 𝑁 𝐼௠௔௫⁄  .The result revealed the Po in IL-1β treat cells was lower 
but not significant compared to control (0.93±0.02 vs 0.88±0.03, P=0.18) (Figure 5-4F). Together, 
the results demonstrate IL-1β mediated reduction in amplitude of single sodium channel current 
caused reduction of total sodium current in IL-1β treated MGE-like cells.  
A) The diagram for NSFA recording with voltage clamp. The cells were holding at -80mv before depolarization to -
10mv. Each set of recording contains at least 50 repeats. The variance against averaged current in rising phase was 
fitted by equation σ2=i*I-1/N *I2. The parabola on the left side represent the date recorded on the right. The slope i 
represents the amplitude of single channel current, N represents the number of opening channels. B-C) Different color 
lines in the graph represent a set of data recorded from an individual cell in control or IL-1β treated MGE-like cells. D) 
The amplitude of single sodium channel current was significantly reduced in IL-1β treated cells compared with control. 
Slope=i 
I=i*N 
i= 5.148 
N=343.2 
-80 mV 
-10 mV 
A 
B 
C 
D E F 
Figure 5-5 Acute exposure of IL-1β caused Reduction in single sodium current 
82 
 
E) The number of opening channels was similar between IL-1β treated cells and control. F) the opening possibility of 
sodium channels didn’t change in IL-1β treated cells compared with control. 
5.2.5 Intermittent exposure to IL-1β didn’t change excitability in MGE-like cells 
Previous experiments revealed that the cellular excitability of MGE-like cells was undermined by 
acute application of IL-1β. Whether this effect of IL-1β on MGE-like cells was transient or 
permanent was still unknown. In the following experiment, the MGE-like neurons were 
intermittently treated by IL-1β every three days from week 5 to week 6 before performing patch 
clamp recording (Figure 5-6 A). However, the data showed RMP and Rin didn’t change in IL-1β 
treated cells (n=16 control, n=15 IL-1β treated -42.93±2.18mv vs -37.89±2.55 mV; 0.71±0.06 
Gohm vs 0.69±0.09 Gohm; umpired t-test, P>0.05) (Figure 5-6B-C). Intermittent application of 
IL-1β did not change cell excitability either. The results showed that all cells in the IL-1β treated 
and untreated groups could fire overshooting APs upon current injection. The distribution of 
group 2 cells (7 vs 5) and group 3 neurons (9 vs 10) were similar in IL-1β treated and untreated 
cells (Figure 5-6D). Likewise, the number of APs in response to injected current steps and total 
number of APs corresponding to all current injection steps did not change in IL-1β treated cells 
compared to control (n=15 control, n=16 IL-1β treated, unpaired t-test, P>0.05) (Figure 5-6E-
F). Subsequent analysis on the properties of single action potentials revealed no significant 
changes in rheobase, threshold voltage or amplitude of action potentials in IL-1β treated cells 
compared with control (two-way unpaired t-test, P>0.05) (Figure 5-6 G-I). These results suggest 
Intermittent application of IL-1β did not affect the excitability of MGE-like cells.  
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A) IL-1β was added every three days in to culture medium from week 5 to week 6 in neuron-astrocyte co-culture. B-
C) The input resistance and RMP of MGE progenitors did not alter in IL-1β treated cells compared with control. D) The 
number of MGE cells showing single or train action potentials with and without IL-1β treatment E-I) The number of 
action potentials in response to current steps, the total number of action potentials, the properties of action potential 
and the threshold current were not affected by chronic exposure to IL-1β. (n=15 for control n=16 for IL-1β treated)    
Figure 5-6 Intermittent treatment of IL-1β did not change the excitability of MGE-like cells 
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5.2.6 Intermittent exposure to IL-1β promoted branch sprouting 
The effect of IL-1β on branch growth of electrophysiological functional MGE neurons was also 
investigated. Alexafluor 555 was added into the internal solution and the images of recorded 
MGE-like neurons were taken after patch clamp recording. Sholl analysis was used to compare 
the morphological difference between IL-1β treated MGE cells and control cells (Figure 5-7A). 
As shown from Figure 5-7 B, the curve showed an increased number of crossings from distance 
50um to 200um in IL-1β treated MGE cells compared to control, suggesting increased branch 
complexity near the soma, but no changes in complexity and branch length in the distal area. 
The area under the curve was larger but not significant in IL-1β treat MGE cells compared with 
control (n=17, each group. Unpaired t-test, P>0.05) (Figure 5-7 C). In line with the Sholl analysis, 
the number of secondary and above branches were significantly higher in IL-1β treated MGE 
cells. The numbers of primary and total branches were not affected(P<0.05) (Figure 5-7 D-F). 
The number of junctions indicates the intersection points between branches. IL-1β treated cells 
have more junctions than control cells (P<0.05) (Figure 5-7 G). On the other hand, the size of 
cells and soma long diameter did not change in IL-1β treated cells compared to control (P>0.05) 
(Figure 5-7 H-I). Together, the results demonstrate that IL-1β promoted branch complexity but 
did not change the morphological maturation of MGE-like neurons.  
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  Figure 5-7 Chronic exposure to IL-1β promotes neurite growth in MGE cells 
A 
C 
F D E 
B 
G H I 
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A) The morphology of represented neurons for patch clamp recording. B) The Sholl analysis compared the morphology 
of neurons with and without treatment of IL-1β. C-I) The area under the curve, the number of branches (total, primary, 
secondary and above), the number of junctions, soma area, soma long diameters were compared between cells with 
or without treatment of IL-1β. (N=15 for each condition, Data show mean± SEM, t-test, *P<0.05.) 
5.2.7 Repetitive application of IL-1β reduced the excitability of MGE-like neurons 
The previous experiment found that in contrast to 24hr treatment of IL-1β, one week’s 
intermittent treatment of IL-1β did not reduce the excitability of MGE-like neurons. The 
contradictory results could be due to an inconsistent concentration of IL-1β in culture medium 
when applied for a week. The half-life for IL-1β is 2.5hr in vivo. So, the given concentration of IL-
1β could be reduced over time in culture medium by metabolism. To investigate the time-
dependent metabolism of IL-1β in the co-culture, the medium was sampled and measured by 
ELISA at 0h, 3h, 6h, 24, 48h and 72h after applying IL-1β (Figure5-8B). As shown in Figure 5-8 C, 
the concentration of IL-1β was maintained at around the initial level (10ng/ml) 24 hours after 
application and was significantly reduced to 2.5±0.3 ng/ml after 48 hours (n=8, one-way ANOVA, 
F (6.49) =155.9, P<0.0001). At 72 hours, the concentration of IL-1β returned to baseline. These 
results suggested the effects of IL-1β on the excitability of MGE-like neurons was related to the 
its high concentration  
Next, the long-term effects of a high concentration of IL-1β on MGE-like cells was investigated. 
As shown in the diagram (Figure 5-8A), MGE-like cells were cultured in two conditions. In 
condition 1, IL-1β was intermittently applied (every 3 days) to cells for a week. In condition 2, IL-
1β was repeatedly applied (every 24 hours) to the cells for a week. Current clamp was used 
compare RMP, Rin and proportion of MGE-like cells fire attempt, single and train APs in condition 
1 and 2 to control. Interestingly, the proportion of MGE-like cells which fired trains of APs was 
similar in condition 1 (63% vs 67%), but much lower in condition 2 compared to control (17% vs 
67%). Moreover, in condition 2, 50% of examined cells fired only a single AP and 33% of cells 
couldn’t fire an over shooting AP (Figure5-8D). The results also revealed no significant changes 
in RMP (n=15 control, n=16 condition 1, n=12 condition 2; one-way ANOVA, P=0.2) and Rin 
(n=15 control, n=16 condition 1, n=11 condition 2; one-way ANOVA, P=0.26) in condition 1 and 
condition 2 compared to control (Figure5-8E-F). Subsequent experiment using voltage clamp 
revealed that repetitive treatment of IL-1β induced 80% reduction of sodium current which could 
be prevented by IL-1RA (Figure 5-8 G-I) (n=10 for each condition, one-way ANOVA, P<0.01). 
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Together, the results suggest repetitive treatment of IL-1β further reduces excitability of MGE-
like neurons. 
5.2.8 Repetitive application of IL-1β induced death of astrocytes and affects the viability of 
MGE-like neurons 
In previous experiment, reduced cell density could be observed in cultures treated by IL-1β. The 
immunostaining revealed that the number of GFAP+ astrocytes significantly reduced in IL-1β 
treated condition (Figure 5-9 A, B). Therefore, the viability of MGE-like cells in different conditions 
was then inspected by PI-Annexin V staining (Figure 5-9 C). Propidium iodide (PI) is used in 
conjunction with Annexin V to determine if cells are viable, apoptotic, or necrotic. In the cell 
culture, the Annexin V+ cells were co-localized PI+, suggesting the cells were either necrotic (PI+) 
or late apoptotic (PI+ Annexin+) (Figure 5-9 D). Only a few PI+ GFP+ cells could be observed in all 
three conditions (Figure 5-9 E). But the number of PI+ and PI+ Annexin V+ cells significantly 
increased in condition 1 and condition 2 compared with control. Especially in condition 2, the 
cells were aggregated together, PI+ and PI+ Annexin V+ cell could be observed predominantly in 
the centre of the cluster. (Figure 5-9 C). These results demonstrate the survival of co-cultured 
astrocytes was significantly reduced by the application of IL-1β.  
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Figure 5-8 Repetitive application of IL-1β further reduced excitability of MGE-like neurons  
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A) The illustration of experimental conditions. In condition 1, the cells were intermittently treated with IL-1β for a week. 
In condition 2, the cells were continuously treated with IL-1β for a week. B-C) The ELISA showed the concentration of 
IL-1β in culture medium significantly reduced after 24 hours (n=4). D) The proportion of cells with attempt, single and 
train action potentials in each condition. E-F) The Rin and RMP of MGE progenitors were not altered in condition 1 and 
condition 2 compared with control. G-I) Sodium current recording revealed that repetitive treatment of IL-1β induced 
80% reduction of sodium current which could be prevented by IL-1RA. J) The capacitance didn’t change in IL-1β treated 
and IL-1β+IL-1RA treated cells. 
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A-B) IL-1β induced significant reduction of GFAP+ astrocytes in MGE-like neuron-astrocyte co-culture. C) The 
PI/Annexin staining showed increased number of cells stained with PI and Annexin V in condition 1 and condition 2. 
And the cells were aggerated in clumps in condition 2. Scale bar 50um. D) Annexin V + cells were co-localized with PI+. 
E) Only a few PI+ GFP+ cells (yellow arrow) could be observed in the culture  
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Figure 5-9 Repetitive application of IL-1β caused death of astrocytes and reduced viability of 
MGE-like neurons  
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5.3 Discussion 
Electrophysiological activity is a key indicator of functional mature MGE-like neurons. The MGE 
progenitors co-cultured with hippocampal astrocytes demonstrated overshooting APs as early 
as 2 weeks after co-culture (differ day 35), but it took 6 weeks for the majority of MGE progenitors 
to acquire mature firing properties. It is consistent with previous research that over shooting APs 
are observed at around differentiation day 40 to 60 in iPSC and hESC-derived MGE neurons 
(Nicholas, Chen et al. 2013, Kim, Yao et al. 2014). The RMP and Rin are corelated with the 
expression of ion channels. During neuronal differentiation, as more and more ion channels 
develop on the cell membrane, the RMP becomes more hyperpolarised and Rin is reduced. In this 
experiment, there was huge diversity among MGE-like neurons in terms of RMP and Rin at week 
2. This suggests that electrophysiological maturation kinetics vary among MGE-derived neurons. 
6 weeks after co-culture, RMP was around -45mV and Rin was around 1Gohm in recorded MGE 
cells. The results are similar to the RMP and Rin recorded from hESC or iPSC-derived MGE neurons 
in vitro (Nicholas, Chen et al. 2013) and early stage transplanted MGE progenitors in vivo 
(Cunningham, Cho et al. 2014). But it is worth noticing that although it may take several months 
after transplantation for differentiation of fully functional GABAergic neurons, the inhibitory 
output could be observed when the transplanted cells showed electrophysiological activity 
(Cunningham, Cho et al. 2014). 
Increasing evidence supports a modulatory effect of IL-1β on different voltage gated ion 
channels, including K+, Ca+ and Na+ channels in the CNS and PNS (Vezzani and Viviani 2015). In 
the experiment above, acute treatment with IL-1β caused a reduction in sodium currents in MGE-
like neurons which led to attenuated excitability. In line with these results, IL-1β caused a 40% 
reduction in voltage-gated sodium current and 10mV reduction in the amplitude of the action 
potential in rat cortical neurons, and an 80% reduction of the sodium current in retinal ganglion 
cells (Diem, Hobom et al. 2003, Zhou, Qi et al. 2011). In contrast, IL-1β did not change sodium 
currents in rat hippocampal neurons and even led to a 67% increase of sodium current in 
trigeminal nociceptive neurons when also applied for 24hr (Liu, Yang et al. 2006). The 
concentration of IL-1β used in these experiments is much higher (ng/ml) than detectable 
concentration in human blood (pg/ml). Therefore, pathologically high levels of IL-1β have distinct 
effects on different types of neurons.  
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Sodium currents play a vital role in evoking and propagating action potentials. The reduction of 
sodium currents in inhibitory neurons is closely related to the occurrence of seizures (Lossin, 
Rhodes et al. 2003, Vanoye, Lossin et al. 2006, Yu, Mantegazza et al. 2006, Tai, Abe et al. 2014). 
Mutations in the gene encoded Nav1.1 (SCN1A) induced a reduction in sodium currents only in 
inhibitory neurons rather than excitatory neurons in mice, which caused hyperexcitability and led 
to spontaneous seizures (Yu, Mantegazza et al. 2006, Tai, Abe et al. 2014). The iPSC-derived 
inhibitory neurons generated from patients with Dravet Syndrome with a mutation in Nav 1.1 
showed deficits in sodium currents and action potential firing (Sun, Pasca et al. 2016). Meanwhile, 
the cortical neurons generated from iPSCs of the same patient did not show alterations in sodium 
currents or firing frequency. These studies indicate that reduced excitability of inhibitory neurons 
accounts for epileptogenesis. Therefore, compromised electrophysiological activities of MGE-like 
neurons could interfere with the benefits of transplanting MGE progenitors in epilepsy.   
The mechanism of how IL-1β affects sodium current is controversial. Although most studies 
suggest IL-1β works by activating its cognate receptor on cell membrane, a previous study 
suggested that the reduction of sodium current is independent of IL-1R1 receptor in RGC (Diem, 
Hobom et al. 2003). Our research found that co-application of the IL-1β antagonist IL-1RA 
blocked the reduction in sodium current caused by IL-1β. It indicated the effect of IL-1β was 
mediated by the IL-1R1 receptor. IL-1β activates its downstream signals as quick as 5 mins after 
binding to IL-1R1 receptors and 2-3% occupation of receptors is enough for biological effects 
(Dinarello 2009). Its rapid effect may elicit fast post-translational alterations in expression or 
structure changes in VGSCs. Sodium channel consist of a pore-forming α subunit, and a β subunit. 
Based on isoforms of the functional α subunit, the VGSCs are named Nav1.1 through Nav1.9, 
among which NaV1.1, NaV1.2, and NaV1.6 isoforms are highly expressed in the CNS (Maurice, 
Tkatch et al. 2001). Consistently, expression of Pan-Nav, NaV1.1, NaV1.2, NaV1.6 and Navβ2 were 
observed in MGE-like cells. So far, only one piece of published research shows a 40% reduced 
expression of the α1 subunit in mRNA levels after 2h treatment with IL-1β in cortical neurons (Liu, 
Yang et al. 2006). It is unclear whether other types of sodium channel could be modulated by IL-
1β treatment. In addition, NSFA analysis suggested the reduction of sodium current is due to a 
reduction in single channel current rather than sodium channel expression.  
Although the results from NSFA showed significant reduction in channel conductance in IL-1β 
treated compared to control, it may not be sufficient to draw a conclusion. One issue in the 
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acquired data is that the variation within groups of recorded cells is large, possibly due to the 
variety of interneuron phenotypes and their different maturation kinetics(Kepecs and Fishell 
2014). Secondly, the single sodium current calculated from NSFA represents macroscopic current 
which is sum of currents from several sodium channels rather than the unitary sodium current 
(Lingle 2006, Nekouzadeh and Rudy 2007). Therefore, the data of single sodium current in 
average from my experiment is significantly larger than previous reports which used excised 
recording (Wartenberg and Urban 2004, Vanoye, Lossin et al. 2006, Chatelier, Zhao et al. 2010). 
In addition, in my experiment, the number of recording sweeps may not be sufficient to accurately 
predict the variance. Based on computer simulation, the variance will be more precisely recorded 
when one increases the number of recording sweeps (Lingle 2006). However, in my experiment, 
the hESC-derived neurons were too fragile to endure repetitive simulation for extended long 
time recording. So, the error of the data can affect the accuracy of calculation for number of 
channels and single channel current. Further experiments using excised patch clamp recording 
will help to confirmed whether conductance of sodium channel is affected by IL-1β.  
Sodium channel current is regulated by phosphorylation sites in segments of the pore forming α 
unit. Those phosphorylation sites are regulated by protein kinase A (PKA) or protein kinase C 
(PKC) in different types of neurons (Marban, Yamagishi et al. 1998, Scheuer and Catterall 2006, 
Scheuer 2011). A single site phosphorylation is sufficient to cause a reduction in the amplitude 
of sodium currents without affecting the activation and inactivation kinetics of sodium channels 
(Smith and Goldin 1997). In rat striatal neurons, the activation of PKA raised the threshold for 
firing and was associated with a 35% reduction in sodium currents. Likewise, the activation of PKC 
also reduces the sodium current in cholinergic interneurons (Maurice, Mercer et al. 2004), 
hippocampal neurons (Numann, Catterall et al. 1991) and other brain neurons (Numann, Catterall 
et al. 1991). There are also several reports which suggest IL-1β can regulate the phosphorylation 
of ion channels. In mouse heart cells, IL-1β increased PKC translocation and led to a reduction of 
calcium current (El Khoury, Mathieu et al. 2014). In rat cortical neurons, activation of PKC by IL-
1β caused a 37% inhibition of sodium current (Zhou, Qi et al. 2011). Therefore, it is highly likely 
that IL-1β regulates sodium currents of MGE-like cells through activation of a phosphorylation 
protein. Further experiments are required for confirmation. 
Pro-inflammatory cytokines are preserved at a high level for several days after seizures and brain 
injury. IL-1β was intermittently or continuously applied to MGE-like neurons to simulate the 
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chronic inflamed environment. The results were interesting. 1 week’s intermittent application of 
IL-1β didn’t change excitability of MGE cells due to concentration of IL-1β returned to baseline 
after 72 hours, but 1 week’s continuous application of IL-1β caused further reduced excitability 
of MGE-like neurons, produced severe death of astrocytes and eventually affected the viability 
of MGE-like neurons. Together, the results suggest the excitability of MGE-like cells could recover 
when IL-1β was reduced to a non-pathological concentration. On the other hand, when IL-1β 
was maintained in high concentration, MGE-like cells lost the essential support from astrocytes 
which affected their functionality and viability. During the sodium current recording, the unhealth 
cells which showed high leaky current and low sodium current were excluded from the results. 
Therefore, the effect of repetitive treatment of IL-1 β  on MGE-like neurons could be 
underestimated. Consistent with the results, a study showed 48 to 72 h incubation of IL-1β didn’t 
affect the viability of pure cortical neuron cultures but caused caspase induced cell death in glia-
neuron cocultures and pure astrocyte cultures (Thornton, Pinteaux et al. 2006). So, it is more likely 
the neurotoxic effect of IL-1β on MGE-like cells is mediated by astrocytes. Although MGE-like 
cells and hippocampal astrocytes both expressed the IL-1 receptor, evidence showed IL-1β 
activated distinct signal pathways in neurons and astrocytes. It can activate the p38 mitogen-
activated protein kinase (MAPK) signalling pathway in hippocampal neurons while activating NF-
κB in hippocampal astrocytes (Srinivasan, Yen et al. 2004). This may be the reason for different 
reaction of MGE-like neurons and astrocytes after IL-1β treatment. 
In contrast to previous findings in hi-spot culture that IL-1β reduced the branch growth of MGE-
like cells, this experiment showed that intermittent treatment of IL-1β promoted neurite growth 
of MGE-like neurons. This contradictory effect could be due to differences in duration for IL-1β 
exposure and culture context. In the present experiments, the cells were co-cultured with 
astrocytes and IL-1β treatment for only 24h. Several studies suggested IL-1β promotes axon 
growth and modulates neurite growth and regeneration when applied in a healthy 
microenvironment. The effect is mediated by facilitating the production of growth factors or 
neurotropic factors from astrocytes or microglia (Parish, Finkelstein et al. 2002, Boato, Hechler et 
al. 2011). In an inflamed microenvironment, IL-1β dominantly demonstrated its detrimental 
effects. For example, IL-1β exacerbates brain damage and mediates neuron degeneration in 
acute brain injury and PD respectively (Touzani, Boutin et al. 2002, Koprich, Reske-Nielsen et al. 
2008).  
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In general, acute exposure to IL-1β temporarily compromised activities of MGE neurons. It could 
be one of the consequences for increased susceptibility of seizures. Blocking the effect of IL-1β 
after seizure may help to restore the balance of neuron circuits. Chronic exposure to IL-1β would 
lead to astrocyte death which would further affect the viability of MGE-like neurons. Therefore, a 
healthy microenvironment is vital to guarantee the functionality of MGE-like neurons.  
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6. Generating a 3D Hi-Spot culture from hESC derived cells to 
further study the inflamed environmental effect on MGE derived 
progenitors  
6.1 Introduction  
In chapter 3&4, hi-spots generated from human brain tissue have been used to simulate the 
inflamed microenvironment of sclerotic hippocampus. However, the disadvantage of the model 
can’t be ignored. Firstly, the availability of human brain tissue is always limited. Secondly, the 
severity of pathological alternations varies between patients, so the concentration and 
combination of inflammatory cytokines are not always consistent or controllable in primary brain 
tissue. To further understand the mechanism of how IL-1β affect MGE progenitors, a new 3D 
culture model which is more consistent and manageable has been established in this chapter. 
With developing understanding of immune response towards injury, infection and neurological 
diseases in CNS, inflammatory cytokines have been discovered to affect cell survival, 
neurogenesis, neuron excitability which are vital for progress of many brain diseases in CNS 
(Kokaia, Martino et al. 2012, Vezzani, Aronica et al. 2013). The inflammatory mediators have 
controversial effects varying from their concentration, and duration. Cells of innate and adaptive 
immune system are activated and release inflammatory mediators to remove lethal pathogens 
immediately after insults (Kokaia, Martino et al. 2012, Xanthos and Sandkuhler 2014). But the 
prolonged and intensive production of inflammatory mediators in certain area may bring more 
detrimental rather than beneficial effects on CNS (Vezzani, Aronica et al. 2013, Xanthos and 
Sandkuhler 2014).  
The microenvironment of CNS is constituted by two parts; the regulatory chemicals released by 
immune cells and the crosstalk via cell-to-cell connection. Conventional single level monolayer 
culture creates a lack of complexity and tissue-organization from different levels of cells. 
Systematic time-consuming animal models produce conflicting and inconsistent results to clinical 
studies due to difference in genetic context between human disease and animal models. Human 
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embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) derived neuronal cells has 
been widely used to study the pathology and physiology of CNS (Choi, Kim et al. 2014, Yu, Di 
Giorgio et al. 2014). The neuronal cells of human origin will be more relevant than primary 
cultures of animal neuronal cells in terms of anticipating therapeutic target and disease modelling 
(Schwartz, Hou et al. 2015). Self-assembled aggregate cultures generated from pluripotent 
neuron stem cells, such as encompass spheroids, embryoid bodies and neurospheres could 
construct cytoarchitecture of cerebellum and cortex (Pasca, Sloan et al. 2015) (Bershteyn, 
Nowakowski et al. 2017) (Muguruma, Nishiyama et al. 2015). But it will take more than half year 
for growing the organoids and cell apoptosis usually observed in the centre of the organoid 
when the organoid grows bigger.  
To solve the problem, 3D culture which preserve the complexity of cell to cell interaction is used 
in some studies. Neurons cultured in special engineered scaffold or nutritious gels matrix have 
better cell survival and neurite outgrowth than the cells in 2D culture (Navaei-Nigjeh, Amoabedini 
et al. 2014, Sun, Liu et al. 2016). To simulate brain microenvironment, a recent study constructs 
the neural cells into tissue-like 3D structure that mimic dynamic mechanical properties and 
biochemical functionalities of whole living organs (Bailey, O'Connor et al. 2011). Therefore, 3D 
culture of human ES-derived neuronal cells could allow us to investigate the effect of 
microenvironment on CNS in a more relevant manner without needed to rely on primary 
human tissue cultures. 
To investigate the influence of microenvironment on survival and differentiation of hESC-derived 
neuron progenitors, a 3D model which include major cellular components with preserved organ-
like structure and complexity is required. In this research, a 3D culture model including hESC-
derived excitatory cortical progenitors, inhibitory neuron progenitor and astrocyte, which is an 
important component for neurogenic niche (Ma, Ming et al. 2005) has been established. The 
results demonstrate three types of cells can proliferate and differentiate in hi-spot culture. 
Furthermore, similar to the previous results observed in human hi-spot culture, IL-1β caused 
reduced survival of MGE progenitors and astrocytes in this 3D model. In addition, reduced cell 
proliferation was also observed in IL-1β treated hi-spots. These results provide evidence for using 
hi-spots generated from hESCs to test the influence of pathological microenvironment in vitro. 
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6.2 Results 
6.2.1 Generate and characterise telencephalic excitatory neurons and inhibitory neurons 
from hESC 
First, hESCs were differentiated into telencephalic excitatory and inhibitory neurons in parallel. To 
generate excitatory neuron progenitors, dual SMAD inhibitors (SB-451542 and LDN-193189) 
were applied from day 0 to day 12 (Figure 6-1 B). The cells were then passaged and plated on 
poly-D-ornithine and laminin coated plate for post-mitotic differentiation. The excitatory 
neurons are derived from dorsal telencephalon. Pax6 is the marker for dorsal telencephalic 
progenitors. The immunostaining revealed that the expression of Pax6 could be observed in 
neural rosettes at post differentiation day 20 (Figure 6-1C). At post differentiation day 40, the 
cells expressed cortical layer specific marker Trb2 and immature neuron marker DCX (Figure 6-
1D). These results suggested the cells achieved identity of excitatory cortical progenitors.   
The protocol for generating inhibitory neurons was described in (3.2.1) 
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Figure 6-1 Generating cortical neuron progenitors from hESC. 
A) The illustration for development of cortical progenitors and inhibitory interneuron progenitors during embryonic 
development. B) Schematic timeline of cortical progenitor differentiation from H7 cell line. SB451542, inhibitor of the 
TGFb1 activin receptor-like kinases; LDN193189, inhibitor of bone morphogenetic protein (BMP) type I receptors. C) 
On differentiation day 20 the cells robustly expressed PAX6 and rosette-like structure Scale bar 100um.D) On 
differentiation day 40, the cells co-expressed specific cortical neuron marker Trb2, early neuron marker DCX and 
Pax6. Scale bar 50um 
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6.2.2 Generating astrocytes from hESC 
Astrocytes are born after neurons during embryonic development(Krencik, Weick et al. 2011). 
Therefore, astroglia differentiation comes after neuron induction. A two-stage protocol was 
applied to generate astrocytes (Figure 6-2 A). At the first stage, from differentiation day 0 to 
differentiation day 20, the cells were differentiated into cortical progenitors by the protocol 
described above. The cells were then dissociated and plated at density of 10000/cm2 on PDL 
coated plate. FGF2 (20ng/ml) and 10% fetal bovine serum (FBS) were applied to induce astroglia 
differentiation from day 21 to day 34(Roybon, Lamas et al. 2013, Shaltouki, Peng et al. 2013, Tcw, 
Wang et al. 2017). The cells were then fixed for immunostaining. The expression of S100β and 
GFAP, which are markers for astrocyte(Ludwin, Kosek et al. 1976), significantly increased in FBS 
and FGF2 treated cells compared to untreated. (Figure 6-2 B, D) (n=4, two-way unpaired t-test, 
P<0.001). In contrast, the expressing of DCX was significantly downregulated in FBS and FGF2 
treated cells compared to untreated (P<0.001). While, the proportion of Pax6+ cell was similar 
between FBS and FGF2 treated and untreated (Figure 6-2C, D). These results suggested FBS and 
FGF2 promote astroglia differentiation without changing the regional identity of where the cells 
derived from (Krencik, Weick et al. 2011).  
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Figure 6-2 Generating astrocytes from hESC 
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A) Schematic timeline for generating astrocyte from hESC. Neuron progenitors were generated from hESC from day 0 
to day 20 with the protocols described previously. The N2B27 medium were replaced by medium containing FBS 10% 
and FGF2 20ng/ml for 14 days to induce differentiation of astrocytes. B) The immunostaining showed expression of 
astrocyte marker S100β and GFAP on cells cultured in FBS and FGF2 containing media and control. Scale bar 50um C) 
The immunostaining showed expression of DCX and Pax6 on cells cultured in FBS and FGF2 containing media and 
control. Scale bar 50um D) The bar graph compared the expression of S100β, GFAP, DCX and Pax6 in FBS and FGF2 
media to control 
 
 
6.2.3 Astrocytes precursors generated from MGE progenitors demonstrated distinct 
phenotypes 
The astrocytes show distinct phenotypes in different brain area(Olude, Mustapha et al. 2015). To 
figure out whether astrocytes arise from different origins affect their phenotypes, I first compared 
morphology of astrocyte precursors derived from MGE progenitors to astrocyte precursors 
derived from cortical progenitors (Figure 6-3 A). As shown in the graph, cortical progenitor 
derived astrocyte precursors showed larger soma than MGE progenitor derived astrocyte 
precursors. Moreover, the cortical progenitor derived astrocyte precursors demonstrated 
ramified structure while most MGE progenitor derived astrocyte precursors were fusiform. Next, 
the immunostaining was used to compare expression of astrocyte marker (GFAP and GLAST) and 
glia marker (nestin) between two types of astrocytes (Figure 6-3 B). The result revealed the 
expression of GFAP, GLAST and nestin were significantly lower in MGE-derived astrocytes 
compared to cortical progenitor derived astrocytes (Figure 6-3 C) (n=4, two-way unpaired t-test, 
P<0.001). These results suggested the astrocytes generated from different telencephalic area 
have different phenotypes.  
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Figure 6-3 Astrocyte generated from cortical and MGE progenitors showed distinct phenotype 
A) The morphology of Cortical progenitor (CP) and MGE progenitors derived astrocytes on differentiation day 
35. B) The immunostaining showed expression of GFAP, GLAST and Nestin. Scale bar 50um. C) The bar graph 
compared the expression ratio of GFAP, GLAST and Nestin between CP and MGE progenitor derived astrocytes. 
(n=4, two-way t-test, **P<0.01, ***P<0.001) 
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6.2.4 Generate hi-spot culture from hESC-derived neural cells 
Hi-Spot culture is a new cell culture method developed for culturing postnatal CNS tissue which 
is hard to maintain in monolayer culture. The brain tissue was reorganized as a self-organised, 
dense, organotypic culture in air-liquid surface. With hi-spot culture, it is possible to recreate 
brain microenvironment and observe survival and differentiation of neuronal cells in vitro. The 
excitatory neuron, inhibitory neuron and astrocyte are the major components of brain tissue. 
Having established the protocol to generate those cells individually, the three types of cell were 
mixed together to generate Hi-spot culture. The method was described by illustration (Figure 6-
4). 1% MGE progenitors generated from GFP-labelled H7 cell line, 9% cortical progenitors from 
normal H7 cell line and 90% astrocyte precursors derived from cortical progenitors were mixed 
to generate hi-spot cultures.  
 
  
Figure 6-4 The illustration of generating hi-spot culture from hESC-derived neural cells 
105 
 
6.2.5 The influence of culture medium on differentiation of neuron progenitors and 
astrocytes precursors  
After generating hi-spot culture, the influence of culture medium on differentiation of neuron 
progenitors and astrocyte precursors was inspected initially. Serum-rich medium (5% horse serum 
+ 20% FBS) is used for culturing hi-spots with human brain tissue. N2B27 medium is used for 
culturing neuronal cells in monolayer culture. Firstly, the number and neurite growth of GFP 
labelled MGE progenitors were compared at 3 weeks and 6 weeks post hi-spot culture in two 
culture mediums (Figure 6-5A-B). The results showed that the number of GFP expressing MGE 
progenitors increased about 50% in both Serum and N2B27 medium 6 weeks post hi-spot culture 
compared to 3 weeks (n=8 for each condition, two-way ANOVA, P<0.001) (Figure 6-5 C). Sidak’s 
multiple comparisons test revealed the number of MGE progenitors was slightly lower but not 
significant in serum medium compared to N2B27 medium (Figure 6-5 C). Correspondingly, total 
neurite length of MGE progenitors increased about three times at 6 weeks post culture compared 
to 3 weeks. And neurite length of MGE progenitors was similar in two media (Figure 6-5D). These 
results suggested the MGE progenitors grew and survived in hi-spot culture with both culture 
medium.  
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Figure 6-5 Culture medium affects the proliferation and neurite growth of MGE neurons 
A-B) The image showed GFP-labeled MGE neurons in two culture media (Serum vs N2B27) at 3 week and 6 
weeks after generating the hi-spot. The neurite tracing image showed the skeleton of processors. Scale bar 
50um. C-D) The bar graph compared the number and neurite length of MGE neurons in hi-spot culture for 3 
and 6 weeks in N2B27 to the cells in Serum-rich medium. (N=8, two-way anova, ***P<0.001, ****P<0.0001. 
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Next, cell proliferation was inspected by comparing the number of ki-67+ cells between two 
media (Figure 6-6A-B). The result revealed the number of ki-67+ cells was around four times 
higher in N2B27 medium compared to serum medium (Figure 6-6C) (n=8, two-way t-test, 
P<0.001). Consistently, the number of total cells was significantly higher in N2B27 medium 
compared to serum medium (Figure 6-6E). Figure 6-6A shows the number of ki-67+ MGE 
progenitors is quite low and similar between two media. (Figure 6-6A-C) (P>0.05). Interestingly, 
the number of GFAP+ Ki-67+ cells was significantly higher in serum medium compared to N2B27 
medium (n=8, two-way t-test, P<0.001). And the number of GFAP+ cells was also higher in serum 
medium compared to N2B27 medium (n=8, two-way t-test, P<0.001). About 60% ki-67+ cells 
were GFAP+ cells in serum medium, but only 5% ki-67+ cells were GFAP+ in N2B27 medium 
(Figure 6-6C). These results suggested in serum medium, hESC-derived astrocyte precursors 
were preserved and proliferated, while in N2B27 medium the astrocyte precursors lose its genetic 
marker. 
Finally, we inspected the growth of neuron cells using immunostaining of Tuj1 and compared the 
growth of processors between two media (Figure 6-6 D). The result showed that the Tuj1+ cells 
formed complex neural network in hi-spot culture in both medium. But the total length of Tuj1+ 
processors was significantly higher in cells cultured with N2B27 medium compared to serum 
medium (Figure 6-6 D-F) (n=8, two-way t-test, P<0.01). Together, these results suggest that 
N2B27 medium is in favour of neuronal differentiation but not astroglia differentiation.  
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Figure 6-6 Culture medium affect astroglia differentiation and cell proliferation 
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A-C) The immunostaining showed only a few MGE progenitors are Ki-67+ (Yellow arrow) in both culture medium. B-
C) The immunostaining showed GFAP+ cells were significantly reduced in hi-spots cultured in N2B27 medium 
compared to serum medium. And in serum medium, some GFAP+ cells also co-stained with Ki-67(Yellow arrow). Scale 
bar 50um. D-F) The number of cells (DAPI) and total length of Tuj1-expressing neurite were significantly lower in hi-
spot cultured in serum medium compared to N2B27 medium. (n=4, two-way t-test, **P<0.01, ***P<0.001, 
****P<0.0001) 
 
6.2.6 Inflamed microenvironment caused reduced cell survival  
Having established hESC hi-spot culture, the next step is trying to investigate whether the effect 
of IL-1β in human hi-spots can be replicated in hESC hi-spots. The hi-spots were cultured in four 
groups. In IL-1β treated groups, IL-1β was given every three days (Figure 6-7A). First, I compared 
the survival of MGE progenitors in IL-1β treated to untreated hi-spots. The result revealed the 
number of MGE progenitors in hi-spots cultured in serum medium was significantly reduced by 
IL-1β (Figure 6-7B, D) (n=8, two-way anova, Tukey’s multiple comparison, P<0.05). But in hi-
spots cultured in N2B27 medium, the number of MGE progenitors is similar between IL-1β 
treated and untreated hi-spot (Tukey’s multiple comparison, P>0.05). Likewise, the neurite length 
of MGE progenitors cultured in serum medium not N2B27 medium was significantly reduced by 
IL-1β compared to untreated cells (Figure 6-7C) (two-way ANOVA, Tukey’s multiple comparisons, 
P<0.05).  
Next, the effect of IL-1β on cell proliferation was evaluated by Ki-67 immunostaining. The result 
showed the number of ki-67+ cells reduced about 50% in IL-1β treated hi-spot cultured with 
serum medium (Figure 6-7F) (n=8, two-way t-test, P<0.01). While in N2B27 medium, the number 
of Ki-67+ cell was similar between treated and untreated hi-spots (Figure 6-7E) (P>0.05). From 
previous result, more than half Ki-67+ cells are GFAP+ cells in serum medium. So, I next inspected 
the number of GFAP+ and GFAP+Ki-67+ cells in hi-spot cultured with serum medium and 
compared them between IL-1β treat and untreated condition. 
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Figure 6-7 IL-1β reduced cell survival and cell proliferation in hi-spot culture
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A) The diagram of experimental condition. Hi-spot cultured in serum and N2B27 medium were treated with IL-
1β(10ng/ml) for 21 days before fixation. B) The image showed the morphology and neurite growth of MGE cells in 4 
different experimental group. C-D) The bar graph compared the number and neurite length of MGE cells and IL-1β 
treated hi-spots to untreated. E) The bar graph compared the number of ki-67+ cells in IL-1β treated to untreated hi-
spots cultured in N2B27 medium. F) The bar graph compared the number of ki-67+ cells in IL-1β treated to untreated 
hi-spots cultured in serum medium. G-I) The bar graph compared the number of GFAP+, GFAP+Ki-67+ cells and ratio 
of Ki-67+GFAP+over GFAP+ cell between IL-1β treated and untreated hi-spot cultured in serum medium. J) The 
immunostaining showed the expression of GFAP and Ki-67 in IL-1β treated and untreated hi-spots cultured in serum 
medium. 
The result revealed the number of GFAP+ cells was significantly lower in IL-1β treated hi-spot 
compared to untreated (Figure 6-7G) (P<0.01). But the ratio of Ki-67+GFAP+ cells over the 
population of GFAP+ cells was similar between IL-1β treated and untreated (Figure 6-7I) (P>0.05). 
Correspondingly, the number of GFAP+ Ki-67+ cells was significantly lower in IL-1β treated hi-
spot compared to untreated (Figure 6-7G) (P<0.05). Together, these results indicated IL-1β 
caused reduced survival of neurons and astrocytes in hi-spot culture in serum medium but not 
in N2B27 medium. 
 
6.3 Discussion 
The microenvironment of the CNS plays an important role in regulating pre- and post-natal 
neurogenesis. In this research, a 3D hi-spot culture model, aiming to simulate the human brain 
microenvironment in vitro, was generated from cortical progenitor, MGE progenitor and 
astrocytes derived from hESCs. First, the hESC hi-spot culture was characterized in serum and 
N2B27 medium. The result showed serum rich medium didn’t alter differentiation of neurons and 
astrocytes in hi-spot culture. While N2B27 medium only favoured neuronal differentiation but 
not astroglia differentiation. Furthermore, decreased number of surviving MGE progenitors and 
astrocytes and reduced cell proliferation was observed when IL-1β was added to the hi-spots 
cultured in serum medium but not the hi-spot cultured in N2B27 medium.  
Serum free medium like N2B27 is usually used for differentiation of neurons. Some research has 
suggested that at neuron stem cell / progenitor stage, addition of serum in high concentration 
will interfere with neuronal differentiation (Hu, Ji et al. 2013). As proved by the experiment, cortical 
progenitors expressed astrocyte marker and lost their neuronal marker when cultured with 10% 
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FBS for two weeks. On the other hand, serum medium is necessary for survival and maintain 
astrocytes precursors in vitro. In the experiment, even defined astrocyte precursors lost their 
genetic marker when cultured in N2B27 medium. So, in monolayer culture, it is hard to maintain 
both types of cell in the same culture medium for a long time. The 3D hi-spot culture seemed to 
be a solution for the conflict. As proved by the experiment, neurons and astrocytes 
simultaneously proliferated and matured in hi-spot culture in serum rich medium.  
Astrocytes are a major component of the neurogenic niche, providing structure support, 
instructive signal for neurogenesis and promote synaptic transmission of neurons (Song, Stevens 
et al. 2002, Johnson, Weick et al. 2007, Bamba, Shofuda et al. 2014). The heterogeneity of 
astrocytes makes it hard to classify their phenotypes(Olude, Mustapha et al. 2015). There is 
evidence suggesting that astrocytes originating from different brain regions have distinct 
regulatory effects on local neurons. Hippocampal astrocytes, rather than spinal cord- derived 
astrocytes, instruct the hippocampal neuron stem cell to adopt a neuronal fate (Song, Stevens et 
al. 2002). Midbrain astrocytes instead of cortical astrocytes promote neuronal progenitors to 
develop into dopaminergic phenotype (Roy, Cleren et al. 2006). Consistently, I found astrocyte 
precursors generated from MGE progenitors and cortical progenitors were different in 
morphology and expression of astrocyte markers, indicating different functions of two type of 
astrocytes. 
The inflamed microenvironment plays an important role in pathology of many neurological and 
neurodegenerative disorders. IL-1β is one of dominant pro inflammatory cytokines released after 
brain injury. Some studies suggested IL-1β reduces neuron progenitor cell proliferation and 
neuronal differentiation and enhances gliogenesis (Crampton, Collins et al. 2012, Zunszain, 
Anacker et al. 2012). In line with these observation, reduced number of MGE progenitors and 
decreased cell proliferation was observed in the hi-spot cultured with serum medium. In contrast, 
there was no evidence for enhanced gliogenesis but reduced number of GFAP+ astrocytes in hi-
spot culture. One possibility is that the hi-spots were repetitively treated with IL-1β for several 
weeks before immunostaining. So, cell apoptosis due to IL-1β is dominant. Interestingly I also 
found hi-spot cultured with N2B27 medium were immune to the detrimental effect of IL-1β. This 
may be due to lack of astrocytes in hi-spots cultured with N2B27 medium. As shown in the 
experiment, the majority of astrocytes induced by FGF2 and FBS in hi-spot culture didn’t express 
astrocyte marker after 3 weeks’ culture in serum free N2B27 medium. Evidence suggest the 
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neurotoxicity of IL-1β is mediated by releasing of free radicals from dying astrocytes (Thornton, 
Pinteaux et al. 2006). And although neurons and astrocyte both express IL-1 receptor, IL-1β 
activated different secondary signals when combined with receptors on neuron and astrocyte. 
Therefore, it is more likely that reduced survival of neurons in serum medium is an astrocyte 
mediated effect from IL-1β.      
In general, the hi-spot culture is an innovative model which simulate brain microenvironment in 
vitro. There are still room left to optimize the hi-spot culture. The local immune cells like microglia 
and macrophage of human origin will be introduced to the hi-spot culture in the future. The hi-
spot culture is based on human cells, so well-constructed hi-spot culture will include structure 
and complexity which is more relative for human disease modelling than monolayer culture. The 
hi-spot culture also provides us with an access to modulate the microenvironment and identify 
the therapeutic target for drug testing.  
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7. General Discussion 
 
7.1 Summary of Results 
This thesis has reported a 3D hi-spot culture model which is composed of human brain tissue coming 
from patients undergoing epilepsy surgery to recreate the pathological microenvironment of 
chronic epilepsy. With this model, it is possible to investigate the effects of epileptic 
microenvironment on human transplanted MGE-progenitors. In Chapter 3, the results revealed 
that the inflamed microenvironment of chronic epilepsy is detrimental for survival, neurite growth 
and differentiation of transplanted hESC-derived MGE progenitors in vitro. As IL-1β is abundant 
in sclerotic hippocampus we identified it as a potential target for improving the outcome of 
transplanted progenitors. In Chapter 4, applying IL-1β alone acutely reduced the survival of 
transplanted MGE progenitors and delayed their morphological maturation in non-inflamed 
hippocampal hi-spots. By blocking IL-1β activation of the ILR1 receptor, the detrimental effects 
of microenvironment on neurite growth and differentiation of MGE progenitors were partially 
reversed. These findings highlight the potential importance of an optimal microenvironment for 
achieving optimal outcomes from cell transplantation for chronic epilepsy and identify the IL-1β 
– IL1R1 pathway as an important component of the pathological microenvironment relevant to 
cell replacement therapy in human TLE.   
Next, in chapter 5, to investigate the effect of IL-1β on the functional profile of MGE progenitors, 
patch clamp recordings were performed on MGE-like neurons which have acquired mature 
electrophysiological activities when cultured with human hippocampal astrocytes in 
physiologically and developmentally relevant media. This experiment revealed that IL-1β acutely 
reduces the excitability of MGE-like neurons by modulating voltage gated Na+ channels (VGSCs), 
and this effect was reversed by IL-1RA. Chronic application experiments showed that the cellular 
excitability of MGE-like neurons can recover when the pathological level of IL-1β returns to 
baseline over 24-72 hours. However, when IL-1β was repetitively applied for a week, MGE-like 
neurons became unhealthy and their excitability was reduced even more. The results provide 
evidence that an inflamed microenvironment can reduce the excitability off MGE-like neurons. It 
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also indicates a potentially novel mechanism of interneuron dysfunction in the inflamed 
microenvironment of epilepsy.   
Finally, the last chapter established a new 3D culture model which is composed of hESC-derived 
human neurons and astrocytes to simulate the microenvironment of human brain. In line with 
previous results, the study shows IL-1β in serum-based medium caused a reduction in the 
survival of hESC-derived MGE progenitors and astrocytes. This model can be refined and 
extended in the future by introducing microglia, epithelial cells and other immune cells, so it will 
be possible to simulate and modify the microenvironment of human brain in vitro to recognize 
elements which affect neuron survival, differentiation and functionality.   
 
7.2 Implications for optimising the microenvironment in neuron 
transplantation. 
Cell replacement therapy for treating neurological and neurodegenerative disorders has been 
investigated for decades. Linage specified hESCs and ihPSCs show great potential for treating PD, 
HD and epilepsy. The potential application can also extend to Alzheimer's, stroke and psychiatric 
disorders in which loss or dysfunction of certain type of neurons are implicated. However, in some 
neurodegenerative disease, such as epilepsy, PD and Alzheimer's Disease, the microenvironment 
may completely change due to pathological activity which causes activation of the innate and 
adaptive immune systems (Vezzani, French et al. 2011, Kokaia, Martino et al. 2012, Meraz-Rios, 
Toral-Rios et al. 2013, Stojkovska, Wagner et al. 2015). Accumulated inflammatory cytokines are 
released from local microglia, and monocytes and immune cells recruited from blood stream 
(Allan, Tyrrell et al. 2005, Aktas, Ullrich et al. 2007, Vezzani, French et al. 2011). Even neurons and 
astrocytes participate in secreting inflammatory cytokines(Watt and Hobbs 2000, Vezzani, 
Moneta et al. 2002). In line with many reports demonstrating that inflammatory cytokines cause 
neuronal injury and degeneration (Toulmond, Parnet et al. 1996, Monje, Toda et al. 2003, Allan, 
Tyrrell et al. 2005, Aktas, Ullrich et al. 2007, Vezzani and Baram 2007, Hewett, Jackman et al. 2012), 
my results show for the first time that the inflammatory microenvironment is detrimental for 
exogenous transplanted MGE progenitors as well. Therefore, it is possible that the benefits 
coming from neuron transplantation will be attenuated in an acutely or chronically inflamed 
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microenvironment. By applying IL-1RA, the detrimental effects of IL-1β on transplanted MGE 
progenitors is partially blocked in inflamed microenvironment of TLE. These results support the 
hypothesis that optimising the microenvironment can potentially improve the outcome from 
neuronal transplantation. 
Although human hi-spots have provided an opportunity to investigate the pathological 
microenvironment in vitro, the disadvantage of the model can't be ignored. Firstly, the availability 
of human brain tissue is always limited. Secondly, in sclerotic hippocampus, there are other 
inflammatory cytokines which are detrimental to transplanted cells. And it is difficult to control 
the inflammatory milieu in primary human Hi-Spots. To further understand the mechanism of 
how inflammatory cytokines work, the hESC-derived hi-spots will be a useful tool which can 
control the complexity of the model, provide consistent and controllable inflammatory 
microenvironment to study interactions between inflammatory cytokines in the future. 
 
7.3 Implications for effect of IL-1β in inflamed microenvironment 
Despite intense research efforts, the mechanisms of IL-1β in regulating neuron survival, 
maturation and functionality are not clearly defined. There are conflicting results between in 
vitro and in vivo findings. For example, some in vitro experiments show that IL-1β has protective 
effects for decreasing neuron death (Strijbos and Rothwell 1995, Diem, Hobom et al. 2003, 
Hewett, Jackman et al. 2012). But clinical data and rodent models of epilepsy favour the idea that 
pathological level of IL-1β increase neuron degeneration which further promote the occurrence 
of seizures (Vezzani, Conti et al. 1999, Vezzani, Moneta et al. 2000, Aronica and Crino 2011). 
Temporal factors are important , as when IL-1β is applied before injury, a predominant increase 
in neuron damage is observed in both in-vivo and in-vitro studies (Vezzani, Conti et al. 1999, 
Fogal, Hewett et al. 2005). One of the reasons for the contradictory results is that IL-1 seems to 
exert complex effects by interacting with, and being influenced by, multiple cell types in the brain 
(Allan, Tyrrell et al. 2005).  
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7.3.1 Cell survival 
When IL-1β was applied to non-inflamed hippocampal hi-spots and hESC-derived hi-spots 
cultured in serum-based medium the survival of MGE progenitors was reduced. However, when 
the IL-1β/ IL1-R1 pathway was blocked in epileptic hippocampal Hi-Spot tissue, the survival of 
transplanted MGE progenitors didn't improve. In non-inflamed cortical hi-spots and hESC-
derived hi-spots cultured in N2B27 medium, addition of IL-1β hasn't affected cell survival at all. 
These apparently conflicting results imply that IL-1β may not directly cause the death of MGE 
progenitors but does so by interacting directly and indirectly with an inflammatory milieu and 
other facilitating cells such as astrocytes and microglia, which also release pro and anti-
inflammatory cytokines. Evidence shows the effect of IL-1β is amplified by recruiting and 
activating local microglia, astrocytes and immune cells from blood stream (Basu, Krady et al. 2002, 
Tichauer, Saud et al. 2007). It is important to remember that in epileptic hippocampal hi-spots, 
immune cells and microglia have been recruited and the inflammatory cytokines have been 
accumulated before generation of the hi-Spot. Therefore, other signaling pathways which cause 
cell death have been already activated before giving IL-1RA. On the contrary, in non-inflamed 
hi-spots, only inactivated local immune cells exist, so adding IL-1β merely evokes immune 
response locally and is not strong enough to cause similar detrimental effect as the inflammatory 
cytokines in epileptic hi-spots do. Although microglia are present in all major divisions of the 
brain, the distribution of microglia is much denser in hippocampus compared to cortex (Lawson, 
Perry et al. 1990) and therefore the immune responses are milder in cortex than hippocampus. 
That may explain why there is no significant death of MGE progenitors in cortical hi-spots treated 
with IL-1β. Similar to my result, a in vivo study shows injection of IL-1β (20ng) into normal cortex 
fails to cause any brain damage (Stroemer and Rothwell 1998).  
Although microglia haven't been included in hESC-derived hi-spots, hESC-derived astrocytes 
comprise 90% of the cell population in these hi-spots. A wide variety of cytokines, chemokines, 
and growth factors are secreted by astrocytes in response to IL-1β (Meeuwsen, Persoon-Deen 
et al. 2003). There is also research showing that the neurotoxicity of IL-1β is mediated by the 
release of free radicals from dying astrocytes (Thornton, Pinteaux et al. 2006). Consistent with this 
discovery, I found a significant decrease in the number of surviving GFAP+ astrocytes along with 
a reduction in MGE progenitors in IL-1β treated hi-spots cultured in serum rich media but not 
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hi-spots cultured in N2B27 media in which GFAP+ astrocytic cells are not preserved. Similarly, 
when IL-1β has been repetitive applied to MGE-like neurons and astrocytes co-culture, in a 
manner that maintains an elevated level, there was significant death of astrocytes with an 
associated reduction in the viability of MGE-like neurons. Together, these results further support 
the hypothesis that IL-1β indirectly causes death of MGE progenitors through an astrocytic 
mediated pathway. An alternative but not necessarily exclusive hypothesis is that IL-1β 
cooperates with other cytokines and damage signals, because IL-1β by itself is not neurotoxic in 
some cell cultures (Fogal, Hewett et al. 2005). For example, HMGB1 which is secreted at the later 
stage after brain injury could enhance the effect of IL-1β through formation of complexes with 
IL-1β (Wähämaa, Schierbeck et al. 2011).  Moreover, combined treatment with TNFα, IL-1β, and 
IFNγ in astrocytes results in distinct upregulation of several genes for cytokines and growth 
factors which can't be induced by applying IL-1β alone (Meeuwsen, Persoon-Deen et al. 2003). 
Therefore, in healthy microenvironment where other cytokines are absent, the effect of IL-1β may 
be limited.  
 
7.3.2Morphological maturation 
Although IL-1R is expressed on the MGE-like neurons (Chapter 5), so far, there is a lack of 
evidence that IL-1β directly regulates neurite growth. Like its effect on cell survival, IL-1β 
indirectly regulates neurite growth through activation microglia and astrocytes. Once activated, 
microglia can promote neuronal injury through the release of low-molecular-weight neurotoxins 
which compromise neurite growth (Bruce-Keller 1999). In the human hi-spot culture, the results 
show impaired neurite growth of MGE progenitors mediated by IL-1β, and this effect can be 
partially reversed by applying IL-1RA. Similar to my observation, IL-1β reduces neurite growth of 
rat hippocampal precursor cells when being applied for 7 days (Green, Treacy et al. 2012). And 
in KA model of epilepsy, the morphological complexity of PV and CCK expressing interneurons 
was significantly reduced (Khan, Shekh-Ahmad et al. 2018). However, in addition to IL-1β, TNF-
α is also upregulated in chronic epilepsy, and can directly inhibit neurite formation by 
activating GTPase RhoA (Neumann, Schweigreiter et al. 2002). This additional signalling may 
explain why IL-1RA can't completely reverse the detrimental effect of the inflamed 
microenvironment on neurite growth. 
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Paradoxically, in MGE-like neuron and astrocyte co-culture, short time exposure to IL-1β slightly 
increased the morphological complexity of MGE-like neurons. In this scenario, it is likely that IL-
1β stimulates the release of neurotropic factors ,such as NGF, IGF and BDNF from astrocytes 
(Fogal, Hewett et al. 2005), which promoted neurite growth (Parish, Finkelstein et al. 2002, Boato, 
Hechler et al. 2011, Gougeon, Lourenssen et al. 2013),  
The conflicting results in my studies are likely due to the difference in duration of IL-1β treatment 
and the presence or absence of a pre-inflamed milieu and the tissue cultured in addition to the 
culture method. In epileptic hippocampal hi-spot, the pathological microenvironment was more 
faithfully maintained and in the non-epileptic hippocampal hi-spot culture experiments, IL-1β 
was given repetitively for 4 weeks. While in neuron-astrocyte’s co-culture, IL-1β was just given 
twice for a week, and not so intensively as in the hi-spot cultures. Studies which suggest that IL-
1β increases neurite growth mainly use cell culture paradigms with short time exposure to IL-1β 
(Strijbos and Rothwell 1995, Boato, Hechler et al. 2011).  
As most interneurons function locally by providing input to a large group of surrounding 
excitatory neurons to coordinate network activities, reduced neurite growth of MGE progenitors 
will affect their innervation territory when these cells become functional interneurons.   
 
7.3.3 Neuronal differentiation 
There are two possible reasons for the reduced number of mature neurons (Tuj1+ and GAD 67+ 
cells) in sclerotic hippocampal hi-spots, one is altered neuronal differentiation; the other is 
delayed neuronal differentiation in inflamed microenvironment. Some researches support the 
idea that pro-inflammatory cytokines, such as IL-1β and TNF-α, promotes astroglial 
differentiation instead of neuronal differentiation(Peng, Whitney et al. 2008, Green, Treacy et al. 
2012). While there is also evidence to support the later assumption. BDNF is an environmental 
neurotrophic factor that promotes neuronal differentiation and improves neuron survival(Jiao, 
Palmgren et al. 2014). IL-1β has been reported to suppress BDNF signal via activating P38-MAPK 
pathway (Tong, Balazs et al. 2008, Tong, Prieto et al. 2012). It is possible that IL-1β prolongs 
neuronal differentiation of MGE progenitors in the inflamed microenvironment by interfering with 
the BDNF neurotrophic signal. This hypothesis needs to be investigated in the future.   
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On the contrary, when IL-1β was applied to non-epileptic cortical and hippocampal hi-spots, it 
didn't reduce the proportion of Tuj1 expressing neurons. It is possible that alternations in neuron 
differentiation requires long lasting / chronic stimulation by IL-1β. In previous research, IL-1β 
shows anti-neurogenic effects on hippocampal neuron precursors when being repetitively 
applied for 7 days not for 2 days (Green, Treacy et al. 2012). In sclerotic hippocampal hi-spots, 
upregulation of IL-1β was long lasting. While in non-epileptic hi-spots, IL-1β was applied every 
three days. When exogenous IL-1β is rapidly metabolized resulting in lower average or poorly 
sustained concentrations (Chapter 5), its anti-neurogenic effect may thus be attenuated. 
 
7.3.4 Electrophysiological functionality 
In addition to the effects of IL-1β on survival and maturation of MGE progenitors, my work also 
provided evidence for a direct modulatory effect of IL-1β on the cellular excitability of MGE-like 
neurons. Many previous studies support the idea that pro-epileptogenic effects of IL-1β is 
mediated by hyperexcitability and excitotoxicity in hippocampal principle neurons. (Vezzani, 
Moneta et al. 2002, Viviani, Bartesaghi et al. 2003, Vezzani and Viviani 2015). In a complimentary 
fashion, my research suggests that IL-1β can reduce cellular excitability in MGE-like interneurons. 
However, except for the difference in the types of neuron used for the experiments, the IL-1β 
concentration which increase cell excitability is quite low compared to that used in my research. 
In previous studies, IL-1β increases neuronal excitability of hippocampal neurons through 
phosphorylation of Src which increases NMDA-R function and Ca2+ influx (Viviani, Bartesaghi et 
al. 2003, Yang, Liu et al. 2005). However, a very low concentration of IL-1β (0.01ng/ml), 1000-
fold lower than that used to stimulate inflammatory responses, was used. And evidence shows 
Src phosphorylation can only be observed at low concentrations of IL-1β (0.01ng/ml) but not in 
any higher concentration in hippocampal neurons (Huang, Smith et al. 2011). This may be one 
of the reasons that IL-1β shows different modulatory effects on cellular excitability in my research 
and I did not examine excitability at these very low levels.  
In contrast to my result, increased GABAergic inhibition has been shown to be mediated by IL-
1β in chronic inflammation. In that study, LPS was given to organotypic brain slices to simulate 
the release of IL-1β and the recording was taken at day 7 when the concentration of IL-1β 
returned to baseline (Hellstrom, Danik et al. 2005),  whilst in my studies, the acute effect of IL-1β 
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on cellular excitability was abolished when IL-1β returned to baseline. Besides, apart from 
presynaptic GABAergic interneuron excitability, postsynaptic GABA receptor responsiveness can 
affect inhibitory post synaptic potential (IPSP) as well. The contradictory results may be partly due 
to the concentrations and duration for the treatment, the type of culture models and the method 
for investigation. In agreement with my results, IL-1β caused a 40% reduction of voltage-gated 
sodium current and 10mV reduction in amplitude of action potential in rat cortical neurons and 
80% reduction of sodium current in retinal ganglion cells (Diem, Hobom et al. 2003, Zhou, Qi et 
al. 2011). In contrast, IL-1β didn't change sodium currents in rat hippocampal neurons and even 
led to 67% increase of sodium current in trigeminal nociceptive neurons (Liu, Yang et al. 2006).  
Sodium currents are regulated by phosphorylation sites in segments of pore forming α unit and 
auxiliary β units. Those phosphorylation sites are regulated by either protein kinase A (PKA) or 
protein kinase C (PKC) in different type of neurons (Marban, Yamagishi et al. 1998, Scheuer and 
Catterall 2006, Scheuer 2011). A single site phosphorylation is sufficient to cause reduction in 
amplitude of sodium currents without affecting activation and inactivation kinetics of sodium 
channels (Smith and Goldin 1997). In rat striatal neurons, activation of PKA raises the threshold 
for firing and is associated with a 35% reduction in sodium currents. Likewise, activation of PKC 
also reduces sodium currents in cholinergic interneurons (Maurice, Mercer et al. 2004), 
hippocampal neurons (Numann, Catterall et al. 1991) and other brain neurons  (Numann, 
Catterall et al. 1991). There are also several reports suggesting that IL-1β can regulate 
phosphorylation of different ion channel. In mouse heart cells, IL-1β increases PKC translocation 
and leads to reduction of calcium current (El Khoury, Mathieu et al. 2014). In rat cortical neurons, 
activation of PKC by IL-1β caused 37% inhibition of sodium currents (Zhou, Qi et al. 2011). 
Therefore, it is highly likely that IL-1β regulates sodium currents of MGE-like neurons through 
activation of phosphorylation protein. Further investigations are required to determine whether 
IL-1β reduces sodium currents in MGE-like neurons by regulating phosphorylation proteins. 
 In an attempt to explore the mechanism of reduced sodium current in IL-1β treated MGE-like 
neuron, I used non-stationary fluctuation analysis (NSFA) (Alvarez, Gonzalez et al. 2002) to 
investigate whether the number of sodium channels or channel conductance was altered by IL-
1β treatment. Although the result showed significant reduction in channel conductance in IL-1β 
treated compared to control, it may not be enough to draw a conclusion. One deficit of acquired 
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data is that the variation within groups of recorded cells are huge, possibly due to the variety of 
interneuron phenotypes and their different maturation kinetics (Kepecs and Fishell 2014). 
Secondly, the single sodium current calculated from NSFA represents a macroscopic current 
which is the sum of currents from several sodium channels rather than the unitary sodium current 
(Lingle 2006, Nekouzadeh and Rudy 2007). Therefore, the data of a single sodium current in 
average from my experiment is significantly larger than previous reports which use excised 
recording (Wartenberg and Urban 2004, Vanoye, Lossin et al. 2006, Chatelier, Zhao et al. 2010). 
In addition, in my experiment, the number of recording sweeps may not sufficient to accurately 
predict the variance. Based on computer simulation, the variance will be more precisely recorded 
when increase the number of recording sweeps (Lingle 2006). However, in my experiment, the 
hESC-derived neurons were too fragile to endure repetitive simulation for extended recording 
time. So, the error of the data can affect the accuracy of the calculation for the number of 
channels and the single channel current. Further experiments using excised patch clamp 
recording will help to confirmed whether the conductance of sodium channel is affected by IL-
1β.  
 
7.4 Implications for reduced excitability of interneurons in the inflamed 
microenvironment of epilepsy. 
Simplistically, the direct cause of seizures is an imbalance between excitatory and inhibitory 
activities in neuronal circuits. Genetic mutations which compromise important inhibitory signals 
would be expected to alter the balance of brain activity. For example, mutation in SCN1A, which 
reduces excitability of inhibitory interneurons, underlies Dravet syndrome, a serious epileptic 
encephalopathy that begins in childhood (Lossin, Rhodes et al. 2003, Vanoye, Lossin et al. 2006, 
Yu, Mantegazza et al. 2006, Tai, Abe et al. 2014). In TLE, interneuron loss is the major reason for 
compromised inhibitory output. Apart from that, recent research intriguingly shows impairment 
of cellular excitability in PV expressing inhibitory interneurons in the KA induced rat model of 
epilepsy (Khan, Shekh-Ahmad et al. 2018) in which the innate immune system is potently 
activated (Sabilallah, Fontanaud et al. 2016). Moreover, increasing the excitability of interneurons 
by activating Nav1.1 shows anti - convulsive effect (Frederiksen, Lu et al. 2017). Nav1.1 
overexpressing, but not wild-type, MGE progenitors enhance behavior-dependent gamma 
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oscillatory activity, reduce epileptiform discharges and improve cognitive functions in human 
amyloid precursor protein (hAPP)-transgenic mice (Martinez-Losa, Tracy et al. 2018). Therefore, 
my finding of an inflammatory mediated reduced excitability of MGE-like interneurons induced 
by IL-1β is consistent with findings in previous transplantation models and also raises the 
possibility that IL-1β in inflamed hippocampus may reduce the excitability of endogenous 
inhibitory neurons. However, hESC-derived MGE-like neurons can't reach the same maturation 
state of post-natal inhibitory interneurons in vitro. Moreover, evidence suggests that the 
dominant isotypes of sodium channel expressed at pre-natal stage are different from the major 
isotypes expressed at the post-natal / adult stage in mice. Therefore, it is critical to figure out the 
isotype of sodium channels expressed at different developmental stages of human neurons and 
to see if they are altered to a developmental phenotype in epilepsy. In addition, interneurons are 
diverse in terms of their morphology, genetic markers and functionality. So, whether IL-1β 
broadly affects all types or certain types of interneuron need to be further investigated in animal 
models. Another important consideration is the effect of other inflammatory cytokines, such as 
TNF-α, which can affect cell excitability as well (Vezzani and Viviani 2015). Therefore, further 
experiments are required to investigate the cellular excitability of inhibitory neurons in a complex 
microenvironment.  
However, in neuron-astrocyte’s coculture, when IL-1β was applied every three days to the cells 
for a week, the excitability of MGE progenitors recorded by the end of the week didn’t change 
compared to the control. It is possibly because IL-1β was completely metabolised after 72 hours 
in the culture medium (Chapter 5). Interestingly, also in that condition, there was significant 
increase in the number of PI+ and PI+ Annexin+ cells compared to the control. Nevertheless, 
PI+GFP+ MGE-like neurons were rarely found and didn’t increase compared to the control. It 
suggested IL-1β caused death of astrocytes but not co-cultured MGE-like neurons. Therefore, it 
may be controversial that reduced excitability of MGE-like neurons in response to pathological 
level of IL-1β is beneficial for their survival and potential recovery when IL-1β is metabolized 
(Diem, Hobom et al. 2003). However, if pathological level of IL-1β lasts, like the condition when 
the cells were repetitively treated by IL-1β, the excitability of MGE-like neurons has reduced even 
more along with increased cell death. Together, these results indicate the utility of modulating 
the inflamed epileptic microenvironment to potentially promote recovery of interneurons.  
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7.5 Limitations and future work 
Firstly, it is hard to guarantee the inflamed microenvironment will be the same among the 
sclerotic hippocampal tissue from different patients. In the future, it is necessary to investigate 
the relation of cell survival with the severity of hippocampal inflammation by plotting cell survival 
against the level and duration of IL-1β in sclerotic hippocampal hi-spots. It will give us a better 
indication about the timing and duration for anti-inflammatory treatment. Secondly, it is 
important to include other key inflammatory cytokines, such as TNF-α, HMGB1 into the hi-spot 
experiment to investigate cooperation between the cytokines. Thirdly, it is critical to understand 
the mechanism of how IL-1β affects the cellular excitability of MGE-like neurons. Whether similar 
phenomena can be observed in mature interneurons is also an exciting avenue for further 
research. In general, my research has found that a non/less-inflamed microenvironment is critical 
to maintain survival, normal growth, differentiation and electrophysiological activities of 
exogenous transplanted MGE progenitors. More research is needed to fully understand the 
mechanism of how IL-1β affects neuron survival and their functionality. hESC-derived hi-spot 
can be used in the future to explore possible mechanism.  
The clinical implications are that we need to consider the inflammatory environment and its 
possible modulation in order to maximize the survival and optimal differentiation and network 
integration of interneurons in future cell replacement therapy research.   
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8. Appendix  
Figure 3-5 C 
     
      
ANOVA table SS (Type III) DF MS F (DFn, DFd) P value 
Interaction 4693 1 4693 
F (1, 70) = 
1.019 P=0.3161 
Row Factor 197419 1 197419 
F (1, 70) = 
42.88 P<0.0001 
Column Factor 54240 1 54240 
F (1, 70) = 
11.78 P=0.0010 
Residual 322252 70 4604   
      
Figure 3-5 D 
     
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 27470 2 13735 
F (2, 66) = 
4.892 P=0.0104 
Row Factor 4675066 2 2337533 
F (2, 66) = 
832.5 P<0.0001 
Column Factor 118922 1 118922 
F (1, 66) = 
42.35 P<0.0001 
Residual 185320 66 2808   
      
Sidak's multiple comparisons 
test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
      
Cortical - Hippocampal      
D1 28.03 -24.96 to 81.03 No ns 0.4871 
D7 120.7 67.67 to 173.7 Yes **** <0.0001 
D14 95.15 42.15 to 148.1 Yes *** 0.0001 
      
      
Figure 3-6 I 
     
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 0.01575 1 0.01575 
F (1, 44) = 
0.9047 P=0.3467 
Row Factor 0.3089 1 0.3089 
F (1, 44) = 
17.74 P=0.0001 
Column Factor 0.9487 1 0.9487 
F (1, 44) = 
54.49 P<0.0001 
Residual 0.7661 44 0.01741   
      
Sidak's multiple comparisons 
test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
      
Cortical - Hippocampal      
D 14 0.1242 
-0.0005203 to 
0.2489 No ns 0.0511 
D 28 0.1967 
0.07194 to 
0.3214 Yes ** 0.0014 
      
      
Figure 4-1 D 
     
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 0.02521 1 0.02521 
F (1, 44) = 
1.608 P=0.2114 
Row Factor 0.273 1 0.273 
F (1, 44) = 
17.42 P=0.0001 
Column Factor 0.12 1 0.12 
F (1, 44) = 
7.655 P=0.0082 
Residual 0.6897 44 0.01568   
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Sidak's multiple comparisons 
test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
      
IL-1RA- - IL-1RA+      
Cortical -0.05417 
-0.1725 to 
0.06418 No ns 0.5031 
Hippocampal -0.1458 
-0.2642 to -
0.02749 Yes * 0.0131 
      
      
 Figure 4-1E 
     
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 0.1151 1 0.1151 
F (1, 44) = 
12.31 P=0.0011 
Row Factor 0.1485 1 0.1485 
F (1, 44) = 
15.89 P=0.0002 
Column Factor 0.0475 1 0.0475 
F (1, 44) = 
5.081 P=0.0292 
Residual 0.4113 44 0.009348   
      
Sidak's multiple comparisons 
test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
      
IL-1RA- - IL-1RA+      
Cortical 0.035 
-0.05639 to 
0.1264 No ns 0.6157 
Hippocampal -0.1608 
-0.2522 to -
0.06944 Yes *** 0.0004 
      
      
Figure 4-2B 
     
ANOVA table SS (Type III) DF MS F (DFn, DFd) P value 
Interaction 4648 1 4648 
F (1, 39) = 
3.185 P=0.0821 
Row Factor 21991 1 21991 
F (1, 39) = 
15.07 P=0.0004 
Column Factor 5749 1 5749 
F (1, 39) = 
3.94 P=0.0542 
Residual 56903 39 1459   
      
Sidak's multiple comparisons 
test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
      
IL-1- - IL-1+      
Cortical 2.366 -38.18 to 42.92 No ns 0.9885 
Hippocampal 44.53 7.45 to 81.62 Yes * 0.016 
      
      
      
Figure 6-7 C 
     
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 424.7 1 424.7 
F (1, 28) = 
1.956 P=0.1730 
Row Factor 3691 1 3691 F (1, 28) = 17 P=0.0003 
Column Factor 1328 1 1328 
F (1, 28) = 
6.117 P=0.0197 
Residual 6081 28 217.2   
      
Sidak's multiple comparisons 
test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
      
IL-1β- - IL-1β+      
Serum 20.17 2.763 to 37.58 Yes * 0.0211 
N2B27 5.6 -11.81 to 23.01 No ns 0.7015 
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Figure 6-7 D 
     
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 304141730 1 304141730 
F (1, 28) = 
8.139 P=0.0081 
Row Factor 603947636 1 603947636 
F (1, 28) = 
16.16 P=0.0004 
Column Factor 46346229 1 46346229 
F (1, 28) = 
1.24 P=0.2749 
Residual 1046351605 28 37369700   
      
Sidak's multiple comparisons 
test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
      
IL-1β- - IL-1β+      
Serum 8573 1351 to 15795 Yes * 0.018 
N2B27 -3759 -10981 to 3463 No ns 0.4056 
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Figure 3-6 E
Measure: MEASURE_1
Type III Sum of Squares df Mean Square F Sig. Partial Eta Squared
patient Linear 20.000 1 20.000 .003 .956 .000
patient * Group Linear 20.000 1 20.000 .003 .956 .000
Error(factor1) Linear 50385.000 8 6298.125
F df1 df2 Sig.
Patient1 .404 1 8 .543
Patient2 .637 1 8 .448
Measure: MEASURE_1
Transformed Variable: Average
Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Intercept 1474245.000 1 1474245.000 202.385 .000 .962
Group 59405.000 1 59405.000 8.155 .021 .505
Error 58275.000 8 7284.375
Figure 3-6 G
Measure: MEASURE_1
Type III Sum of Squares df Mean Square F Sig. Partial Eta Squared
Patient Linear 9919.904 1 9919.904 .735 .416 .084
Patient * Group Linear 14889.261 1 14889.261 1.103 .324 .121
Error(factor1) Linear 108021.703 8 13502.713
F df1 df2 Sig.
Patient1 1.127 1 8 .319
Patient2 1.310 1 8 .285
Measure: MEASURE_1
Transformed Variable: Average
Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Intercept 1901159.701 1 1901159.701 321.930 .000 .976
Group 168268.595 1 168268.595 28.493 .001 .781
Error 47244.079 8 5905.510
Figure 3-6 H
Measure: MEASURE_1
Type III Sum of Squares df Mean Square F Sig. Partial Eta Squared
Patient Linear 1385.463 1 1385.463 .462 .516 .055
Patient * Group Linear 445.389 1 445.389 .149 .710 .018
Error(factor1) Linear 23991.450 8 2998.931
F df1 df2 Sig.
Patient1 4.067 1 8 .078
Patient2 1.663 1 8 .233
Measure: MEASURE_1
Transformed Variable: Average
Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Intercept 580606.993 1 580606.993 179.623 .000 .957
Group 49046.688 1 49046.688 15.174 .005 .655
Error 25858.853 8 3232.357
Tests of Within-Subjects Contrasts
Source
Tests of Between-Subjects Effects
Source
a. Design: Intercept + Group 
 Within Subjects Design: factor1
Tests of Between-Subjects Effects
Source
Levene's Test of Equality of Error Variancesa
Tests the null hypothesis that the error variance of the dependent variable is equal across groups.
a. Design: Intercept + Group 
 Within Subjects Design: factor1
Tests of Within-Subjects Contrasts
Source
Levene's Test of Equality of Error Variancesa
Tests the null hypothesis that the error variance of the dependent variable is equal across groups.
Tests of Between-Subjects Effects
Source
Tests of Within-Subjects Contrasts
Source
Levene's Test of Equality of Error Variancesa
Tests the null hypothesis that the error variance of the dependent variable is equal across groups.
a. Design: Intercept + Group 
 Within Subjects Design: factor1
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Figure 4-1 G
Measure: MEASURE_1
Type III Sum of Squares df Mean Square F Sig. Partial Eta Squared
Patient Linear 13781.250 1 13781.250 3.916 .083 .329
Patient * Treatment Linear 3001.250 1 3001.250 .853 .383 .096
Error(factor1) Linear 28155.000 8 3519.375
F df1 df2 Sig.
Patient1 7.096 1 8 .029
Patient2 .474 1 8 .510
Measure: MEASURE_1
Transformed Variable: Average
Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Intercept 712531.250 1 712531.250 269.197 .000 .971
Treatment 19531.250 1 19531.250 7.379 .026 .480
Error 21175.000 8 2646.875
Figure 4-1 J
Measure: MEASURE_1
Type III Sum of Squares df Mean Square F Sig. Partial Eta Squared
factor1 Linear 111.656 1 111.656 .099 .761 .012
factor1 * Treatment Linear 4746.219 1 4746.219 4.228 .074 .346
Error(factor1) Linear 8979.891 8 1122.486
F df1 df2 Sig.
Patient1 .373 1 8 .558
Patient2 .572 1 8 .471
Measure: MEASURE_1
Transformed Variable: Average
Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Intercept 406091.371 1 406091.371 291.025 .000 .973
Treatment 9359.042 1 9359.042 6.707 .032 .456
Error 11163.062 8 1395.383
Tests of Between-Subjects Effects
Source
Tests of Within-Subjects Contrasts
Source
Levene's Test of Equality of Error Variancesa
Tests the null hypothesis that the error variance of the dependent variable is equal across groups.
a. Design: Intercept + Treatment 
 Within Subjects Design: factor1
Tests of Between-Subjects Effects
Source
Tests of Within-Subjects Contrasts
Source
Levene's Test of Equality of Error Variancesa
Tests the null hypothesis that the error variance of the dependent variable is equal across groups.
a. Design: Intercept + Treatment 
 Within Subjects Design: factor1
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